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SUMMARY 
Summary 
Prenyl transfer reactions occur ubiquitously in nature and play an important role in primary and 
secondary metabolism in all domains of life. Prenylated secondary metabolites including indole 
alkaloids usually demonstrate improved biological and pharmacological activities and thus 
makes them to promising candidates for drug discovery and development. Important producers 
of such bioactive compounds are fungi of ascomycetes and bacteria of actinomycetes. The 
transfer reactions of a prenyl moiety  from prenyl diphosphate, primarily dimethylallyl 
diphosphate (DMAPP), onto indole derivatives including tryptophan are mainly catalyzed in 
nature by the members of the dimethylallyltryptophan synthase (DMATS) superfamily. In the 
last years, remarkable progress has been achieved in their biochemical, molecular biological, 
and structural characterization, especially for DMATS enzymes from fungi.  
The major challenge of this thesis is to provide a better understanding of the catalytic features 
of these enzymes from different origins. Several putative genes for new tryptophan 
prenyltransferases were identified in diverse actinomycetes via blast search by using two known 
Streptomyces prenyltransferases (SCO7467 and IptA). Cloning and expression of these genes 
as well as the subsequent biochemical investigations of the three novel tryptophan 
prenyltransferases provided several new intriguing features. Initially, two tryptophan C6-
prenyltransferases were identified, i.e. 6-DMATSSa from Streptomyces ambofaciens and 6-
DMATSSv from Streptomyces violaceusniger. Biochemical investigation on these enzymes 
revealed a remarkable broad substrate specificity. In addition to a number of indole derivatives 
also several hydroxynaphthalenes were accepted by 6-DMATSSa and 6-DMATSSv. 
Interestingly, they catalyze the prenylation at the unsubstituted benzene rings of the tested 
hydroxynaphthalenes. Moreover, they represent the first examples of tryptophan 
prenyltransferases that accept both DMAPP and geranyl diphosphate (GPP) as prenyl donors 
and catalyze the same prenylation positions.  
Consequently, the studied 6-DMATSs were used for further investigations on the acceptance 
of unnatural alkyl or benzyl donors. Prior to this study, investigations on this issue are limited 
to fungal C4- and C5- prenyltransferases. The L-tyrosine prenyltransferase TyrPT with a 
tryptophan C7-prenyltransferase activity, the two mentioned 6-DMATSs as well as the bacterial 
5-DMATSSc (SCO7467) were included in this project. In total, five C5-, C6- and C7-
prenytransferases (5-DMATS, 5-DMATSSc, 6-DMATSSa, 6-DMATSSv, TyrPT) were 
investigated in the presence of the DMAPP analogs methylallyl (MAPP), 2-pentenyl (2-
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pentenyl-PP) and benzyl diphosphate (benzyl-PP). The unnatural donors were accepted by all 
tested enzymes with different relative activities and regioselectivities. C6-alkylated or 
benzylated derivatives were identified in all the reactions, as unique product of the two 6-
DMATSs or as one of the main products of the other enzymes. These results demonstrated a 
clear preference of the five enzymes for alkylation/benzylation at C-6 of the indole ring in the 
presence of the unnatural DMAPP derivatives. Furthermore, homology modeling of the 5-
DMATS and subsequent docking as well as molecular dynamics studies with DMAPP, MAPP 
and 2-pentenyl-PP, led to a distance-based explanation of the observed reaction results.  
Later on, a third tryptophan C6-prenyltransferase 6-DMATSMo from Micromonospora 
olivasterospora was identified and characterized. Similar to the previously characterized 6-
DMATSs, 6-DMATSMo uses indole derivatives, cyclic dipeptides and naphthalenes as prenyl 
acceptors and DMAPP as well as GPP as prenyl donors. The most notable feature of 6-
DMATSMo is the high relative activity toward D-tryptophan. This result led to the comparative 
study on enantioselectivity of the seven DMATS enzymes from fungi and bacteria. The tested 
prenyltransferases displayed different substrate preferences as well as different 
regioselectivities toward the L- and D-enantiomers of tryptophan and their methylated 
derivatives. Interestingly, the bacterial 5-DMATSSc and 6-DMATSMo highly preferred the D-
enantiomer of 5-methyltryptophan to the L-enantiomer, although that was the better substrate 
in all other reactions. In the presence of the racemate, the D-enantiomer reaction was strongly 
inhibited, which could be explained by the high affinity to the respective L-form as the main 
reason. Another interesting output of this project is the reduced or even completely changed 
regioselectivity for the reactions of FgaPT2, 5-DMATSSc, and 7-DMATS with the D-
enantiomers of tryptophan or 5-methyltryptophan. Moreover, the observed diprenylation by 5-
DMATSSc was the first report on a tryptophan prenyltransferase which catalyzes two successive 
prenylation steps.  
In conclusion, identification and characterization of the three new 6-DMATSs from 
actinomycetes expand our knowledge on bacterial tryptophan prenyltransferases. Furthermore, 
prenyltransferases including the three 6-DMATSs could serve as valuable biocatalysts in 
chemoenzymatic synthesis for alkylated compounds with potential biological activities. 
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Zusammenfassung 
Prenylierungsreaktionen sind in der Natur weit verbreitet und spielen eine wichtige Rolle in 
dem Primär- und Sekundärmetabolismus aller Lebensformen. Prenylierte Sekundärmetabolite 
einschließlich Indolalkaloide weisen häufig eine verstärkte biologische und pharmakologische 
Aktivität auf, wodurch sie vielversprechende Kandidaten für die Arzneistoff-Findung und 
Entwicklung darstellen. Wichtige Produzenten solcher bioaktiver Substanzen sind Pilze der 
Askomyzeten und Bakterien der Aktinomyzeten. Die Übertragung eines Prenylrestes von 
Prenyldiphosphat, meistens Dimethylallyldiphosphat (DMAPP), auf Indolderivate mitunter 
Tryptophan werden in der Natur durch Enzyme der Dimethylallyltryptophan-Synthase 
(DMATS)-Superfamilie katalysiert. Bemerkenswerte Fortschritte wurden in den letzten Jahren 
in der biochemischen, molekularbiologischen und strukturellen Charakterisierung dieser 
Enzyme, insbesondere solcher aus Pilzen, erzielt.  
Die größte Herausforderung dieser Arbeit besteht darin, ein besseres Verständnis über die 
katalytischen Eigenschaften dieser Enzyme unterschiedlicher Herkunft zu erlangen. Mittels 
einer „Blast“-Suche zweier bekannter Streptomyces-Prenyltransferasen (SCO7467 und IptA), 
wurden mehrere potenzielle Gene neuer Tryptophan-Prenyltransferasen in verschiedenen 
Aktinomyzeten identifiziert. Die Klonierung, Expression und die anschließenden 
biochemischen Untersuchungen drei neuer Tryptophan-Prenyltransferasen offenbarten neue, 
interessante Eigenschaften.  
Zunächst wurden mit 6-DMATSSa aus Streptomyces ambofaciens und 6-DMATSSv aus 
Streptomyces violaceusniger zwei Tryptophan-C6-Prenyltransferasen identifiziert. Die 
biochemischen Untersuchungen dieser Enzyme ergaben eine breite Substratspezifität. Neben 
einer Vielzahl an Indolderivaten wurden auch mehrere Hydroxynaphthaline von 6-DMATSSa 
und 6-DMATSSv akzeptiert. Interessanterweise katalysieren diese eine Prenylierung an nicht 
substituierten Benzolringen der getesteten Hydroxynaphthaline. Zudem handelt es sich um die 
erstmalige Beschreibung für Tryptophan-Prenyltransferasen, die sowohl DMAPP als auch GPP 
als Prenyldonor akzeptieren und die Prenylierung an derselben Position katalysieren. Folglich 
stellen die untersuchten 6-DMATS Enzyme interessante Kandidaten für weitere 
Untersuchungen bezüglich der Akzeptanz von unnatürlichen Alkyl- oder Benzyldonoren dar. 
Bisherige Studien zu diesem Thema beschränken sich auf die pilzlichen C4- und C5-
Prenyltransferasen. Im Rahmen dieses Projektes wurden daher die L-Tyrosin-Prenyltransferase 
TyrPT mit Tryptophan-C7-Prenyltransferase Aktivität, zwei 6-DMATS sowie die bakterielle 
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5-DMATSSc (SCO7467) analysiert. Hierzu wurde das Verhalten der C5-, C6- und C7-
Prenytransferasen (5-DMATS, 5-DMATSSc, 6-DMATSSa, 6-DMATSSv, TyrPT) in Gegenwart 
der unnatürlichen Prenyldonoren Methylallyl- (MAPP), 2-Pentenyl (2-Pentenyl-PP) oder 
Benzyldiphosphat (Benzyl-PP) untersucht. Diese DMAPP-Analoga wurden von allen 
getesteten Enzymen mit unterschiedlichen, relativen Aktivitäten und Regioselektivitäten 
akzeptiert. C6-alkylierte/benzylierte Derivate wurden in allen Reaktionen identifiziert, 
entweder als einzelnes Produkt der beiden 6-DMATS oder als eines der Hauptprodukte der 
anderen Enzyme. Diese Ergebnisse weisen auf eine deutliche Präferenz der fünf Enzyme für 
die Alkylierung/Benzylierung an C-6 des Indolrings in Gegenwart der unnatürlichen DMAPP-
Derivate hin. Des Weiteren führte das „homology modeling“ der 5-DMATS und anschließende 
„docking“- sowie „molecular dynamics“-Studien mit DMAPP, MAPP und 2-Pentenyl-PP zu 
einer distanzbasierten Erklärung für die beobachteten Reaktionsergebnisse.  
Später wurde mit 6-DMATSMo aus Micromonospora olivasterospora eine dritte Tryptophan-
C6-Prenyltransferase identifiziert und charakterisiert. Ähnlich wie die zuvor untersuchten 6-
DMATS-Enzyme, verwendet 6-DMATSMo Indolderivate, zyklische Dipeptide und Naphthaline 
als Prenylakzeptoren sowie DMAPP und GPP als Prenyldonoren. Das auffälligste Merkmal der 
6-DMATSMo ist die hohe relative Aktivität gegenüber D-Tryptophan. Dieses Resultat führte zu 
der vergleichenden Studie über die Enantioselektivität von sieben DMATS-Enzymen aus 
Pilzen und Bakterien. Für die verschiedenen Prenyltransferasen wurden unterschiedliche 
Substratpräferenzen sowie eine unterschiedliche Regioselektivität bezüglich der L- und D-
Enantiomere von Tryptophan und deren methylierten Derivaten festgestellt. Interessanterweise 
bevorzugten die bakteriellen 5-DMATSSc und 6-DMATSMo das D-Enantiomer von 5-
Methyltryptophan gegenüber dem L-Enantiomer, was in allen anderen Reaktionen das bessere 
Substrat darstellte. In Gegenwart des Racemats, führt die hohe Affinität zur L-Form zur 
Hemmung der D-Enantiomer-Reaktion. Weiterhin konnte eine reduzierte oder sogar 
grundlegend veränderte Regioselektivität der Reaktion von FgaPT2, 5-DMATSSc und 7-
DMATS mit dem D-Enantiomer von Tryptophan und 5-Methyltryptophan beobachtet werden. 
Außerdem konnte mit 5-DMATSSc erstmals eine Tryptophan-Prenyltransferase beschrieben 
werden, die eine Diprenylierung in einem sukzessiven Reaktionsmechanismus katalysiert. 
Zusammenfassend lässt sich sagen, dass die Identifizierung und Charakterisierung drei neuer 
6-DMATS-Enzyme aus Aktinomyzeten zu einem besseren Verständnis bakterieller 
Tryptophan-Prenyltransferasen führen. Auf Grund der besonderen Eigenschaften untersuchter 
Prenyltransferasen ergibt sich schließlich die Möglichkeit, mittels neuer Biokatalysatoren das 
Repertoire alkylierter, potenziell aktiver Substanzen zu erweitern.
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Introduction 
1.1. Ascomycota  
Ascomycota or colloquially called ascomycetes represent the largest phylum of fungi including 
more than 64,000 species, whereas it is assumed that the majority is still not discovered (Kirk 
et al., 2008). Their characteristic feature is the sac-like reproductive structure called ascus 
containing the sexual produced ascospores. The asci can form a macroscopic fruiting body, the 
ascocarp, which is clearly obvious in many species including the familiar truffels (James et al., 
2006). Compared to sexual reproduction, the ascomycetes reproduce also asexually via budding 
or production of conidiospores formed by conidiophores. Ascomycota are spread ubiquitous in 
nature and occur in various lifestyles as saprotrophs, necrotrophic or biotrophic parasites of 
plants and animals (Webster & Weber 2007). Members of this phylum can also pose risks for 
human’s health. For example, the yeast Candida albicans infects mouth and vagina, while 
Aspergilllus fumigatus (A. fumigatus) causes chronic pulmonary aspergillosis in 
immunocomprised individuals (Latge 1999). Each year more than 200,000 cases of invasive 
aspergillosis were estimated (Brown et al., 2012). Also plant pathogens cause harm in 
agriculture and affect humans directly via mycotoxins or indirectly via harvest losses or food 
spoilage. For instance, mycotoxins such as the cancerogenic aflatoxins and cytotoxic gliotoxin 
are produced by Aspergillus flavus (A. flavus) and by both A. flavus and Aspergillus terreus (A. 
terreus), respectively (Amaike & Keller 2011; Stanzani et al., 2005). The plant pathogen and 
ergot fungus Claviceps purpurea (C. purpurea) grows on cereal grains and produces ergot 
alkaloids, which causes ergotism in human. Nevertheless, research on these mycotoxins 
revealed that ergot alkaloids are potent drugs e.g. in obstetrics or for treatment of migraines 
(Gerhards et al., 2015). This example demonstrates also the beneficial effects of ascomycetes 
i.e. their usage as sources for drugs. The important antibiotic penicillin G is produced by 
Penicillium chrysogenum (Flemming 1929) and Aspergillus nidulans (A. nidulans) (Brakhage 
et al., 2004; MacCabe et al., 1990). Another example is the immunosuppressant agent 
cyclosporine isolated at first from Tolypocladium inflatum (Dittmann et al., 1994). A further 
important medicinal agent is the cholesterol-lowering lovastatin produced by A. terreus 
(Manzoni & Rollini 2002). Beside the pharmaceutical function of secondary metabolites 
derived from ascomycetes, which will be described more detailed in the following sections in 
this thesis, several species are important in food industry. Yeast has been used for centuries in 
production of bread, beer and wine, whereas some Penicillum species produces different mold 
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cheeses (Ropars et al., 2012). Aspergillus oryzae (A. oryzae) is used as efficient producer of α-
amylase, glucoamylase, and α-glucosidase (Hata et al., 1991; Minetoki et al., 1995; Yin et al., 
2015). Moreover, baker’s yeast (Saccharomyces cerevisiae) as well as Neurospora crassa are 
common model organisms with great scientific significance (Cherry et al., 1997; Davis & 
Perkins 2002; Galagan et al., 2003; Webster & Weber 2007). In addition, genetic manipulation 
can be easily carried out with several ascomycetes like yeast or several Aspergillus species 
(Punt et al., 2002; Webster & Weber 2007). Therefore they also play an important 
biotechnological role for example in production of peptides and proteins such as insulin 
(Kjeldsen 2000).  
1.2. Actinobacteria 
The phylum of actinobacteria constitutes the largest group of the Gram-positive bacteria. Most 
members belong to the order actinomycetales and are distinguished by their high genomic 
guanine-cytosine (GC) content. As fungi of ascomycetes also the actinobacteria were wide 
spread in nature as terrestrial but also marine or freshwater bacteria. In soil, they are important 
ecological decomposer and therefore also economically significant in agriculture for human. 
Similar to fungi, they usually reproduce via spores and also growth as hyphae. Two third of the 
known microbial antibiotics are produced by actinobacteria and the main part by the genus of 
Streptomyces (Kieser et al., 2000). Intensive research on antibacterial agents from Streptomyces 
began in 1940 with the discovery of actinomycin from Actinomyces antibioticus, followed by 
streptomycin, chloramphenicol, tetracyclines, erythromycin from diverse actinomycetes, and 
countless more (Mahajan & Balachandran 2012). A recent example is the discovery of the 
antimicrobial prenylated isatin antibiotic from Streptomyces sp. MBT28. Thereby an indole 
prenyltransferase play the key role in the conversion of tryptophan to 7-prenylisatin (Wu et al., 
2015). In addition, Streptomyces are also producers of antifungal agents (Gupte, 2001) or 
compounds with other important properties including anticancer (Shah et al., 2016; Shan et al., 
2005), antiviral (Kohno et al., 1996; Zhang et al., 2016), and anti-inflammatory 
immunosuppressive activities (Hassan et al., 2016). The search for novel metabolites based on 
the identification and analyses of new biosynthetic gene clusters. Genome mining is required 
due to the common occurrence of cryptic gene clusters among actinomycetes with unknown 
natural products. Activation of silent genes could be achieved either by genetic manipulation 
of the host strain or by heterologous expression of the cryptic genes in a related host. 
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Streptomyces coelicolor (S. coelicolor) A3(2), the most studied species, is a very suitable 
heterologous host for production of secondary metabolites derived from actinomycetes 
(Gomez-Escribano & Bibb 2014). Its chromosome was completely sequenced and annotated 
by Bentley et al. in 2002. The more efficient and cheaper sequencing technics including 
advanced computational tools led to an increased number of sequenced genomes of 
Streptomyces and related species (Gomez-Escribano & Bibb 2014; Harrison & Studholme 
2014). Therefore significant progress in elucidation of actinomycetous genetics and 
metabolisms was achieved in the last decade. The availability of the genome sequences of 
Streptomyces ambofaciens (S. ambofaciens) (Choulet et al., 2006; Thibessard et al., 2015), 
Streptomyces violaceusniger (S. violaceusniger) and Micromonospora olivasterospora (M. 
olivasterospora) apart from numerous other species is the basis for a major part of this thesis.  
1.3 Prenylated aromatic secondary metabolites  
Aromatic natural products bearing an isoprenoid residue or moiety derived thereof are widely 
distributed in nature. These compounds show a vast structurally diversity regarding their 
aromatic scaffolds such as indoles, xanthones, flavonoids, hydroxynaphthalenes and so on. In 
addition, the chain length and the number of the attached prenyl moieties as well as their 
position on the scaffold can varied. The prenylation reactions take place either in regular or 
reverse manner. The regular prenylation implies the connection of the prenyl moieties via their 
C-1 to an acceptor and the reverse prenylation via their C-3 atoms (Fig 1.1) (Heide 2009a; Yu 
& Li 2012). 
Fig. 1.1 Regular and reverse prenyl pattern and numbering of the indole. Ar: aromatic residue. 
The broad variety could be further extended by other modifications such as rearrangement, 
cyclization or oxidation (Raju et al., 2011; Tagami et al., 2013). Producers of such compounds 
include several families of plants, fungi of ascomycetes and bacteria of actinomycetes, where 
the latter two received the most attention in this thesis. Several studies demonstrated that the 
presence of the prenyl group gives the aromatic secondary metabolites improved biological and 
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pharmacological activity (Alhassan A.M. et al., 2014; Botta et al., 2005a; El-Seedi et al., 2010; 
Heide 2009b; Li 2010; Sunassee & Davies-Coleman 2012). For instance, the plant 
prenylflavonoid 8-prenyl-quercetin has a stronger anti-inflammatory effect than its non-
prenylated derivative (Hisanaga et al., 2016). 6-prenylindole as another example from 
Streptomyces revealed antifungal activity affected by its substituted allyl-side-chain (Sasaki et 
al., 2002). The influence of the prenyl group on pharmaceutical activity of aromatic molecules 
was attributed to an enhanced affinity and access to lipophilic membranes or interactions with 
proteins by their increased lipophilicity (Alhassan A.M. et al., 2014; Botta et al., 2005a).  
1.3.1. Prenylated indole alkaloids 
Prenylated indole alkaloids contain an indole core, derived from L-tryptophan, its precursors or 
derivatives thereof, and isoprenoid moieties. These hybrid natural products exhibit a wide 
diversity of chemical structures and bioactivities and thus they fulfill an important role in 
pharmaceutical research and drug development. Prenylated indole alkaloids can be classified 
according to their backbones, inter alia, into simple indole derivatives, tryptophan-containing 
cyclic dipeptides, and indole terpenes (Li 2010). Such compounds are found in ascomycetes 
but also in several bacteria and plants. Beside the aforementioned toxic and pharmaceutical 
effects of the ergot alkaloids from Claviceps, further prenylated indole alkaloids with important 
pharmacological and biological activities were isolated and identified (Li 2010). For example, 
neoechinulin B from Eurotium rubrum, semicochliodinols A, B, and isocochliodinol from 
Chrysosporium merdarium show antiviral activities (Fig. 1.2) (Chen et al., 2015; Debbab et al., 
2009; Fredenhagen et al., 1997). Other biologically active compounds of this group are 
fumitremorgin C (Fig. 1.2) from A. fumigatus, which inhibits the breast cancer resistance 
protein, and the anti-inflammatory cyclomarin A and B from the actinomycete Salinispora 
arenicola (S. arenicola) CNS-205 (Allen et al., 2002; Rabindran et al., 2000; Schultz et al., 
2008; Yamazaki et al., 1980). 
Fig. 1.2 Examples of bioactive prenylated indole alkaloids from distinct ascomycetes. 
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1.3.1.1. Prenylated simple indole derivatives derived from L-tryptophan 
This thesis deals with the enzyme group of the indole prenyltransferases catalyzing the 
formation of prenylated tryptophan and simple indole derivatives with the prenyl moiety 
attached at C-4, C-5, C-6, and C-7 of the indole ring. For instance, C4-prenylated L-tryptophan 
represents the first precursor in the biosynthesis of the prominent ergot alkaloids isolated from 
Claviceps, Aspergillus, Penicillium and even plants (Gerhards et al., 2014). Further 
representatives with C4-prenylation are the cytotoxic α-cyclopiazonic acid, rugulovasines A, B 
and 8-chloro-rugulovasines A and B from diverse Penicillium species (Cole et al., 1976; 
Holzapfel 1968; Hymery et al., 2014). The C5-prenylated simple indole alkaloid 5-
dimethylallylindole (DMAI)-3-acetonitrile, several C6-prenylated indole derivatives such as 6-
DMAI-3-carbaldehyde and 6-DMAI, as well as the C7-prenylated antibiotic 7-DMA-isatin 
were identified in diverse Streptomyces spp. (Fig. 1.3) (Ozaki et al., 2013; Sasaki et al., 2002; 
Takahashi et al., 2010; Wu et al., 2015). In addition, N1-prenylated indole derivatives such as 
the antibacterial cyclomarazines were found in actinomycetes (Schultz et al., 2010). Simple 
indole derivatives were also produced by plants e.g. C5- and C7-prenylindole or the 
diprenylated hexalobines (Fig. 1.3) (Achenbach et al., 1995; Vougogiannopoulou et al., 2011). 
Furthermore, the prenylated tryptamine derivative deformylflustrabromine with anti-cancer 
activity was isolated from the marine bryozoan Flustra foliacea (Adla et al., 2013). 
Fig. 1.3 Examples of prenylated indole alkaloids derived from L-tryptophan with prenyl moiety attached on 
different positions. 
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1.3.1.2. Prenylated tryptophan-containing cyclic dipeptides 
Prenylated cyclic dipeptides form a major and diverse group of prenylated indole alkaloids with 
important pharmaceutical significance. Cyclic dipeptides usually contain a 2,5-
diketopiperazine scaffold, emerged from the double condensation of two α-amino acids, or a 
benzodiazepindine scaffold (Giessen & Marahiel 2015; Li 2010). The assembly of usually L-
tryptophan and a second amino acid is catalyzed mainly by non-ribosomal peptide synthetases 
(NRPSs), but also by the recently identified tRNA-dependent cyclic dipeptide synthetases 
CDPSs (Giessen & Marahiel 2014; Koglin & Walsh 2009). Cyclic dipeptides synthesized by 
NRPSs were found in fungi and in bacteria mostly in the phylum of ascomycota and 
actinobacteria, whereas the biosynthetic system including CDPSs is almost limited to bacteria 
e.g. Streptomyces (Giessen & Marahiel 2015). The most common prenylated cyclic dipeptides 
are C2-prenylated derivatives derived from the precursor cyclo-L-tryptophanyl-L-prolinyl 
(cyclo-L-Trp-L-Pro) also known as brevianamide F (Williams et al., 2000). Diverse tremorgenic 
mycotoxins with genotoxic effects e.g. fumitremorgines and verruculogen, result from the 
conversion of the regularly C2-prenylated brevianamide F i.e. trypostatin B (Fig. 1.4). These 
prenylated natural products were identified in several Aspergillus and Penicillium strains and 
display diverse biological activities e.g. the antitumor activity of trypostatin B and its 
methoxylated derivative trypostatin A (Borthwick 2012; Gallagher & Latch 1977; Kosalec et 
al., 2005; Yamazaki et al., 1974; Yamazaki & Suzuki 1986). Beside the aforementioned 
regularly prenylated cyclic dipeptides, the family of brevianamides, notoamides, stephacidins, 
and other related structures are derived from the reversely C2-prenylated brevianamide F 
(deoxybrevianamide E) (Li 2010). The antibacterial brevianamide S isolated from Aspergillus 
versicolor (A. versicolor) was reported to represent a potential antitubercular drug (Song et al., 
2012). Another group of prenylated cyclic dipeptides consist of two L-tryptophan molecules 
e.g. the okaramines with insectidal activities or the fellutanines derived from Penicillium (Fig. 
1.4) (Hayashi et al., 1989; Hayashi et al., 1991; Kozlovsky et al., 2001). A famous example of 
the reversely C3-prenylated cyclo-L-tryptophanyl-L-histidinyl is roquefortine C from 
Penicillium roqueforti (Fig. 1.4) (Scott & Kennedy 1976). Moreover, acetylaszonalenin derived 
from L-tryptophan and anthranilic acid was isolated from diverse ascomycetes (Fig. 1.4) (Li et 
al., 2009). Further examples for the great diversity of prenylated cyclic dipeptide are echinulin 
and its analogs representing cyclo-tryptophanyl-alaninyl (cyclo-L-Trp-L-Ala) derivatives 
substituted by three prenyl moieties (Chen et al., 2015; Zou et al., 2014). 
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Fig. 1.4 Examples of prenylated cyclic dipeptide derivatives. 
1.3.2. Prenylated naphthalenes and quinones 
Prenylated naphthalenes are a less abundant class of prenylated secondary metabolites, which 
were isolated from plants and bacteria (Hussein et al., 2004; Monache et al., 1985). Examples 
for prenylated naphthalenes from plants are the cytotoxic two- or threefold prenylated 
adenoforins A-D (Fig. 1.5) from Adenaria floribunda as well as the potential anti-malarial 
vismione B from Cratoxylum and Psorospermum (Botta et al., 1983; Hussein et al., 2004; 
Laphookhieo et al., 2009). The antibiotic merochlorin A was identified with the 
naphthoquinones merochlorin B-D from Streptomyces (Kaysser et al., 2012). The more 
common prenylated naphthoquinones and quinones are distributed throughout various marine 
and terrestrial organisms including plants, fungi, bacteria as well as algae and sponges (Hussain 
et al., 2007; Sedmera et al., 1991; Sunassee & Davies-Coleman 2012; Suzuki et al., 2014). 
These compounds received pharmaceutical interest, particularly due to their anti-inflammatory 
and antitumor activities (de los Reyes et al., 2013; Sunassee & Davies-Coleman 2012). 
Moreover, a potential agent for treatment of malaria was obtained within the C-diprenylated 
quinone scabellone B from the sea squirt Aplidium scabellum (Andersen et al., 2011). The 
highly oxygenated and cytotoxic terreumol C (Fig. 1.5) was isolated from Tricholoma terreum 
(Yin et al., 2013a). The antioxidant naphterpin is a prenylated naphthoquinone derived from 
the polyketide 1,3,6,8-tetrahydroxynaphthalene and produced by some Streptomyces species 
(Shin-Ya et al., 1990a; Shin-Ya et al., 1990b). 
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1.3.3. Prenylated flavonoids 
Prenylated flavonoids are a large class of naturally occurring products, urgently distributed in 
the plant kingdom and in particular in the families of Fabaceae (Leguminosae) and Moraceae 
(Botta et al., 2005a). These polyphenolic compounds with a C6-C3-C6 carbon skeleton and one 
or more prenyl side chains, usually C5 or C10 units, exhibit a wide range of bioactivities 
including anti-inflammatory, antibacterial, antioxidant, cytotoxic as well as estrogenic activities 
(Hosek et al., 2011; Kim et al., 2013; Urmann et al., 2015; Vogel et al., 2008). The structure 
diversity includes mainly the subclasses of flavones, isoflavones, chalcones and flavanoles 
(Barron & Ibrahim 1996; Botta et al., 2005b). For example, the most abundant prenylated 
chalcone from hop, the xanthohumol (Fig. 1.5), display pharmaceutical important properties 
such as antiviral (Lou et al., 2014), anti-angiogenic and anti-inflammatory activities (Gallo et 
al., 2016). A further example for a prenylated flavonoid is the isoflavone isowighteone isolated 
from Lupinus albus (Fig. 1.5) (Shen et al., 2012). 
1.3.4. Prenylated xanthones 
Prenylated xanthones or dibenzo-γ-pyrones are produced in higher plants, fungi and lichens. As 
natural secondary metabolites, these compounds has drawn attention from diverse scientists 
(El-Seedi et al., 2009; Pinto et al., 2005). For example, the HIV-inhibitory macluraxanthone B 
was found in the extract of Maclura tinctoria (Fig. 1.5) (Groweiss et al., 2000). Further multiple 
C-prenylated xanthones such as α- and γ-mangostin as well as garcinone C were extracted from 
Garcinia species. These compounds inhibit acetylcholinesterase and thus makes them to potent 
agents for treatment of Alzheimer’s disease (Khaw et al., 2014; Wang et al., 2012). Moreover, 
cytotoxic activities were reported for γ-mangostin and garcinone C (Xu et al., 2014), while α-
mangostin was evaluated as a potential anticancer agent (Kwak et al., 2016) and also exhibit 
anti-inflammatory activity (Gutierrez-Orozco et al., 2013). Beside the reported C-prenylated 
xanthones in plants, both C- and O-prenylated derivatives were found in fungi e.g. 
variecoxanthones from Aspergillus species (Fig. 1.5) (Simpson 2012). 
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1.3.5. Prenylated coumarins 
The major producer of prenylated coumarins are plants, but also several species of fungi and 
bacteria. The structures based on a 1,2-benzopyron scaffold are modified at C- or O-atom by 
an isoprenoid moiety (Venugopala et al., 2013). Whereas coumarins are distributed throughout 
all families of plant kingdom, many prenylated coumarins were found in the family of Apiaceae 
(Gliszczynska & Brodelius 2012; Venugopala et al., 2013). For instance, several genera of 
Apiaceae produce the bioactive secondary metabolite umbelliprenin (Fig. 1.5) displaying anti-
bacterial (Rosselli et al., 2007), anti-inflammatory (Zamani Taghizadeh et al., 2016), 
cytotoxic/anti-cancer (Barthomeuf et al., 2008) and anti-leishmanial activities (Iranshahi et al., 
2007). Another example for this class of natural products with various bioactivities is the O-
prenylated imperatorin (Venugopala et al., 2013). Furthermore, novobiocin from the 
actinobacterium Streptomyces sphaeroides belong to the family of aminocoumarin antibiotics 
featured with a 3-amino-4,7-dihydroxycoumarin moiety and act as gyrase inhibitor (Fig. 1.5). 
One related structure of this family is clorobiocin and also derived from Streptomyces. The 
biosynthesic pathways of these two antibiotics have been completely understood by genetic and 
biochemical investigations on the corresponding gene clusters (Heide 2009b). 
Fig. 1.5 Examples of prenylated aromatic compounds. 
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1.4. Prenyltransferases  
The manifold enzyme family of prenyltransferases and their catalyzed prenylation reactions are 
found in all living organisms and are crucial in primary and secondary metabolism. They 
catalyze the transfer reactions of prenyl moieties from different prenyl donors to various 
aliphatic or aromatic acceptors of both low and high molecular substances including proteins 
and nucleic acids (Dumelin et al., 2012; Heide 2009a; Li 2009a; Oldfield & Lin 2012; 
Palsuledesai & Distefano 2015; Xie et al., 2007; Yazaki et al., 2009). The prenyl donors 
consisting of n × C5 units are derived from the terpenoid biosynthetic pathways e.g. 
dimethylallyl (DMAPP with a branched C5-chain), geranyl (GPP, C10), farnesyl (FPP, C15) or 
geranylgeranyl (GGPP, C20) diphosphate. Prenyltransferases are classified into different 
subgroups based on their primary amino acid sequences, biochemical and structural 
characteristics. In the last years, remarkable progress has been achieved in research on this 
enzyme group, especially on the members of the dimethylallyltryptophan synthase (DMATS) 
superfamily. These enzymes are the main focus of research in this thesis. Therefore they will 
be discussed in more detail.  
1.4.1. Prenyl diphosphate synthases: trans- and cis-prenyltransferases 
Prenyl diphosphate synthases using prenyl diphosphate as donor e.g. DMAPP and isopentenyl 
diphosphate (IPP) as acceptor are involved in the biosynthesis of over 63,000 isoprenoid natural 
products including terpenoids, steroids and membrane components (Liang et al., 2002; Oldfield 
& Lin 2012; Ramamoorthy et al., 2015). Sequential condensation of the donor and a given 
number IPP lead to the formation of the carbon backbone with a certain chain length. Depending 
on the formed double bond configuration (trans (E) and cis (Z)) in the resulting prenyl units, 
these chain elongating enzymes can be classified into two major groups, i.e. trans- and cis-
prenyltransferases. For instance, the formation of the all-trans C15 precursor FPP was catalyzed 
by FPP synthases (FPPase) which belongs to the first group (Poulter 2006). In contrast, cis-
prenyltransferases, e.g. undecaprenyl diphosphate synthase, produce prenyl diphosphates 
containing both Z- and E-configured double bonds. Trans- and cis-prenyltransferases are both 
Mg2+-dependent enzymes but their amino acid sequence as well as their tertiary structures are 
completely different from each other (Guo et al., 2004; Guo et al., 2005; Winkelblech et al., 
2015a). 
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1.4.2. Protein, peptide and tRNA prenyltransferases 
Protein prenylation including farnesylation or geranylgeranylation is a post-translational 
modification which is found in all eukaryotic cells (Palsuledesai & Distefano 2015). The 
isoprenoid moieties derived from FPP and GPP were attached by farnesyltransferase (FTase) 
and geranylgeranyltransferase type 1 (GGTase-I), respectively, to the cysteine residue in the C-
terminal consensus sequence CaaX. In contrast, geranylgeranyltransferase type 2 (GGTase-II 
or Rab geranylgeranyltransferase) catalyzes the transfer reaction of two geranylgeranyl 
moieties to special sequence motifs like CXC or CCXX. Protein prenyltransferases play an 
important role in cellular protein localization, protein-protein interactions and protein activity. 
This makes them to interesting drug targets e.g. in tumor therapy (Palsuledesai & Distefano 
2015).  
Modification of large molecules by prenylation are not limited to proteins, but were also found 
for peptides or even nucleic acids. The peptide prenyltransferase ComQ from Bacillus subtilis 
was suggested to catalyze a regular C3-geranylation of tryptophan in a heptapeptide resulting 
in the ComX pheromone (Tsuji et al., 2012). SelU is a tRNA prenyltransferase from 
Escherichia coli (E. coli) which catalyze S-geranylation of 5-methylaminomethyl-2-thiouridyl 
residue in tRNA (Dumelin et al., 2012).  
1.4.3. Aromatic prenyltransferases 
Aromatic prenyltransferases contribute significantly to the large diversity of prenylated 
secondary metabolites in plants, fungi and bacteria (Heide 2009b; Li 2009b; Yazaki et al., 
2009). They catalyze the attachment of the prenyl moiety to C-, O- or N-atom of a wide range 
of aromatic substances, such as phenols, phenolic acids, flavonoids, coumarins, naphthalenes, 
phenazines or indole derivatives. For classification of these enzymes, several aspects for 
discrimination could be considered such as structural fold, substrate binding motifs, metal ion 
dependency, and soluble or membrane-bound form. 
1.4.3.1. Membrane-bound prenyltransferases for aromatic substrates 
In contrast to the soluble aromatic prenyltransferases, the membrane-bound prenyltransferases 
are not only involved in secondary metabolism, but also in primary metabolism. They play an 
important role in the biosynthesis of ubiquinones and menaquinones (Boronat & Rodriguez-
Concepcion 2015; Meganathan & Kwon 2009) or diverse secondary metabolites from fungi, 
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bacteria and plants (Holm et al., 2014; Wang et al., 2014; Yazaki et al., 2009; Zeyhle et al., 
2014a; Zeyhle et al., 2014b). Enzymes of this family contain characteristic aspartate-rich 
motifs, e.g. NDxxDxxxD and their catalyzed reactions are dependent on the presence of 
divalent ions. Natural substrates of membrane-bound prenyltransferase include 4-
hydroxybenzoate (4HB), homogentisic acid, coumarins, flavonoids, 1,4-dihydroxy-2-
naphthoate or phenazines (Heide 2009a; Karamat et al., 2014; Yazaki et al., 2009; Zeyhle et 
al., 2014a; Zeyhle et al., 2014b). The most famous representative of this group is UbiA from 
E. coli, which catalyze the transfer of an all-trans octaprenyl moiety onto 4HB. Furthermore, a 
high flexibility of UbiA toward prenyl donors lead to formation of ubiquinones CoQ6 to CoQ10
in different species (Cheng & Li 2014). The crystal structure of an archeal UbiA was solved 
and reported in 2014 (Cheng & Li 2014). Recently, two membrane-bound prenyltransferases 
from Humulus lupulus were reported to catalyze three sequential prenylation steps in the 
biosynthetic pathway of bitter acid in hop (Li et al., 2015). Two examples for membrane-bound 
prenyltransferases from bacteria were identified in Streptomyces catalyzing phenazine 
prenylations (Zeyhle et al., 2014a; Zeyhle et al., 2014b).  
1.4.3.2. Soluble prenyltransferases  
Compared to the aforementioned membrane-bound enzymes, metal ions are not essential for 
the enzyme activity of the soluble PTs in most cases and they usually contain no aspartate-rich 
motif (Bonitz et al., 2011; Heide 2009a). This enzyme group of soluble aromatic 
prenyltransferases includes the CloQ/NphB group and the extensively investigated DMATS 
superfamily (Winkelblech et al., 2015a). Enzymes of both subgroups comprise a PT-barrel, 
termed aßßa-fold (ABBA). Firstly, this structure was observed for the naphthalene 
geranyltransferase NphB (Kumano et al., 2008; Kuzuyama et al., 2005) and later for four fungal 
indole prenyltransferases. 
1.4.3.2.1. Prenyltransferases of the CloQ/NphB group 
The name of the CloQ/NphB group derived from the first identified members from 
Streptomyces. CloQ and its orthologue NovQ catalyze the prenylation of 4-
hydroxyphenylpyruvic acid in the biosynthesis of clorobiocin and novobiocin, respectively 
(Pojer et al., 2003; Steffensky et al., 2000). Afterwards, NphB involved in the biosynthesis of 
naphterpin (Kuzuyama et al., 2005) was found in Streptomyces sp. (Kuzuyama et al., 2005; 
Pojer et al., 2003). In general, the known enzymes of this group use naphthalenes, quinones, 
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phenols and phenazines as substrates (Heide 2009a). In the last years, a number of further 
enzymes of the CloQ/NphB group have been identified (Winkelblech et al., 2015a).  
1.4.3.2.2. Enzymes of the DMATS superfamily 
The DMATS superfamily is the most investigated group among the prenyltransferases. 
Enormous progress has been made in the last years, concerning the great number of newly 
identified and biochemically characterized enzymes as well as the availability of novel crystal 
structures. So far, more than 40 members of the DMATS superfamily were identified and 
investigated by mining of fungal and bacterial genomes. A detailed summary comprising all 
known studied DMATSs up to 2015, was provided in the overview article (Chapter 4.4) 
(Winkelblech et al., 2015a). In Fig. 1.6 several examples of DMATSs and their distinct 
functions are illustrated. Generally, a broad substrate promiscuity and a high regioselectivity 
regarding the prenylation position are characteristics for the DMATS superfamily. The 
common prenyl donor is DMAPP, while a few DMATSs use GPP. Most enzymes of this group 
catalyze the prenylation of indole derivatives including tryptophan and tryptophan-containing 
cyclic dipeptides. In the following, bacterial and fungal tryptophan prenyltransferases will be 
discussed more detailed.  
The first enzyme of the DMATS superfamily, DmaW, was identified in the ascomycete and 
ergot alkaloid producer C. purpurea in 1995 (Gebler & Poulter 1992; Tsai et al., 1995). DmaW 
and its orthologue FgaPT2 from A. fumigatus catalyze the C4-prenylation of L-tryptophan with 
DMAPP as prenyl donor and are involved in the biosynthesis of ergot alkaloids. Thus, these 
enzymes function as 4-dimethylallyltryptophan synthases (Tudzynski et al., 1999; Unsöld & Li 
2005). Later on, the two fungal prenyltransferases 7-DMATS from A. fumigatus and 5-DMATS 
from Aspergillus clavatus were identified, which acting as C7- and C5-prenylating enzymes, 
respectively (Kremer & Li 2010; Yu et al., 2012). At least eight fungal DMATSs were 
identified until now, which act as C4-, C5-, and C7-prenylating enzymes (Winkelblech et al., 
2015a). CymD identified in S. arenicola was the first bacterial tryptophan prenyltransferase. 
CymD is involved in the biosynthesis of the abovementioned cyclomarin A and cyclomarazine 
A by catalyzing the reverse N1-prenylation at the indole ring (Schultz et al., 2010). Only two 
further bacterial tryptophan prenyltransferases with C5- and C6-tryptophan prenylating 
activities were known at the beginning of this thesis. The C5-prenyltransferase SCO7467 and 
the flavin-dependent monooxygenase SCO7468 from S. coelicolor were found to be involved 
in the biosynthesis of 5-DMAI-3-acetonitrile (Ozaki et al., 2013; Subramanian et al., 2012). 
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IptA functions as 6-DMATS in the biosynthesis of 6-DMAI-3-carbaldehyde in Streptomyces 
sp. SN-593 (Takahashi et al., 2010). In the present work, the knowledge on bacterial tryptophan 
prenyltransferases was expanded by identification and characterization of three new 
outstanding 6-DMATS from different actinomycetes. Moreover, within the last two years, the 
IptA orthologue, IptAAm from Actinoplanis missouriensis (A. missouriensis) (Satou et al., 2014) 
and the C7-prenyltransferase IsaA from Streptomyces MBT28-91, which catalyzes the 
formation of the new antibiotic 7-prenylisatin (Wu et al., 2015), were reported.  
Tryptophan-containing cyclic dipeptides were regiospecific prenylated, especially at N-1, C-2, 
C-3, and C-7 position at the indole ring by diverse prenyltransferases (Winkelblech et al., 
2015a). A regular C2-prenylation was catalyzed by FtmPT1 from A. fumigatus in the 
biosynthesis of the previously reported fumitremorgines/verruculogen (Grundmann & Li 2005; 
Li 2011), while NotF from an Aspergillus sp. and BrePT from A. versicolor catalyze the reverse 
C2-prenylation in the biosynthesis of notoamides (Ding et al., 2010; Yin et al., 2013b). In 
addition, the cyclic dipeptide reverse C2- prenyltransferase CdpC2PT from Neosartorya 
fischeri (N. fischeri) was suggested to be involved in the biosynthesis of fellutanine (Mundt & 
Li 2013). Furthermore, AnaPT from N. fischeri catalyzes a reverse C3-prenylation of (R)-
benzodiazepinedinone in the biosynthesis of acetylaszonalenin (Yin et al., 2009). In contrast, 
the reverse C3ß-prenylation of cyclic dipeptides was catalyzed by CdpNPT from A. fumigatus 
and CdpC3PT from N. fischeri (Schuller et al., 2012; Yin et al., 2010). After identification of 
the cyclic dipeptide C7- and simultaneous N1- prenyltransferase CTrpPT from A. oryzae (Zou 
et al., 2010), the C7-prenylating CdpC7PT, revealing a much higher regioselectivity and 
substrate flexibility toward cyclic dipeptides, was identified in A. terreus (Wunsch et al., 2015). 
Some bacterial cyclic dipeptide prenyltransferases including LtxC from Lyngbya majuscula, 
TleC from Streptomyces blastmyceticus and MpnD from Marinactinospora thermotolerans 
catalyze the reverse prenylation of (-)-indolactam V at position C-7 in the biosynthesis of 
lyngbyatoxins, teleocidin B, and methylpendolmycin, respectively (Awakawa et al., 2014; 
Edwards & Gerwick 2004; Ma et al., 2012; Mori et al., 2016). In contrast to the first two 
geranyltransferases, MpnD uses DMAPP as prenyl donor. Recent studies on TleC and MpnD 
revealed a high flexibility toward prenyl donors with different chain length. Furthermore, 
enzyme engineering based on their crystal structures led to an altered donor specificity, regio- 
and stereoselectivities of the prenylation reactions (Mori et al., 2016). 
In addition to tryptophan and tryptophan-containing cyclic dipeptides, other indole derivatives 
were used as prenyl acceptor by several members of the DMATS family such as the indole 
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diterpene prenyltransferases AtmD and PaxD from A. flavus and Penicillium paxilli, 
respectively (Liu et al., 2013a; Liu et al., 2014). TdiB from A. nidulans and AstPT from A. 
terreus are involved in the biosynthesis of prenylated bisindolyl benzoquinones (Balibar et al., 
2007; Schneider et al., 2008; Tarcz et al., 2014a). 
Beside the numerous indole prenyltransferases, several prenyltransferases use non-indole 
substrates e.g. the tyrosine O-prenyltransferase SirD from Leptosphaeria maculans and TyrPT 
from Aspergillus niger (A. niger) (Fan et al., 2014; Kremer & Li 2010). One example for a 
prenyltransferases from DMATS superfamily, PAPT from Phomopsis amygdali uses a non-
aromatic derivative for O-prenylation in the glucose moiety (Noike et al., 2012). 
Fig. 1.6 Selected prenyltransferases of distinct subgroups (A-F) belonging to the DMATS superfamily. A: 
tryptophan prenyltransferase, B/C: tryptophan-containing cyclic dipeptide prenyltransferase, D: prenyltransferases 
of other indole derivatives, E: tyrosine prenyltransferases, F: prenyltransferases of non-aromatic derivatives. 
To understand the mechanisms of the DMATS reactions, structural analyses based on the 
crystal structures were essential. The first structure was obtained for the tryptophan 
prenyltransferase FgaPT2 (Metzger et al., 2009), followed by the crystal structures for FtmPT1, 
CdpNPT and AnaPT (Jost et al., 2010; Schuller et al., 2012; Yu et al., 2013). All four structures 
contain the PT-barrel, formed by five repetitive αββα-elements (ABBA), which is similar to the 
tertiary structure of the bacterial prenyltransferase NphB, although the primary and secondary 
amino acid sequences including the active site strongly differ between these two enzyme 
groups. Recently, the crystal structures of the bacterial indolactam prenyltransferases TleC and 
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MpnD were determined, sharing the ABBA barrel fold (Mori et al., 2016). The binding sites 
are located in the hydrophobic pocket inside the PT-barrel. The amino acids in the binding site 
for the prenyl donor DMAPP are strictly conserved in these structures, whereas the binding 
sites for the aromatic substrates are different. This makes molecular modeling or functional 
predictions for specific amino acids more difficult. Nevertheless, the gained structural 
information provide substantial insights into the reaction mechanism (Jost et al., 2010). The 
first step of a proposed three step reaction is the cleavage of the pyrophosphate from the 
isoprenoid chain, resulting in a dimethylallyl cation, proved by a positional isotope exchange 
with O18-labeled DMAPP (Luk & Tanner 2009; Metzger et al., 2009; Shibuya et al., 1990). 
Subsequent electrophilic substitution on the indole nucleus leads to the formation of an 
areniumion, which is deprotonated in the third step. The second step have been strongly 
disputed, whether the described substitution take place directly at the prenylation site or initially 
at C-3, followed by rearrangement to the final position (Luk et al., 2011; Mahmoodi et al., 
2013; Mahmoodi & Tanner 2013; Tanner 2014).These results could be further used in 
molecular modeling and site-directed mutagenesis experiments in order to get deeper insights 
into the function of DMATSs and to create new enzymes with modified features for application 
in chemoenzymatic synthesis. 
1.5. DMATSs as biocatalysts in chemoenzymatic synthesis of 
prenylated compounds 
The above presented biochemical properties of the DMATSs such as the high substrate 
specificity facilitated an enzyme-driven regiospecific production of various prenylated 
products. These products in turn could provide potential drug candidates with biological 
activities due to the attached prenyl moieties. As aforementioned, the presence of a prenyl group 
has strong effects on bioactivity due to the increased lipophilicity of prenylated compounds. 
Therefore, the enzymes of the DMATS superfamily serve as valuable biocatalysts for usage in 
biotechnology and pharmacy. The advantage of using this simple method is the easy-handling 
and the high efficiency compared to the more complicated chemical synthesis. Targeted 
production of tryptophan and derivatives substituted by a dimethylallyl residue at N-1, C-4, C-
5, C-6 or C-7 was achieved by the usage of regiospecific prenyltransferases of the DMATS 
superfamily. Regiospecific synthesis of C4,C7-diprenylated tryptophan was reported for 
FgaPT2 and 7-DMATS (Ruan et al., 2009). The tyrosine prenyltransferases SirD and TyrPT 
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can be also used for the synthesis of 7-DMA-L-tryptophan, while the tryptophan 
prenyltransferases FgaPT2 and 7-DMATS also accepted L-tyrosine and 4-amino-L-
phenylalanine as substrates (Fan et al., 2015a; Fan & Li 2014). Cyclic dipeptide 
prenyltransferases catalyze prenylation of diverse peptides with distinct prenylation positions 
and different stereochemistry. For instance, the regular C2-prenyltransferase FtmPT1 and the 
two reverse C2-prenylating enzymes BrePT and CdpC2PT produce in total 30 regularly or 
reversely C2-prenylated products (Fan et al., 2015b). Ten prenylated cyclic dipeptides were 
obtained from the CdpC7PT reactions with six substrates. CdpC7PT even catalyze a O-
prenylation of cyclo-L-Tyr-L-Tyr, which was not observed prior to that study (Wunsch et al., 
2015). The C4-prenyltransferase FgaPT2 is also applicable for production of C4-prenylated 
cyclic dipeptides (Steffan & Li 2009). Mutation on R244 of FgaPT2 increased its activity 
toward cyclic dipeptides (Fan & Li 2016). Beside the natural substrates also unnatural 
compounds were accepted by DMATS e.g. the unnatural cyclic dipeptide cyclo-L-
homotryptophan-D-valine was accepted by cyclic dipeptide prenyltransferases as well as by 
tryptophan prenyltransferases (Fan & Li 2013). Further prenylated aromatic compounds 
comprises xanthones reported for XptB (Pockrandt et al., 2012) and naphthalenes reported for 
7-DMATS, AnaPT, CdpNPT as well as CdpC3PT (Kremer et al., 2007; Schuller et al., 2012; 
Yin et al., 2009; Yin et al., 2010). Membrane-bound prenyltransferases in plants are natural 
biocatalysts for prenylated flavonoids, but their potential use in chemoenzymatic synthesis is 
impaired due to difficult protein isolation and low catalytic efficiency. Therefore 7-DMATS 
and AnaPT, accepting several flavonoids, represent alternative biocatalysts (Yu & Li 2011; 
Zhou et al., 2015). In addition, indolocarbazoles and acylphloroglucinols, which are natural 
bacterial and plant metabolites, can also be prenylated by DMATS enzymes (Fan et al., 2015b). 
Previously, the usage of DMATSs in biotechnology was discussed based on the large pool of 
aromatic substrates, but another possibility to expand the product range of alkylated compounds 
affect the used prenyl donor. Although DMATSs are often high regiospecific toward their 
natural donor, recent studies have demonstrated the acceptance of other prenyl donors like GPP, 
FPP or even unnatural alkyl and benzyl donors (Liebhold et al., 2012; Liebhold et al., 2013; 
Liebhold & Li 2013). The identification of the geranyltransferase VrtC from Penicillium 
aethiopicum initiated further investigations on the acceptance of different prenyl donors. Over 
the last three years, GPP was reported to be used as prenyl donor by AnaPT (Pockrandt & Li 
2013), while GPP and FPP were used by AstPT in the presence of hydroxyxanthones (Tarcz et 
al., 2014b) as well as by BAE61387 for prenylation of hydroxynaphthalenes (Pockrandt et al., 
2014). 
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To get deeper insights into the donor promiscuity of DMATSs and for production of novel 
unnatural prenylated indole derivatives, five unnatural DMAPP analogs were synthesized and 
tested as alternative donors (Liebhold et al., 2012). The results demonstrated that the double 
bond at ß-position to pyrophosphate is essential for the enzyme activity. One methyl group can 
be deleted as in the case of MAPP or shifted to the δ-position as in the case of 2-pentenyl-PP. 
For FgaPT2 and 5-DMATS, the alkylation positions of tryptophan were shifted partially or 
completely to the neighboring position in the presence of the unnatural donors MAPP and 2-
pentenyl-PP (Liebhold et al., 2012). FgaPT2 even used the more space-demanding substrate 
benzyl-PP as donor and produced regiospecifically C5-benzylated tryptophan (Liebhold & Li 
2013). In addition, the acceptance of unnatural DMAPP analogs was proven for several cyclic 
dipeptide prenyltransferases, resulting in a mixture of C2- and C3-reversely alkylated 
diastereomers, contrary to the natural reactions (Liebhold et al., 2013).  
In this thesis, the investigations on unnatural alkylation of L-tryptophan by further DMATSs 
including C6- and C7-prenyltransferases should be extended. Recently, the acceptance of 
unnatural DMAPP analogs was also reported for the two tyrosine O-PTs TyrPT and SirD with 
L-tyrosine as substrate (Yu et al., 2015). 
An approach in synthetic biology for the production of prenylated metabolites in high amounts 
with a minimum cost represents the development of whole cell biocatalyst e.g. coexpression of 
NRPS and prenyltransferase genes in the same organism. For instance, the NRPS gene ftmPS 
was expressed together with the cyclic dipeptide prenyltransferase genes cdpC2PT, cdpNPT or 
cdpC3PT resulting in the NRPS produced brevianamide F and subsequently the corresponding 
prenylated derivatives thereof (Mundt & Li 2013; Yin et al., 2010; Yu et al., 2013). 
Furthermore, the “Autodisplay” technique reported for the C4-prenyltransferase FgaPT2, which 
was displayed on the surface of E. coli cells, is a further example for an advanced technique in 
chemoenzymatic synthesis.  
A further important point for chemoenzymatic synthesis is the creation of new biocatalysts by 
site-directed mutagenesis based on structural analyses including the availability of crystal 
structures or modeling experiments. Thereby enzymes with changed substrate specificity and 
regioselectivity or enzymes with optimized catalytic efficiency could be generated. One 
example for successful mutant design was shown for the intensively studied FgaPT2. Modeling-
guided site-directed mutagenesis of FgaPT2 resulted in a changed substrate preference from a 
tryptophan C4- to a tyrosine C3-prenylating enzyme (Fan et al., 2015a). 
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2. Aims of this thesis
The following issues have been addressed in this thesis: 
Identification and biochemical investigations of tryptophan prenyltransferases from 
actinomycetes 
The DMATS superfamily represents the largest and most investigated subgroup among 
aromatic prenyltransferases. Whereas the recent research was primarily focussed on 
prenyltransferases from fungi, this study should offer more insights into the function of bacterial 
DMATSs. The known bacterial tryptophan prenyltransferases are all from actinomycetes and 
involved in the biosynthesis of prenylated indole derivatives. In order to identify and 
characterize further bacterial indole prenyltransferases, following experiments were carried out: 
 Sequence homology search with known bacterial tryptophan prenyltransferases to
identify putative indole prenyltransferases.
 Amplifying and cloning of the putative prenyltransferase genes SAML0654, Strvi8510,
and MolI14.36 from gDNA of S. ambofaciens ATCC2387, S. violaceusniger Tü 4113,
and M. olivasterospora DSM 43868, respectively.
 Overproduction and purification of the recombinant proteins SAML0654, Strvi8510 and
MolI14.36.
 Proving enzyme activity with several indole derivatives and other substances by enzyme
assays and HPLC analysis.
 Proving acceptance of different prenyl donors.
 Isolation of enzyme products for structure elucidation by NMR and mass analyses.
 Biochemical characterization of the recombinant enzymes by proving the ion
dependency and determination of kinetic parameters for several substrates.
 Comparison of the biochemical properties of the newly identified prenyltransferases
with those of other DMATSs.
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Investigations on the acceptance of unnatural allyl and benzyl diphosphates by tryptophan  
C5-, C6-, and C7-prenylating enzymes 
Members of DMATS superfamily show a remarkably high flexibility toward aromatic 
substrates and are usually more specific toward their prenyl donor. Nevertheless prenyl 
diphosphates like GPP and FPP were also accepted with lower activity by few DMATS e.g. 6-
DMATSSa and 6-DMATSSv identified within this work. These two enzymes accepted both 
DMAPP and GPP as prenyl donor. Previous investigations with tryptophan C4- and C5-
prenyltransferases showed that they also used the unnatural MAPP, 2-pentenyl-PP or benzyl-
PP as alkyl/benzyl donors (Liebhold et al., 2012; Liebhold & Li 2013). Due to the availability 
of the two 6-DMATSs from Streptomyces and the L-tyrosine prenyltransferase TyrPT with a 
tryptophan C7-prenyltransferase activity in our laboratory, these studies could be expanded by 
investigations with tryptophan C-6- and C-7-prenylating enzymes. The aim of this project was 
to analyze the behaviors of the DMATSs in the presence of unnatural DMAPP analogs and to 
expand their potential usage in chemoenzymatic synthesis. 
 Overexpression and subsequent purification of the recombinant proteins of two C5-
prenyltransferases 5-DMATS and 5-DMATSSc, two C6-prenyltransferases 6-DMATSSa
and 6-DMATSSv as well as the L-tryptophan C7-prenylating TyrPT.
 Preparation of enzyme assays containing the recombinant proteins, DMAPP analogs
and L-tryptophan.
 Evaluation of the assays on HPLC and determination of enzyme activities.
 Isolation of enzymatic products for structure elucidation by NMR spectroscopy and MS
analysis.
 Determination of the kinetic parameters for the three DMAPP analogs.
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Investigation on DMATSs regarding their substrate specificity and regioselectivity for mono- 
and diprenylation of enantiomers of tryptophan and methylated derivatives thereof 
As mentioned in the previous project, the tryptophan prenyltransferase 6-DMATSMo from M. 
olivasterospora was identified and characterized. The finding of the unusually high acceptance 
of D-tryptophan by 6-DMATSMo prompted us to study the enantioselectivity of several 
DMATSs toward L- and D-isomers of tryptophan and analogs. In addition, the regioselectivity 
and the capability for diprenylation of the enzymes were analyzed and compared to each other. 
For this propose the following experiments were carried out: 
 Overproduction and purification of the recombinant proteins FgaPT2, 5-DMATS, 5-
DMATSSc, 6-DMATSSv, 6-DMATSSa and 7-DMATS.
 Enzyme assays with L- and D-tryptophan and subsequent HPLC analysis.
 Determination of kinetic parameters of DMATSs toward L- and D-tryptophan.
 NMR analysis of the enzyme products of D-tryptophan with 5-DMATSSc.
 LC-MS and HPLC analyses for detection and identification of prenylated tryptophan
products.
 Isolation of L- and D-enantiomers of 5-methyltryptophan, 6-methyltryptophan, and 7-
methyltryptophan from their racemates by using chiral column on HPLC.
 Enzyme assays with isolated enantiomers of methylated tryptophan derivatives.
 HPLC and LC-MS analyses for enzyme activities and prenylation of methylated
tryptophan derivatives.
 Isolation of enzyme products for 5-methyl-D-tryptophan with 6-DMATSMo and 5-
DMATSSc and structure elucidation by NMR analysis.
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3. Results and Discussion
3.1. Identification and biochemical investigations of tryptophan 
prenyltransferases from actinomycetes 
Previous studies on prenyltransferases were mainly focused on the DMATS enzymes, 
especially on those with fungal origin. Tryptophan prenyltransferases from fungi and bacteria 
have different polypeptide lengths, 420 to 470 amino acids of those from fungi versa 370 to 390 
amino acids from bacteria. They share practically no homology on the amino acid level, but 
catalyze independent of their origins the regiospecific prenylation of tryptophan in the presence 
of DMAPP, in some cases even the same reaction (Winkelblech et al., 2015a). In contrast to 
the extensively investigated DMATS enzymes from fungi, only few members of the bacterial 
tryptophan prenyltransferases were characterized biochemically. Therefore, biochemical 
characterization of new tryptophan prenyltransferases from bacteria will contribute to our 
understanding on these enzymes from different origins.  
Fig. 3.1 Gene clusters containing selected tryptophan prenyltransferase genes from actinomycetes (modified from 
Ozaki et al., 2013 and Satou et al., 2014). 
The identified bacterial tryptophan prenyltransferases involved in the biosynthesis of 
prenylated indole derivatives are all from actinomycetes. Two gene clusters containing iptA for 
a 6-DMATS and SCO7467 for a 5-DMATS (5-DMATSSc) were identified in the biosynthesis 
of 6- DMAI-3-carbaldehyde in Streptomyces sp. SN-593 and 5-DMAI-3-acetonitrile in S. 
coelicolor A3(2), respectively (Ozaki et al., 2013; Subramanian et al., 2012; Takahashi et al., 
2010). BLAST searching with these two enzymes led to identification of several homologues 
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in bacterial genomes, including SAML0654 from S. ambofaciens ATCC2387, Strvi8510 from 
S. violaceusniger Tü 4113 and MolI14.36 from M. olivasterospora (Fig. 3.1) (Ozaki et al., 
2013; Subramanian et al., 2012; Takahashi et al., 2010).  
 
3.1.1. Identification and characterization of the two 6-DMATSs SAML0654 
and Strvi8510 from Streptomyces 
The deduced proteins of SAML0654 and Strvi8510 with 375 (39.9 kDa) and 380 (40.9 kDa) 
amino acids, respectively, share a sequence identity of 63 % on the amino acid level. The coding 
gene Strvi8510 was found in a gene cluster accompanied by a tryptophanase gene (type A gene 
cluster). Such gene clusters consist of four further genes encoding for a sensor-like histidine 
kinase, two hypothetical proteins and an ATP/GTP-binding protein (Satou et al., 2014) (Fig. 
3.1). Type A gene clusters with corresponding prenyltransferase genes have been identified in 
several actinomycetes, e.g. Streptomyces sp. SN-593 with the gene for IptA, A. missouriensis 
with IptAAm, Streptomyces sp MBT28 with IsaA and M. olivasterospora with MolI14.36, which 
was part of the present study (Ozaki et al., 2013; Satou et al., 2014; Wu et al., 2015). In 
comparison, the tryptophan prenyltransferase gene SAML0654 is associated with genes coding 
for a flavin-dependent monooxygenase and a cytochrome P450. This gene cluster belongs to 
so-called type B gene clusters similar to that with SCO7467 (5-DMATSSc) from S. coelicolor 
(Fig. 3.1).  
For heterologous expression in E. coli, SAML0654 and Strvi8510 were cloned into the 
expression vector pQE60 (pJW12) and pHIS8 (pJW18), respectively. The recombinant His-
tagged proteins were purified to near homogeneity and analyzed by SDS-PAGE. Monomeric 
characteristics were suggested for 6-DMATSSa with a molecular mass at 36.9 kDa and for 6-
DMATSSv with a molecular mass at 46.0 kDa determined by size exclusion chromatography.  
Evaluation of the respective enzyme assays on HPLC revealed a high flexibility toward indole 
derivatives for both enzymes with almost similar conversion yields. Structure elucidation of the 
isolated enzyme products led to identification of SAML0654 and Strvi8510 as C6-prenylating 
enzymes referred to as 6-DMATSSa and 6-DMATSSv, respectively. These results were 
somewhat surprising due to the higher sequence identity of SAML0654 to 5-DMATSSc (75 %) 
than to the 6-DMATS IptA (60 %). Therefore, it provided a good example that the function of 
enzymes cannot be predicted with accuracy by protein sequence alignments and thus illustrates 
the necessity of experimental proof. Their functions as L-tryptophan prenyltransferase were 
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further confirmed by determination of the kinetic parameters. Detailed biochemical 
investigations of the two 6-DMATSs and especially of 6-DMATSSa revealed several interesting 
features for tryptophan prenyltransferases (Fig. 3.2). For instance, these enzymes show a high 
promiscuity not only toward the prenyl acceptor, as characteristic feature of most DMATS 
enzymes, but also toward the prenyl donor. So far, the most of the known tryptophan 
prenyltransferases utilize solely DMAPP as prenyl donor (Ozaki et al., 2013; Schultz et al., 
2008; Subramanian et al., 2012; Takahashi et al., 2010; Yu & Li 2012). 6-DMATSSa and 6-
DMATSSv are the first examples that also accept GPP as prenyl donor with the same 
regiospecific prenylation as for DMAPP. 
Fig. 3.2 Substrate specificity and regioselectivity of 6-DMATSSa. 6-DMATSSa catalyzes a regiospecific C6-
prenylation of tryptophan and derivatives in the presence of DMAPP and GPP. Dihydroxynaphthalenes are 
prenylated at the unsubstituted ring by 6-DMATSSa (modified graphical content of Winkelblech et al., 2014). 
Moreover, their broad substrate specificity was demonstrated by the acceptance of several 
hydroxynaphthalenes, which are the natural substrates of some prenyltransferases of the 
CloQ/NphB group. Several DMATSs from fungi including FgaPT2 and 7-DMATS also 
catalyze the prenylation of several hydroxynaphthalenes (Yu et al., 2011), but no report for an 
acceptance of hydroxynaphthalenes by bacterial tryptophan prenyltransferases was found prior 
to this study. The substrate preferences of 6-DMATSSa and 6-DMATSSv toward the naphthalene 
derivatives differ from those of fungal indole prenyltransferases. For example, 1,3- and 2,3-
hydroxynaphthalenes were better accepted by 6-DMATSSa, while 1-naphthol was a better 
substrate for fungal DMATSs. More interestingly, 1,3- and 2,3-dihydroxynaphthalenes were 
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prenylated at their unsubstituted benzene rings, which has not been reported previously for an 
enzymatic prenylation (Fig. 3.2). 
In summary, two new bacterial 6-DMATS were identified and characterized. Their special 
characteristics including the broad flexibility toward prenyl donor and acceptor as well as their 
high regioselectivity makes them good candidates for chemoenzymatic synthesis. Furthermore, 
crystal structures of these enzymes would provide new insights for understanding the reaction 
mechanism of bacterial prenyltransferases. 
For details of this work, please see the publication (section 4.1) 
Winkelblech, J. & Li, S.-M. (2014). Biochemical investigations of two 6-DMATS enzymes 
from Streptomyces revealing novel features of L-tryptophan prenyltransferases. Chembiochem. 
15, 1030-1039.
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3.1.2. Biochemical investigations on MolI14.36 from Micromonospora 
olivasterospora 
After identification of 6-DMATSSa and 6-DMATSSv, the putative homologous bacterial 
tryptophan prenyltransferase MolI14.36 from M. olivasterospora was successfully 
overproduced in E. coli. MolI14.36 shares a sequence identity of 68 % with IptAAm from A. 
missouriensis (Satou et al., 2014), 44 % with IptA from Streptomyces sp. SN-593 (Takahashi 
et al., 2010), 42 % with 6-DMATSSv from S. violaceusniger (Winkelblech & Li 2014), and 38 
% with 6-DMATSSa from S. ambofaciens (Winkelblech & Li 2014) (Table 1). Due to these 
differences in the amino acid sequences we proved the function of MolI14.36 by biochemical 
investigations in order to expand our knowledge on tryptophan prenyltransferases with bacterial 
origin. Similar to Strvi8510 and several other genes of bacterial tryptophan prenyltransferases, 
the coding gene MolI14.36 belong to type A gene cluster (Fig. 3.1).  
The corresponding coding gene sequence was cloned into pHIS8 resulting in the expression 
construct pJW32. The His8-tagged protein with a calculated molecular mass of 43.5 kDa was 
purified to near homogeneity with a protein yield of 16 mg per liter of culture for comprehensive 
investigations. The molecular mass of the recombinant protein was determined by size 
exclusion chromatography to be 46 kDa as in the case of 6-DMATSSv, indicating that 
MolI14.36 presumably acts as a monomer. 
Table 1 Comparison of protein identities of selected bacterial tryptophan prenyltransferases. 
SAML0654 
(6-DMATSSa) 
Strvi8510 
(6-DMATSSv) 
MolI14.36 
(6-DMATSMo) 
IptA 
AMIS_22580 
(IptAAm) 
Strvi8510 
(6-DMATSSv) 
63 % 
MolI14.36 
(6-DMATSMo) 
38 % 42 %
IptA 60 % 64 % 44 % 
AMIS_22580 
(IptAAm) 
38 % 39 % 68 % 39 % 
SCO7467 
(5-DMATSSc) 
75 % 60 % 40 % 59 % 38 % 
MolI14.36 was assayed with L-tryptophan, its enantiomer and eight analogs thereof, which were 
all well accepted with conversion yields of higher than 15 %. These results demonstrate its high 
substrate flexibility for indole derivatives. Structure elucidation of the isolated enzyme products 
by MS and NMR analyses revealed that MolI14.36 catalyzes a unique or predominant C6-
prenylation at the indole ring of tryptophan and analogs. As in the case of IptA and 6-DMATSSa 
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a switch of the prenylation site to C-7 was detected for 6-methyl-DL-tryptophan which is 
blocked at position C-6 (Takahashi et al., 2010; Winkelblech & Li 2014). In conclusion, 
MolI14.36 was identified as a L-tryptophan C6-prenyltransferase and therefore termed 6-
DMATSMo. Moreover, the enzyme also accepted several cyclic dipeptides as well as 
naphthalene derivatives. Thereby the preferences of the orthologues 6-DMATSMo, 6-DMATSSa, 
and 6-DMATSSv differ from each other (Fig 3.3). In addition, GPP was also used as a prenyl 
donor by 6-DMATSMo, which is similar to the two other 6-DMATSs. Investigations on 
biochemical properties revealed that metal ions are not essential for the enzyme activity as 
observed for other members of the DMATS superfamily (Takahashi et al., 2010; Winkelblech 
& Li 2014; Yu et al., 2012). 
Fig. 3.3 Comparison of the substrate preferences of the three 6-DMATS enzymes 6-DMATSMo, 6-DMATSSv, and
6-DMATSSa. The conversion yields toward several indole derivatives, cyclic dipeptides as well naphthalene 
derivatives were determined relative to L-tryptophan. 
The high affinities to L-tryptophan and DMAPP demonstrated by kinetic parameters are in the 
same range of those of other tryptophan prenyltransferases (Ozaki et al., 2013; Takahashi et al., 
2010; Unsöld & Li 2005; Winkelblech et al., 2015b; Yu et al., 2012), justifying its function as 
a tryptophan prenyltransferase. The KM value for L-tryptophan is nearly the same as that of 6-
DMATSSa, but the calculated kcat value of 6-DMATSMo is much smaller than those of other 
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DMATS enzymes. Comparison of the enzyme activities for tryptophan and analogs revealed 
that the newly identified 6-DMATSMo showed clearly different preferences from those of 6-
DMATSSa and 6-DMATSSv. Therefore, these enzymes can be complementarily used as 
biocatalysts for specific prenylation of a given tryptophan analog. Interestingly, unusually high 
relative activity of approximately 50 % of that of L-tryptophan was found toward D-tryptophan. 
To the best of our knowledge, such high conversion for D-tryptophan has not been reported 
prior to this study. In contrast, relative activities of less than 25 % were observed for 6-
DMATSSa and 6-DMATSSv with D-tryptophan, respectively. These values are already relative 
high in comparison to other DMATS enzymes (Kremer & Li 2008; Steffan et al., 2007; 
Winkelblech & Li 2014).  
The natural function of MolI14.36 is unknown and no prenylated aromatic derivatives have 
been isolated from the fortimicin producer M. olivasterospora. Due to the high sequence 
similarity between 6-DMATSMo and IptAAm and genes in their neighbourhood, it can be 
speculated that both enzymes are involved in a very similar or the same biosynthetic pathway. 
IptAAm was proven to be responsible for the formation of 6-dimethylallyltryptophan, which was 
converted to 6-DMAI by the tryptophanase TnaAAm. 6-DMAI then serves as precursor for the 
biosynthesis of 3-hydroxy-6-DMAIN-2-one (Satou et al., 2014). Together with 6-DMATSMo, 
five 6-DMATSs, one 5-DMATS, and recently one 7-DMATS have been identified from 
actinomycetes (Winkelblech et al., 2015a; Wu et al., 2015). The increased number of known 
6-DMATS enzymes strengths the importance of C6-prenylated indole derivatives in 
actinomycetes, which should be explored in the future. In comparison, 6-DMATS enzyme was 
reported neither for fungi nor plant, although several indole derivatives with a dimethylallyl 
moiety at C-6 have been identified in these organisms (Achenbach et al., 1995; Fredenhagen et 
al., 1997).  
For details of this work, please see the publication (section 4.3) 
Winkelblech, J., Xie, X., Li, S.-M. (2016). Characterisation of 6-DMATSMo from 
Micromonospora olivasterospora leading to identification of divergence in enantioselectivity, 
regioselectivity and multiple prenylation of tryptophan prenyltransferases. Org. Biomol. Chem. 
DOI: 10.1039/C6OB01803C.  
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3.2. Investigations on the acceptance of unnatural allyl and benzyl 
diphosphates by tryptophan C5-, C6-, and C7-prenylating enzymes 
Due to the importance of bioactive prenylated secondary metabolites for medicinal research 
and drug development (Clardy & Walsh 2004; Newman & Cragg 2012), research on DMATSs 
has been enhanced regarding their potential application as biocatalysts for production of such 
compounds. Their remarkable broad substrate specificity and high regioselectivity toward 
aromatic prenyl acceptors provide an useful tool for increasing the diversity of desired 
prenylated products. DMAPP is the mostly used prenyl donor for the prenylation of a wide 
range of substrates catalyzed by DMATSs. Their potential usage in chemoenzymatic synthesis 
could be strongly widen by the acceptance of various donors. Therefore, investigations on the 
acceptance of different natural and also unnatural donors have been focussed in the recent years. 
Previous studies by Liebhold et al. demonstrated that the unnatural DMAPP analogs MAPP 
and 2-pentenyl-PP were accepted by tryptophan C4-, C5- as well as cyclic dipeptide C2- and 
C3-prenyltransferases (Liebhold et al., 2012; Liebhold & Li 2013). Furthermore, the more 
space-demanding benzyl-PP was accepted by the tryptophan C4-prenyltransferase FgaPT2 
(Liebhold & Li 2013). In the presence of these unnatural donors, the alkylation position of the 
enzyme products could be changed compared to the natural donor DMAPP. The finding of the 
high flexibility of 6-DMATSSa and 6-DMATSSv toward their prenyl donor and acceptor makes 
them interesting candidates for further investigations on the acceptance of unnatural alkyl or 
benzyl donors (Winkelblech & Li 2014). With identification of these two bacterial C6- 
prenyltransferases as well as the L-tyrosine prenyltransferase TyrPT with a tryptophan C7-
prenyltransferase activity, we were able to expand the previous studies which were limited to 
the fungal C4- and C5-prenylating enzymes. Moreover, the studies on tryptophan alkylation or 
benzylation by 5-DMATSSc from S. coelicolor completed the elucidation on the distinct 
behaviors of bacterial tryptophan prenyltransferases.  
The recombinant proteins of 5-DMATS, 5-DMATSSc, 6-DMATSSa, 6-DMATSSv and TyrPT 
were overproduced in E. coli, purified, and assayed with L-tryptophan and the aforementioned 
unnatural DMAPP analogs. MAPP, 2-pentenyl-PP as well as benzyl-PP were accepted by all 
the tested enzymes with different relative activities. More importantly, the selected enzymes 
showed different regioselectivities toward the unnatural donors. The unique enzyme products 
of 6-DMATSSa and 6-DMATSSv were identified as C6-alkylated or benzylated L-tryptophan by 
NMR and MS analyses. These findings are consistent with the previously reported data for GPP 
(see Chapter 3.1.1) and demonstrated that the two 6-DMATSs catalyze a very regiospecific 
reaction independent on the used donors. In comparison, the regioselectivity of 5-DMATS and 
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FgaPT2 was partially or completely shifted in the presence of the DMAPP analogs (Liebhold 
et al., 2012; Liebhold & Li 2013). In the case of the C7-prenylating enzyme TyrPT, C6-
alkylated or benzylated L-tryptophan was found as main or one of two predominant products. 
To compare alkylation or benzylation reactions catalyzed by bacterial and fungal enzymes, the 
regioselectivity of 5-DMATS and 5-DMATSSc were investigated. For 5-DMATS, the previous 
data were reproduced with MAPP and 2-pentenyl-PP, which revealed a shift of the prenylation 
from C-5 to C-6 of the indole ring (Liebhold et al., 2012). C6-alkylated tryptophan was the sole 
product of 2-pentenyl-PP and the main product of MAPP. In the assays with benzyl-PP, C5- 
and C6-benzylated products were detected, with the latter one as main product, Similar to the 
TyrPT reactions with 2-pentenyl-PP and benzyl-PP, 5-DMATSSc produced C5-, C6- and C7-
alkylated or benzylated derivatives, confirming the preference for an alkylation at C-6 of the 
indole ring in the presence of the unnatural DMAPP analogs. Furthermore, the reduced 
regioselectivity of 5-DMATSSc disproved the bacterial origin as reason for a high 
regioselectivity as observed for the 6-DMATSs.  
To explain the observed phenomenon of divergence in regioselectivity, a homology model for 
5-DMATS was generated, using the structure of FgaPT2 as template. Docking studies and MD 
simulations with the 5-DMATS homology model and DMAPP, MAPP or 2-pentenyl-PP 
resulted in a distance-based explanation for the observed regioselectivities. Therefore, the 
donor-acceptor distance was speculated as major factor for the regioselectivity of the 
prenyltransferases. MD simulation with benzyl-PP was not successful, because it became 
unstable.  
In conclusion, we completed the study on the acceptance of unnatural DMAPP analogs by 
comprehensive investigations on the regioselectivity of two C5-prenyltransferases 5-DMATS 
and 5-DMATSSc, two C6-prenyltransferases 6-DMATSSa and 6-DMATSSv as well as one C7-
prenyltransferase TyrPT. The results demonstrated a clear preference of the five enzymes for 
alkylation or benzylation at C-6 of the indole ring in the presence of unnatural DMAPP analogs 
(Fig. 3.4). 
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Fig. 3.4 Tryptophan C5-, C6- and C7-prenylating enzymes preffered C6-prenylation of the indole ring in the 
presence of the indicated unnatural dimethylallyl diphosphate analogs. 
This study provides new opportunities for the production of new alkylated or even benzylated 
indole derivatives. New insights into the substrate binding sites of such enzymes and a more 
accurate explanation for their differences in regioselectivity could be obtained by further 
analyses on protein structures in complex with unnatural DMAPP analogs. 
This project was a cooperation with Dr. Mike Liebhold. Homology modeling, docking 
experiments, and MD simulation were done in cooperation with Jakub Gunera and Prof. Dr. 
Peter Kolb from Philipps-Universität in Marburg. 
For details of this work, please see the publication (section 4.2) 
Winkelblech, J., Liebhold, M., Gunera, J., Xie, X., Kolb, P. & Li, S.-M. (2015). Tryptophan 
C5-, C6- and C7-prenylating enzymes displaying a preference for C-6 of the indole ring in the 
presence of unnatural dimethylallyl diphosphate analogs. Adv. Synth. Catal. 357, 975-98.
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3.3. Investigation on DMATSs regarding their substrate specificity 
and regioselectivity for mono- and diprenylation of enantiomers of 
tryptophan and methylated derivatives thereof 
Chiral molecules such as amino acids can occur as L- and D-isomers and fulfill essential roles 
in biological and chemical processes of life (Shimada & Ozaki 2012). In nature, the occurrence 
of α-amino acids is strongly predominated by the L-enantiomer, but the less abundant D-form 
is also widely spread in nature and play an important role in biological systems (Gao et al., 
2015). For instance, D-amino acids provide protease resistance in cell walls of bacteria, function 
as neurotransmitter in nervous system of animals or contained fungal and bacterial peptide 
antibiotics (Cava et al., 2011; D'Aniello et al., 2011; Gao et al., 2015; Strauch et al., 2015). 
Such compounds are also interesting candidates for diverse industrial applications. For 
example, D-amino acids were used in pharmaceutical industry for semi-synthetic antibiotics or 
as potential agents for treatment of several disease such as Alzheimer’s diseases, HIV and 
cancers (Gao et al., 2015; Kumar & Sim 2014; Veine et al., 2014; Welch et al., 2007). In this 
thesis, the amino acid tryptophan and derivatives thereof play a significant role. L-tryptophan 
serves a key precursor for various secondary metabolites including prenylated indole 
derivatives (Li 2010).  
The transfer reaction of the isoprenoid moiety onto the aromatic substrate is catalyzed by 
prenyltransferases, comprising C4-, C5-, C6- and C7- prenyltransferases and usually improve 
their biological activity (Botta et al., 2005a; Li 2010; Liu et al., 2013b; Oya et al., 2015; 
Winkelblech et al., 2015a; Wollinsky et al., 2012). In previous reports on substrate specificity 
of DMATSs, a much lower enzyme activity toward D-tryptophan than to L-tryptophan were 
reported (Fan et al., 2015b). More substrate flexibility toward the D-form was observed for 6-
DMATSSa and 6-DMATSSv and a remarkably high acceptance was found for the recently 
identified 6-DMATSMo. This result prompted us to carry out comparative investigation on the 
divergence of microbial DMATSs regarding their preferences and regioselectivities for 
enantiomers. Therefore, we evaluated the acceptance of L- and D-tryptophan and their 
methylated derivatives 5-, 6-, and 7-methyltryptophan by seven DMATSs. The corresponding 
enzyme assays with FgaPT2, 5-DMATS, and 7-DMATS from fungi and 5-DMATSSc, 6-
DMATSSa, 6-DMATSSv, and 6-DMATSMo from bacteria were elucidated by HPLC on a chiral 
column as well as by LC-MS analysis. The results displayed different preferences for the tested 
recombinant enzymes toward L- and D-enantiomers of tryptophan and methylated derivatives.  
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In most cases, the L-form of the tested substrates was accepted with significantly higher 
conversion yields than the D-form by the DMATSs. In contrast, 5-DMATSSc and 6-DMATSMo 
revealed a very high flexible enantioselectivity. Both enzymes accepted all of the tested D-
enantiomers. More interestingly 5-DMATSSc and 6-DMATSMo accepted the D-enantiomer of 
5-methyltryptophan much better than the respective L-enantiomer, confirmed by determination 
of the kinetic parameters. In the presence of the racemate conversion yields of the D-enantiomer 
were reduced or even completely disabled. Corresponding kinetic studies with the enantiomers 
of 5-methyltryptophan explained the repression of the D-enantiomer reaction by the high 
affinities toward the L-enantiomers. However, the strong inhibition of the D-tryptophan reaction 
in the presence of the racemate cannot be attributed solely to the high affinity to the L-form, 
due to the fact that the L-form was almost completely converted at the end of incubation. 
Therefore, we speculated that the products of L-tryptophan could also function as inhibitors.  
As already mentioned, the tested enzymes all catalyze a highly regiospecific prenylation on L-
tryptophan by using DMAPP as donor. In contrast, the L-tryptophan C4-prenyltransferase 
FgaPT2 and C5-prenyltransferase 5-DMATSSc displayed a reduced regioselectivity toward D-
tryptophan with C5- and C6-prenylated derivatives as main products, respectively. Clearly 
different regioselectivities were also identified for enantiomers of 5-methyltryptophan with 
FgaPT2, 5-DMATSSc and 7-DMATS.  
An additional interesting output of this study is the capability for diprenylation observed for the 
bacterial 5-DMATSSc. For L-tryptophan, the two diprenylated products 5,6- and 5,7-di-
dimethylallyl-L-tryptophan were identified in a ratio of 1:1 by NMR analysis. In comparison, 
5,6-di-dimethylallyl-D-tryptophan was detected as main diprenylated product in the reaction 
mixture with D-tryptophan. Diprenylation of tryptophan by 5-DMATSSc was the first example 
for a tryptophan prenyltransferase, which catalyzes two successive prenylation steps. The 
presented results pointed out the different biochemical behaviors of the tryptophan 
prenyltransferases in many respects and therefore expand significantly our knowledge in this 
field. For instance, this was the first comprehensive study on enantioselectivity of 
prenyltransferases which supplied interestingly new features.  
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Fig. 3.5 Microbial tryptophan C4-,C5-, C6- and C7-prenyltransferases catalyze prenylation of L- and D-tryptophan 
(A-E). FgaPT2 (A), 5-DMATSSc (B), and 5-DMATS (C) differ in their reactions toward L- (red) and D- enantiomer 
(blue). 6-DMATSs (D) and 7-DMATS (E) catalyze the same reaction with both enantiomers. 
Moreover D-amino acids and also monosubstituted tryptophan derivatives are of great 
medicinal value. For instance, D-Phe or D-Pro derivatives can be used for treatment of several 
disease such as Alzheimer’s disease, diabetes mellitus, familial amyloid polyneuropathy, 
scrapie, and Kreuzfeld-Jacob disease or depression and Parkinson’s disease, respectively (Gao 
et al., 2015; Heller 1982). Furthermore, the monosubstituted tryptophan derivatives 6-
chlorotryptophan, 1-methyl-L- and 1-methyl-D-tryptophan were found as inhibitors of 
indoleamine 2,3-dioxygenase, which is involved in several disorders such as cataracts, 
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Alzheimer’s disease and cancer (Di et al., 2010; Fukushima et al., 2015; Jia et al., 2008; Saito 
et al., 1993; Tanaka et al., 2013). Therefore the presented biochemical properties of these 
enzymes make them potential biocatalyst in chemical synthesis for prenylated indole 
derivatives, which represent promising candidates for drug development. Testing the 
bioactivity of these compounds is intended in near future.  
 
For details of this work, please see the publication (section 4.3) 
Winkelblech, J., Xie, X., Li, S.-M. (2016). Characterisation of 6-DMATSMo from 
Micromonospora olivasterospora leading to identification of divergence in enantioselectivity, 
regioselectivity and multiple prenylation of tryptophan prenyltransferases. Org. Biomol. Chem. 
DOI: 10.1039/C6OB01803C.  
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Biochemical Investigations of Two 6-DMATS Enzymes from
Streptomyces Reveal New Features of l-Tryptophan
Prenyltransferases
Julia Winkelblech[a, b] and Shu-Ming Li*[a, b]
Introduction
Natural products and their derivatives are important resources
for drug discovery and development.[1] Prenylated aromatic
compounds, including prenylated indole derivatives, represent
a large group of secondary metabolites and are widely distrib-
uted across bacteria, fungi, and plants. Prenylation (transfer re-
actions of nxC5-units) contributes largely to structural diversity
and often significantly increases the biological and pharmaco-
logical activity of the resulting compounds. These prenylation
reactions and the responsible enzymes are of interest not only
to biologists but also to scientists from other disciplines.[2–6]
The transfer reactions of prenyl moieties from prenyl donors
(usually dimethylallyl diphosphate, DMAPP) onto indole nuclei
are catalyzed in nature by indole prenyltransferases. A large
number of such enzymes of the dimethylallyltryptophan syn-
thase (DMATS) superfamily have been identified in recent years
in bacteria and fungi, and these have been studied biochemi-
cally.[7–10] They mainly accept tryptophan and tryptophan-con-
taining cyclic dipeptides as substrates and catalyze regiospecif-
ic prenylation at the indole ring.[8] Three DMATS enzymes that
use l-tryptophan and DMAPP as substrates have been identi-
fied in Aspergillus fumigatus and Aspergillus clavatus : FgaPT2,
5-DMATS, and 7-DMATS. They were shown to catalyze prenyla-
tion of l-tryptophan at C-4, C-5, and C-7, respectively.[11–13]
Three bacterial DMATSs have shown prenylation at positions
N1, C-5, and C-6: CymD (Salinispora arenicola), SCO7467 (Strep-
tomyces coelicolor), and IptA (Streptomyces sp. SN-593), respec-
tively.[7, 9,10,14] Fungal DMATS enzymes share very little sequence
similarity with those from bacteria.
Similarly to most known indole prenyltransferases, FgaPT2,
5-DMATS, IptA, and 7-DMATS exhibit high specificity for their
prenyl donor DMAPP and do not accept geranyl diphosphate
(GPP) as a substrate.[9, 11,13, 15] In contrast, they show high pro-
miscuity for the aromatic substrate and accept a large number
of tryptophan derivatives.[9,11, 16,17] FgaPT2 and 7-DMATS even
used hydroxynaphthalenes as prenyl acceptors;[18] these are
natural substrates of prenyltransferases of the CloQ/NphB
group, from both bacteria and fungi.[19,20] The acceptance of
hydroxynaphthalenes by FgaPT2 and 7-DMATS encouraged us
to compare the biochemical properties and substrate specifici-
ties of DMATSs from bacteria and fungi. BLAST searching with
the 6-DMATS IptA from Streptomyces sp. SN-593 and the 5-
DMATS SCO7467 from S. coelicolor revealed several homo-
logues in bacterial genomes, including SAML0654 from Strep-
tomyces ambofaciens ATCC2387[7,21] and Strvi8510 from Strepto-
myces violaceusniger T 4113. SAML0654 shares 75% amino
acid sequence identity with SCO7467, 60% with IptA, and 63%
with Strvi8510, thus it was speculated that SAML0654 func-
tions as a 5-DMATS. Strvi8510 showed 60 and 64% identity
with SCO7467 and IptA, respectively, so the specific reaction
catalyzed by this enzyme could not be predicted from se-
quence analysis. Here, we report the cloning and expression of
SAML0654 and Strvi8510 and their identification as 6-DMATSs.
Two putative prenyltransferase genes, SAML0654 and Strvi8510,
were identified in Streptomyces ambofaciens and Streptomyces
violaceusniger, respectively. Their deduced products share 63%
sequence identity. Biochemical investigations with recombi-
nant proteins demonstrated that l-tryptophan and derivatives,
including d-tryptophan, 4-, 5-, 6- and 7-methyl-dl-tryptophan,
were well accepted by both enzymes in the presence of
DMAPP. Structural elucidation of the isolated products revealed
regiospecific prenylation at C-6 of the indole ring and proved
unequivocally the identification of two very similar 6-dimethyl-
allyltryptophan synthases (6-DMATS). Detailed biochemical in-
vestigations with SAML0654 proved l-tryptophan to be the
best substrate (Km 18 mm, turnover 0.3 s
1). Incubation with dif-
ferent prenyl donors showed that they also accepted GPP and
catalyzed the same specific prenylation. Utilizing GPP as
a prenyl donor has not been reported for tryptophan prenyl-
transferases previously. Both enzymes also catalyzed prenyla-
tion of some hydroxynaphthalenes; this has not previously
been described for bacterial indole prenyltransferases. Interest-
ingly, SAML0654 transferred prenyl moieties onto the unsubsti-
tuted ring of hydroxynaphthalenes.
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Biochemical characterization of the recombinant proteins re-
vealed several new features for the tryptophan prenyltransfer-
ases in terms of substrate specificity towards both prenyl
donor and acceptor as well as the unusual prenylation position
of hydroxynaphthalenes.
Results
Sequence analysis
SAML0654 is a member of a small gene cluster (type B) found
in several actinomycetes strains, for example, S. coelicolor and
Streptomyces lividans ; it contains genes for a prenyltransferase
and for a flavin-dependent monooxygenase.[7,9] Heterologous
expression of the prenyltransferase gene SCO7467 and the
flavin-dependent monooxygenase gene SCO7468 from S. coeli-
color A3(2) in S. lividans TK23 resulted in the formation of 5-di-
methylallylindole-3-acetonitrile.[7] It was speculated that similar
clusters in other strains including S. ambofaciens would also be
responsible for the biosynthesis of 5-dimethylallylindole-3-ace-
tonitrile.[7] In comparison to those in S. coelicolor A3(2) and
S. lividans, the SAML0654-containing gene cluster in S. ambofa-
ciens has an additional gene coding for a cytochrome P450,
but its end product is unknown.[7] Strvi8510 from S. violaceus-
niger and IptA from Streptomyces sp. SN-593 belong to type A
gene clusters found in different actinomycetes.[7] Although no
gene coding for a flavin-dependent monooxygenase is found
in these clusters, there is a gene for tryptophanase. These clus-
ters were speculated to be responsible for the formation of 6-
dimethylallylindole-carbardehyde.[7]
The deduced product of SAML0654 has 375 amino acids and
a calculated mass of 39.9 kDa. The deduced product of
Strvi8510 has 380 amino acids and a calculated mass of
40.9 kDa.
Cloning and purification of overexpressed His-tagged
SAML0654 and Strvi8510
To prove its function biochemically, SAML0654 was amplified
by PCR from genomic DNA of S. ambofaciens DSM40053. The
PCR product (1133 bp) was cloned into pGEM-T Easy and then
subcloned into vector pQE-60, thereby resulting in the expres-
sion construct pJW12. The C-terminal His6-tagged protein was
overproduced in Escherichia coli M15 (induction with 0.5 mm
IPTG) at 30 8C for 16 h and purified by Ni-NTA affinity chroma-
tography.
For the overproduction of Strvi8510, expression plasmid
pJW13 was constructed by PCR amplifying the gene from ge-
nomic DNA of S. violaceusniger T 4113 and subcloning into
pQE-70. After unsuccessful expression attempts with pJW13,
the gene was again amplified, and the product (1155 bp) was
cloned into pGEM-T Easy and subcloned into vector pHIS8,
thereby resulting in the expression construct pJW18. The N-ter-
minal His8-tagged protein was overproduced in E. coli BL21
(DE3) pLysS cells (induction with 0.5 mm IPTG) at 22 8C for 16 h
and purified by Ni-NTA affinity chromatography.
SDS-PAGE analysis of the purified proteins showed signifi-
cant bands just below the 45 kDa size marker (Figure S1 in the
Supporting Information); these correspond well to the calculat-
ed masses of the His6- and His8-tagged proteins (41.1 and
43.3 kDa, respectively). Protein yields of 3.5 mg purified protein
per liter of culture were obtained for both enzymes.
Acceptance of tryptophan and derivatives by SAML0654
and Strvi8510
Because of their high sequence similarity to tryptophan prenyl-
transferases, such as SCO7467 from S. coelicolor and IptA from
Streptomyces sp. SN-593, SAML0654 and Strvi8150 were firstly
assayed with l-tryptophan (1a) in the presence of DMAPP.
HPLC analysis clearly revealed the presence of one significant
product peak each in the incubation mixtures (Figure 1); this
was dependent on the presence of prenyl donor and active
protein (data not shown). Incubation of 1 mm 1a with 1 mm
DMAPP and 2.4 or 2.3 mm recombinant enzyme for 16 h at
37 8C achieved product yields of 59.4 and 42.2% for SAML0654
and Strvi8510, respectively.
d-tryptophan and 12 tryptophan derivatives (modifications
on the indole ring and at the side chain) were assayed subse-
quently with the purified proteins in the presence of DMAPP.
One product for each was detected in the incubation mixtures
of the tested tryptophan derivatives (Table S1). HPLC analysis
showed that d-tryptophan was well accepted by SAML0654
and Strvi8510, respectively (activities of 73.5 and 60.7% relative
to those for l-tryptophan; Table S1). Such high relative activity
for d-tryptophan by an l-tryptophan prenyltransferase has not
been reported previously. The known DMATS enzymes FgaPT2,
IptA, and 7-DMATS showed activities of 1.8, 4.3, and 15.5%,
respectively, relative to those with l-tryptophan.[9,12,13]
High conversion yields were also achieved for tryptophan
derivatives. In the incubation mixtures of SAML0654, conver-
sion yields for l-abrine (2a) and l-b-homotryptophan (3a)
were nearly the same as for l-tryptophan. Some of the incuba-
tion mixtures contained racemic substrates, and the conversion
yields of each enantiomer could not be determined. However,
the sum of their conversion yields was estimated from the
total amount of substrates. Relative activities of 96.4, 87.9,
72.2, and 51.3% (relative to l-tryptophan) were calculated for
4- (4a), 5- (5a), 6- (6a), and 7-methyl-dl-tryptophan (7a), re-
spectively (Figure 1, Table S1), thus proving high conversion of
d-configured tryptophan derivatives. In comparison, low prod-
uct formation was observed for 1-methyl-dl-tryptophan under
the same conditions.
HPLC analysis of the incubation mixtures of Strvi8510
showed that it, too, accepted well the tested tryptophan deriv-
atives. The relative activities of tryptophan derivatives with
Strvi8510 were in the same range as for SAML0654 (Table S1).
One significant exception was 3a (product yield 36.7%, relative
to that of 1a ; Table S1). Remarkably, for a given substrate the
products of Strvi8510 and SAML0654 had the same retention
times in the HPLC chromatograms, thus indicating the pres-
ence of same product. On the basis of substrate specificity to-
wards methylated tryptophan derivatives, one would conclude
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prenylation at position N1 by the tested enzymes. This con-
flicts with the high sequence similarity of SAML0654 and
Strvi8510 with the C5-prenyltransferase SCO7467 and C6-pre-
nyltransferase IptA.
Confirmation of the prenylation position of the enzyme
products
Based on the high sequence similarity with SCO7467, we
speculated that 5-DMAT could be the enzyme product of
SAML0654 with l-tryptophan and DMAPP. In the HPLC chroma-
togram of the incubation mixture with 1a, the enzyme peak
showed nearly the same retention time as C5-prenylated tryp-
tophan produced by 5-DMATS from A. clavatus (data not
shown). To confirm prenylation and determine the prenylation
position, seven enzyme products (1b–7b) were isolated by
HPLC from incubation mixtures of SAML0654 with 1a–7a in
the presence of DMAPP and subjected to MS and NMR analy-
ses (Tables S3–S4.1 and Figures S3.1–S3.7). High resolution EI-
MS (HR-EI-MS) revealed molecular masses 68 Da larger than
those of the respective substrates, thus verifying the attach-
ment of one dimethylallyl moiety to the substrates. The signals
in the 1H NMR spectra of the isolated enzyme products at dH=
3.37–3.56 (d, 2H-1’), 5.09–5.35 (t sept, H-2’), 1.74–1.83 (s, 3H-4’),
1.68–1.75 ppm (s, 3H-5’) confirmed the attachment of a regular
dimethylallyl moiety to a C atom.[9,11,16, 17] Comparison of the
NMR spectra of 1b–7b with those of 1a–7a revealed the dis-
appearance of signals for one aromatic proton, thus proving
the attachment of the prenyl moiety at the indole ring. The
singlet at dH=7.08–7.15 ppm for H-2 in all the spectra indicat-
ed that prenylation did not take place at C-2.
In the 1H NMR spectra of the enzyme products of 1a–3a,
the ABM coupling systems of three protons with coupling con-
stants of 8.2 and 1.2–1.5 Hz indicated attachment of a prenyl
moiety to C-5 or C-6. The 1H NMR spectra of 1b–3b clearly dif-
fered from those of the enzyme products of 5-DMATS with
1a–3a (coupling pattern and chemical shifts),[11] thus indicat-
ing prenylation at C-6. Furthermore, the 1H NMR spectra of 1b
and 2b corresponded well to those of the enzyme products of
IptA with 1a and 2a.[9] These findings unequivocally prove C6-
prenylation in 1b–3b (Figure 1).
The NMR spectrum of the product peak of 4a represents
a mixture of two products, 4b and 4c (2.4:1). Unfortunately,
4b and 4c could not be separated. However, it was possible
to assign the prenylation positions as C-6 in 4b and C-7 in 4c.
The presence of three singlets for aromatic protons in the
spectra of 4b and 5b unambiguously confirmed prenylation at
C-6. The two doublets at 7.4 and 6.9 ppm with a coupling con-
stant of 8.1 Hz in 6b and 7b proved prenylation at C-7 and C-
6, respectively. The structure of 4c was elucidated by interpre-
tation of the NMR spectrum and by comparison with those of
C5- and C7-prenylated derivative of 4a.[11,22]
In conclusion, SAML0654 from S. ambofaciens catalyzed the
prenylation of l-tryptophan and derivatives at C-6 of the
indole ring; it therefore functions as a 6-DMATS, (hereafter
termed 6-DMATSSa). If this position is blocked, for example by
a methyl group as in the case of 6a, the prenylation is shifted
to C-7, as observed for another 6-DMATS, IptA. Interestingly,
blocking of the C-6 by the methyl group did not significantly
reduce the enzyme activity of 6-DMATSSa. For 6a the activity
was 72.2% relative to that of 1a. In the case of IptA, for 6a
the activity was only 9.3% relative to that of 1a.
The enzyme product of Strvi8510 with 1a and DMAPP was
also isolated, and its structure was elucidated by NMR analysis :
the product (1b) was the same as for the incubation mixture
with SAML0654. This demonstrates clearly that Strvi8510 from
S. violaceusniger also functions as a tryptophan C6-prenyltrans-
ferase (hereafter termed 6-DMATSSv). As mentioned, the prod-
uct with 6-DMATSSv for a given tryptophan derivative showed
the same HPLC retention time as that with 6-DMATSSa. We con-
cluded that it produces the same products and decided not to
isolate these peaks.
GPP also serves as a prenyl donor for 6-DMATSSa and
6-DMATSSv
HPLC analysis of the DMATSSa reaction with 1a and GPP or far-
nesyl diphosphate (FPP) indicated product formation in the re-
action mixture of GPP, but not in that of FPP (data not shown).
Therefore, 1a and six derivatives (2a–7a) with high conversion
yields in the presence of DMAPP were incubated with GPP and
6-DMATSSa or 6-DMATSSv. Product formation was detected in
five cases with 6-DMATSSa (Table S1). In the assays with GPP
under the condition used for DMAPP, 1a, 2a, and 5a were ac-
cepted by 6-DMATSSa with conversion yields of 26.45, 10.8, and
21.6%, respectively (Figure 2), that is, with activities of 46.2,
18.8, and 37.8% relative to that of 1a with DMAPP (Table S1).
With 9.6 mm 6-DMATSSa in the reaction mixtures of l-trypto-
phan and GPP, an absolute conversion yield of 40% was ach-
ieved. In comparison, GPP was a poor prenyl donor for 6-
DMATSSv : low product formation was only detected with 1a
and 5a (activities of 3.7 and 6.2%, respectively, relative that for
DMAPP with 1a). For structure elucidation, 1a, 2a, and 5a
were incubated with 6-DMATSSa in large scale (10 mL) at 37 8C
for 16 h. The enzyme products 1c, 2c, and 5c with GPP were
isolated on HPLC and subjected to MS and NMR analyses.
MS analysis showed that the molecular masses of 1c, 2c,
and 5c were 136 Da larger than those of 1a, 2a, and 5a,
respectively, thus proving attachment of a geranyl moiety. De-
tailed inspection of the 1H NMR spectra revealed signals for
a regular geranyl residue attached at a C atom.[15] The chemical
Figure 1. HPLC analysis of enzyme assays with 1a–7a in the presence of DMAPP (left), and prenyl transfer reactions catalyzed by 6-DMATSSa and 6-DMATSSv
(right). Reaction mixtures (100 mL) contained 50 mm Tris·HCl (pH 7.5), 5 mm MgCl2, 1 mm aromatic substrate, 1 mm DMAPP, 0.15–5% (v/v) glycerol, 0–5% (v/v)
DMSO, and 2.4 or 2.3 mm purified recombinant protein, and were incubated at 37 8C for 16 h. Detection was carried out with a photodiode array detector (ab-
sorption at 277 nm). Conversion yields are shown in parentheses (mean of two independent measurements).
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shifts and coupling patterns for aromatic protons in the NMR
spectra of 1c, 2c, and 5c, respectively, were nearly early identi-
cal to those of 1b, 2b and 5b, thus unequivocally proving the
same prenylation position for 1c, 2c, and 5c as for 1b, 2b,
and 5b. In other words, 6-DMATSSa also catalyzed C6-prenyla-
tion of l-tryptophan and derivatives in the presence of GPP
(Figure 2).
Acceptance of dihydroxynaphthalenes by 6-DMATSSa and
C-prenylation on the unsubstituted benzene ring
As mentioned above, hydroxynaphthalenes are natural sub-
strates of some prenyltransferases of the CloQ/NphB group
from bacteria and fungi.[19,20] These enzymes share no se-
quence similarity with members of the DMATS superfamily, but
do share structural similarity.[23] It has been demonstrated that
several enzymes of the DMATS superfamily from fungi (includ-
ing FgaPT2 and 7-DMATS) also catalyze prenylation of several
hydroxynaphthalenes.[18] There are no reports of acceptance of
hydroxynaphthalenes by bacterial indole prenyltransferases.
For naphthalene derivatives with 9.6 mm 6-DMATSSa in the
presence of DMAPP, HPLC analysis revealed clear product for-
mation in 9 of 15 incubation mixtures (Table S2). Product yields
of more than 10% were achieved for five substrates after incu-
bation at 37 8C for 16 h. For 6-DMATSSv, product formation was
found for four hydroxynaphthalenes (Table S2). As observed for
fungal indole prenyltransferases,[18] activation of the naphtha-
lene ring was necessary for acceptance. The substrate prefer-
ences among hydroxynaphthalenes by 6-DMATSSa and 6-
DMATSSv differed, however, from those of fungal indole prenyl-
transferases. For example, 1-naphthol was very well accepted
by fungal indole prenyltransferases, but only poorly accepted
by 6-DMATSSa and 6-DMATSSv (total conversion yield of 3 and
0.2%, respectively). Compounds 1,3- (8a), 1,7- (9a), and 2,3-
dihydroxynaphthalene (10a) were very well accepted by 6-
DMATSSa (conversion yields 61.5, 33.7, and 43.8%, respectively;
Figure 3). Compounds 8a and 10a were also good substrates
for 6-DMATSSv (conversion yields 66 and 14%, respectively;
Table S2). Again, the retention times on HPLC of products of 6-
DMATSSa and 6-DMATSSv for a given hydroxynaphthalene were
the same, although 2,7-dihydroxynaphthalene was not accept-
ed by DMATSSa but was well accepted by DMATSSv (conversion
yield 42.1%). Other dihydroxynaphthalenes, such as 1,4-, 1,5-,
1,6-, and 2,6-dihydroxynaphthalene, were poor substrates for
Figure 2. HPLC analysis of enzyme assays with 1a, 2a, and 5a in the presence of GPP (left), and prenyl transfer reactions catalyzed by 6-DMATSSa (right). Re-
action mixtures (100 mL) contained 50 mm Tris·HCl (pH 7.5), 5 mm MgCl2, 1 mm aromatic substrate, 1 mm GPP, 0.15–5% (v/v) glycerol, 0–5% (v/v) DMSO and
2.4 mm purified recombinant protein, and were incubated at 37 8C for 16 h. Detection was carried out with a photodiode array detector (absorption at
277 nm). Conversion yields are shown in parentheses (mean of two independent measurements).
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both 6-DMATSSa and 6-DMATSSv (Table S2). For structure eluci-
dation, 8b–10b were isolated from the incubation mixtures of
the three best accepted naphthalene derivatives (8a–10a)
with 6-DMATSSa in the presence of DMAPP (Figure 3) and sub-
jected to MS and NMR analyses (Table S3 and Figure S3.8–
S3.10). HR-EI-MS analysis confirmed a prenyl moiety in each of
8b–10b by their molecular masses (68 Da larger than for the
respective substrates; Table S3). The 1H NMR spectra of 8b–
10b show clear signals for a regular dimethylallyl moiety at-
tached to a C atom at dH=3.40–3.59 (d, 2H-1’), 5.31–5.37
(t sept, H-2’), 1.76 or 1.78 (s, 3H-4’), 1.76 or 1.73 (s, 3H-5’;
Table S5, Figure S3.8–S3.10). Comparison of the spectra of 9b
with those of 9a proved prenylation at C-4 of 1,7-dihydroxy-
naphthalene, that is, at a para-position of a hydroxyl group.
Compound 9b has also been identified as an enzyme product
of fungal prenyltransferases.[18]
Surprisingly, inspection of the NMR spectra of 8b and 10b
revealed prenylation in both cases at the unsubstituted ben-
zene ring. The structure of 10b was easily identified as 6-dime-
thylallyl-2,3-dihydroxynaphthalene by the presence of one new
three spin system with coupling constants at 8.4 and 1.8 Hz.
The 1H NMR spectrum of 8b indicated the presence of three
coupling protons at dH=7.80 (br s), 7.44 (d, 8.4 Hz), and 7.15
(dd, 8.4 and 1.8 Hz) ppm, caused by prenylation at C-6 or C-7
of 1,3-dihydroxynaphthalene (this cannot be confirmed or ex-
cluded from the obtained spectrum). Even with additional
spectroscopic analyses, such as HSQC, HMBC, NOE or NOESY, it
would be difficult to distinguish the two possibilities. We favor
Figure 3. A) HPLC analysis of enzyme assays with 8a–10a in the presence of DMAPP (left) and prenyl transfer reactions catalyzed by 6-DMATSSa (right). Reac-
tion mixtures (100 mL) contained 50 mm Tris·HCl (pH 7.5), 5 mm MgCl2, 1 mm aromatic substrate, 2 mm DMAPP, 0.15–5% (v/v) glycerol, 0–5% (v/v) DMSO and
9.6 mm purified recombinant protein, and were incubated at 37 8C for 16 h. Detection of the compounds was carried out with a photodiode array detector
(absorption at 296 nm). Conversion yields are shown in parentheses. B) Proposed reaction mechanism for 8a and 10a.
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C7-prenylated 1,3-dihydroxynaphthalene as a plausible struc-
ture for 8b, because the prenylation position is at the para-po-
sition of a hydroxyl group, although they are located on two
benzene rings. Previously, prenylation of hydroxynaphthalenes
at the unsubstituted benzene ring (as in the case of 8b and
10b) has not been reported for either indole prenyltransferas-
es of the DMATS superfamily, or enzymes of the NphB/CloQ
group. The bacterial prenyltransferase Fnq26 of NphB/CloQ
group catalyzed O-prenylation of 8a.[24]
Biochemical characterization and kinetic parameters of
6-DMATSSa
The dependency of the 6-DMATSSa reaction on metal ions was
examined by incubation of DMAPP with 1a and different
metal ions (5 mm). Reaction mixtures without additives (or
with the chelating agent EDTA) served as controls (Figure S2).
Addition of Mg2+ , Ca2+ , or EDTA did not have any influence on
the enzyme activity, thus indicating that the 6-DMATSSa re-
action is likely independent of the presence of divalent ions.
CuCl2, ZnCl2, and NiSO4 strongly inhibited enzyme activity.
To better understand the 6-DMATSSa reaction, kinetic param-
eters (Michaelis–Menten constant Km, turnover number kcat)
were determined for tryptophan (1a), six derivatives (2a–7a),
three hydroxynaphthalenes (8a–10a), DMAPP, and GPP. The re-
actions with all tested substrates were consistent with Michae-
lis–Menten kinetics. For calculation of the kinetic parameters
(Table 1), data processing was carried out by constructing
Hanes–Woolf, Lineweaver–Burk, and Eadie–Hofstee plots (Fig-
ure S4.1–S4.7). High affinities (Km 0.018 to 0.092 mm) were de-
termined for 1a–7a, with 1a as the best aromatic substrate
(Km 0.018 mm, kcat 0.3 s
1, thus catalytic efficiency
16.7 s1mm1). 1,7-Dihydroxynaphthalene (9a, Km 0.059 mm)
showed affinity similar to those of the indole derivatives. The
other two hydroxynaphthalenes showed much lower affinity.
Consistent with the high conversion yields for 2a–5a (Fig-
ure 1), high turnover numbers (0.19–0.43 s1) were determined
for these substrates. Consequently, 6-DMATSSa had higher cata-
lytic efficiency with 1a–5a (Table 1). The kinetic parameter of
6-DMATSSa towards l-tryptophan and derivatives are compara-
ble with those of the C6-prenyltransferase IptA (Takahashi
et al).[9] GPP (Km 0.070 mm) showed a slightly higher affinity to
6-DMATSSa than did DMAPP (Km 0.095 mm). However, GPP turn-
over (kcat 0.043 s
1) was much slower than for DMAPP (kcat
0.63 s1).
Discussion
Indole prenyltransferases catalyze the transfer of prenyl moiet-
ies onto different positions of indole rings; they have been
identified mainly in fungi (ascomycetes)[8] and occasionally in
bacteria (actinomycetes).[7, 9, 10] These enzymes belong to the
DMATS superfamily and accept tryptophan, tryptophan-con-
taining cyclic dipeptides, or more-complex indole derivatives
as prenyl acceptors. The important features of these enzymes
are high promiscuity with the aromatic substrate, high regiose-
lectivity of the prenylation position, and high substrate specif-
icity towards the prenyl donor. The known tryptophan prenyl-
transferases use solely DMAPP as the prenyl donor.[7–10,14]
In this study, we successfully identified two putative prenyl-
transferases, SAML0654 from S. ambofaciens and Strvi8510
from S. violaceusniger, as indole prenyltransferases with broad
substrate specificity. Determination of the kinetic parameters
with diverse aromatic substrates showed that l-tryptophan
was best accepted as a substrate, and that the enzymes func-
tion as a 6-DMATS. Detailed biochemical characterization of
the enzymes (especially of 6-DMATSSa) revealed a number of
new features of these indole prenyltransferases:
1) The identification of SAML0654 as a 6-DMATS was some-
what surprising, because amino acid sequence alignment
revealed much higher similarity to the 5-DMATS SCO7467
(75%) from S. coelicolor[10] than to the 6-DMATS IptA (60%)
from Streptomyces sp. SN-593.[9] Our results highlight that
the functions of enzymes should be proven experimentally,
not just inferred from sequence comparison with known
proteins.
2) 6-DMATSSa and 6-DMATSSv accepted well a number of
indole derivatives, including d-tryptophan and 6-methyl-dl-
tryptophan (6a ; Figure 1 and Table S1). Conversion yields
of 73.5 and 60.7% of that of l-tryptophan were calculated
for d-tryptophan. The conversion yields for 6-methyl-dl-
tryptophan were 72.2 and 82%. These values are unusually
high for l-tryptophan C6-prenyltransferases. Other known
DMATSs, such as IptA (Streptomyces sp. SN-593), FgaPT2,
and 7-DMATS (both from A. fumigatus), accepted d-trypto-
phan with activities of only 4.3, 1.8, and 15.5%, respectively,
relative to that for l-tryptophan.[9,12, 13] IptA also accepted 6-
methyl-dl-tryptophan as a substrate, but with activity of
only 9.33% relative of that of l-tryptophan. As in the case
of IptA, highly regiospecific C7-prenylation of 6-methyl-dl-
tryptophan (6a) was observed with 6-DMATS from S. ambo-
faciens.
Table 1. Kinetic parameters of 6-DMATSSa for selected substrates.
Substrate Km kcat kcat/Km Relative
[mm] [s1] [s1mm1] catalytic
efficiency [%]
l-tryptophan (1a) 0.018 0.30 16.67 100
l-abrine (2a) 0.023 0.27 11.74 69
l-b-homotryptophan (3a) 0.092 0.23 2.50 15
4-methyl-dl-tryptophan (4a) 0.063 0.19 3.02 18
5-methyl-dl-tryptophan (5a) 0.074 0.43 5.81 35
6-methyl-dl-tryptophan (6a) 0.030 0.028 0.93 5.6
7-methyl-dl-tryptophan (7a) 0.072 0.013 0.18 1.1
1,3-dihydroxynaphthalene (8a) 0.29 0.43 1.47 8.8
1,7-dihydroxynaphthalene (9a) 0.059 0.088 1.49 8.9
2,3-dihydroxynaphthalene (10a) 0.28 0.13 0.46 2.7
DMAPP[a] 0.095 0.63 6.63 40
GPP[a] 0.070 0.043 0.61 3.7
[a] l-tryptophan (1a) as prenyl acceptor.
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3) 6-DMATSSa showed relatively high promiscuity towards the
prenyl donor. In the presence of l-tryptophan and several
tryptophan derivatives, GPP was accepted by 6-DMATSSa as
the prenyl donor (activities of up to 46.2% relative of that
for DMAPP); 6-DMATSSv also accepted GPP, but with lower
conversion yields. In contrast, no known DMATS (including
A. fumigatus FgaPT2, A. clavatus 5-DMATS, Streptomyces sp.
SN-593 IptA, and A. fumigatus 7-DMATS) have been report-
ed to use GPP or other prenyl donors.[9, 11–13] Therefore, 6-
DMATSSa from S. ambofaciens and 6-DMATSSv from S. viola-
ceusniger represent the first examples of tryptophan prenyl-
transferases that accept both DMAPP and GPP as prenyl
donors.
4) Isolation and structure elucidation of the enzyme products
from l-tryptophan (1a) and two derivatives (2a and 5a)
with GPP led to the identification of C6-geranylated deriva-
tives, that is, the same prenylation position as for the prod-
ucts from DMAPP. This differs from the situation for some
fungal indole prenyltransferases in the presence of DMAPP
analogues, GPP, or benzyl diphosphate. In those cases,
complete or partial shifts of the prenylation position were
observed.[25–27]
5) 6-DMATSSa and 6-DMATSSv also accepted several hydroxy-
naphthalenes as prenyl acceptors; these are natural sub-
strates of prenyltransferases of the bacterial and fungal
CloQ/NphB group.[19,20, 24] It has been demonstrated that
some members of the fungal DMATS superfamily can also
use these compounds as substrates.[18] However, there is no
report on the behavior of bacterial indole prenyltransferase
like IptA or SCO7467 towards hydroxynaphthalenes.[7,9,10] In-
terestingly, all fungal indole prenyltransferases accept 1-
naphthol as one of the best substrates. In contrast, 1-naph-
thol was not accepted by 6-DMATSSv, and it was barely ac-
cepted by 6-DMATSSa (<3%, Table S2). In contrast 1,3- and
2,3-dihydroxynaphthalenes were better accepted by 6-
DMATSSa than by fungal indole prenyltransferases. 1,7-Dihy-
droxynaphthalene was accepted by both bacterial and
fungal enzymes.
6) Structure elucidation of the enzyme products of 1,3- (8a)
and 2,3-dihydroxynaphthalenes (10a) identified the preny-
lation position at the unsubstituted benzene ring. This
clearly differs from fungal indole prenyltransferases and
prenyltransferases of the NphB/CloQ group; these attached
prenyl moieties to para- or ortho-position of a hydroxyl
group at the same benzene ring, or onto a hydroxyl
group.[18–20,28] The structure of 10b was unequivocally
proven to be 6-dimethylallyl-2,3-dihydroxynaphthalene. In
the case of 8b, we favor 7-dimethylallyl-1,3-dihydroxynaph-
thalene as the more likely of the two possible structures.
This means that prenyl moieties in both structures are para
to a hydroxy group on the second benzene ring. It could
be speculated that activation by a hydroxyl group (al-
though at another benzene ring) is important for the stabi-
lization of an intermediate cation (Figure 3B).
Conclusion
In summary, the identified and characterized 6-DMATSSa and 6-
DMATSSv showed several new intriguing biochemical features,
and greatly expand our knowledge of bacterial indole prenyl-
transferases. These enzymes are very good candidates for fur-
ther investigations, such as protein crystallization and structur-
al analysis of the active sites, to understand their broad sub-
strate specificity towards prenyl donor and acceptor, as well as
their reaction mechanisms.
Experimental Section
Computer-assisted sequence analysis: Sequence identities were
obtained by alignments of amino acid sequences with the pro-
gram BLASTP (http://www.ncbi.nlm.nih.gov ).
Chemicals: DMAPP, GPP, and FPP were prepared according to the
method described for GPP by Woodside et al.[29] Indole and hydrox-
ynaphthalene derivatives of the highest available purity were pur-
chased from TCI, Acros Organics, Sigma–Aldrich, Bachem, and Alfa
Aesar.
Bacterial strains, plasmids, and culture conditions: pGEM-T Easy
and pQE-60/70 were purchased from Promega and Qiagen, respec-
tively. pHIS8
[30] was a kind gift from Prof John Noel (Salk Institute
for Biological Studies). E. coli strains XL1 Blue MRF’ (Stratagene/Agi-
lent Technologies), M15 [pREP4] (Qiagen), and BL21 (DE3) pLysS
(AMS Biotechnology, Abingdon, UK) were used for cloning and ex-
pression. They were grown in liquid lysogeny broth (LB) or on solid
LB medium (with agar (1.5% w/v)) at 37 or 30 8C. Carbenicillin
(50 mgmL1) or kanamycin (25 mgmL1) were used for selection of
recombinant E. coli XL1 Blue MRF’ strains containing pQE-60 or
pHIS8 constructs, respectively. Kanamycin (25 mgmL
1) with carbe-
nicillin (50 mgmL1) or chloramphenicol (12.5 mgmL1) was used for
selection of recombinant E. coli M15 [pREP4] or BL21 (DE3), respec-
tively. S. ambofaciens DSM40053 (ATCC 23877) was purchased from
Deutsche Sammlung von Mikroorganismen und Zellkulturen
(Braunschweig, Germany). S. violaceusniger T 4113 was obtained
from Prof. Wolfgang Wohlleben (Tbingen University). For genomic
DNA isolation, these were cultivated in a 300 mL cylindrical flask
containing liquid YMG medium (50 mL; yeast extract (0.4% w/v),
malt extract (1% w/v), glucose (0.4% w/v)) at 28 8C on a rotary
shaker (160 rpm) for 3 days.
DNA manipulation and PCR amplification: DNA propagation in
E. coli was carried out by standard methods.[31] DNA isolation from
Streptomyces strains was carried out by phenol-chloroform extrac-
tion.[32] PCR amplification was performed on an iCycler (Bio-Rad).
PCR products containing the coding sequence of SAML0654 and
Strvi8510 were obtained by using Expand High Fidelity kit (Roche
Diagnostic) with genomic DNA as template. The primers for
SAML0654 were SAML0654_fw (5’-CCATGG CCACCG TACGGA
CCGGCG CGG-3’) and SAML0654_r (5’-GGATCC GCGCAC CGCCAC
CGGGCG G-3’), and for Strvi8510 they were Strvi_bam_fw (5’-
GGATCC ATGAAC GGTTTC CATTCG GGTG-3’) and Strvi_hind3_r (5’-
AAGCTT TCACAG CCCTGC CCGCAC C-3’). Underlined letters repre-
sent the restriction sites for NcoI, BamHI, and HindIII, located at the
predicted start and stop codon in the primer sequences. The PCR
products for SAML0654 (1133 bp) and Strvi8510 (1155 bp) were
cloned into pGEM-T Easy to create plasmids pJW09 and pJW16,
and then subcloned into pQE-60 and pHIS8 to produce the expres-
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sion plasmids pJW12 (SAML0654) and pJW18 (Strvi8510), respec-
tively.
Gene expression and purification of recombinant 6-DMATSSa
and 6-DMATSSv: For expression of SAML0654, an overnight culture
of E. coli M15 [pREP4] harboring pJW12 was inoculated into LB
medium (1 L) supplemented with carbenicillin (50 mgmL1) and
kanamycin (25 mgmL1), and cultivated at 37 8C and 220 rpm to
A600=0.6. For induction of gene expression, isopropyl thiogalacto-
sid (IPTG, 0.5 mm) was added. After further cultivation for 16 h at
30 8C, cells were harvested by centrifugation and the pellet was re-
suspended in lysis buffer (NaH2PO4 (50 mm, pH 8.0), imidazole
(10 mm), NaCl (300 mm)) at 2–5 mL per gram wet weight. After ad-
dition of lysozyme (1 mgmL1), the cell suspension was incubated
on ice for 30 min then sonicated (6, 10 s, 200 W). Cellular debris
was separated from the soluble proteins by centrifugation
(20000g, 30 min, 4 8C). Recombinant His6-tagged fusion protein
was isolated by affinity chromatography with Ni-NTA agarose resin
(Qiagen) according to the manufacturer’s instructions. The protein
was eluted with imidazole (250 mm) in NaH2PO4 (50 mm, pH 8.0)
with NaCl (300 mm). In order to change the buffer, the protein
fraction was passed through a PD-10 column (GE Healthcare), pre-
viously equilibrated with Tris·HCl (50 mm, pH 7.5) containing glyc-
erol (15% v/v). Purified 6-DMATS-His6 was used immediately for
enzyme assays or stored at 80 8C. The proteins were analyzed by
12% (w/v) SDS-PAGE gels according to the method of Laemmli[33]
and stained with Coomassie Brilliant Blue G-250.
For overproduction of His8-Strvi8510, E. coli BL21 (DE3) pLysS cells
harboring pJW18 were cultivated in LB medium (1 L) supplement-
ed with chloramphenicol (12.5 mgmL1) and kanamycin
(25 mgmL1) at 37 8C to A600=0.6. Gene expression was induced by
addition of IPTG (0.5 mm). Cells were cultivated for a further 16 h
at 22 8C and then centrifuged to harvest the cells. Protein purifica-
tion was carried out as described above.
Enzyme assays for 6-DMATSSa and 6-DMATSSv: To determine the
relative activities of 6-DMATSSa for different substrates, enzyme
assay mixtures (100 mL) contained Tris·HCl (50 mm, pH 7.5), MgCl2
(5 mm), aromatic substrate (1 mm), DMAPP or GPP (1 or 2 mm),
glycerol (0.15–5% v/v), DMSO (0–5% v/v), and purified recombi-
nant protein (10 or 40 mg; 2.4 or 9.6 mm). Mixtures were incubated
at 37 8C for 16 h, before reaction termination by addition of metha-
nol (100 mL). For determination of the kinetic parameters of l-tryp-
tophan and derivatives, DMAPP (1 mm) and aromatic substrate (up
to 2 mm) were used. Protein concentrations: 61 nm (for 1a and
2a), 122 nm (3a, 4a, and 5a), 244 nm (6a), 732 nm (7a). Incubation
times were 15 min (1a–5a), 30 min (6a), or 60 min (7a). For deter-
mination of the kinetic parameters of DMAPP, 1a (1 mm) was used
as prenyl acceptor. DMAPP (up to 2 mm) and protein (122 nm)
were incubated for 15 min. For determination of the kinetic param-
eters of GPP, the reaction mixtures contained GPP (up to 1 mm)
and protein (732 nm) and were incubated for 30 min. For determi-
nation of the kinetic parameters of dihydroxynaphthalenes, the
assays contained aromatic substrate (up to 5 mm), DMAPP (1 mm),
and protein (0.5 mm for 8a and 10a, 0.73 mm for 9a) and were in-
cubated at 37 8C for 30 min (8a, 10a) or 45 min (9a).
For determination of 6-DMATSSv substrate specificity, the enzyme
assays were carried out as for 6-DMATSSa. The reaction mixtures of
simple indole derivatives and naphthalene derivatives contained
DMAPP (1 mm) and recombinant protein (10 mg (2.3 mm) or 20 mg
(4.6 mm), respectively).
Preparation and isolation of enzyme products for structure elu-
cidation: For isolation of the enzyme products, large-scale enzyme
reactions (10 mL) were carried out. The reaction mixtures con-
tained substrate 1a–10a (1 mm), DMAPP (2 mm), MgCl2 (5 mm),
Tris·HCl (50 mm, pH 7.5) and 6-DMATSSa (2.4 mm for 1a–7a, 4.8 mm
for 8a–10a). The reaction mixture with 6-DMATSSv and 1a was car-
ried out as described above for 6-DMATSSa (2.3 mm). For isolation of
geranylated products, 1a, 2a, and 5a (1 mm) were also incubated
with GPP (2 mm), MgCl2 (5 mm), Tris·HCl (50 mm, pH 7.5), and 6-
DMATS (2.4–10 mm) at 37 8C for 16 h. For 1a–7a reactions were ter-
minated by addition of methanol (10 mL). The precipitated protein
was removed by centrifugation, and the obtained supernatants
were concentrated on a rotating vacuum evaporator at 30 8C to
0.5–1 mL for HPLC purification. For 8a–10a the mixtures were ex-
tracted three times with ethyl acetate immediately after incuba-
tion. The ethyl acetate phases were concentrated on a rotating
vacuum evaporator at 30 8C to dryness and dissolved in methanol
(0.5–1 mL) for HPLC purification.
HPLC conditions for analysis and isolation of enzyme products:
The enzyme products of the incubation mixtures were analyzed on
an series 1200 HPLC device (Agilent Technologies) with a Multos-
pher 120 RP-18 column (2504 mm, 5 mm; C+S Chromatography
Service, Langenfeld, Germany) at a flow rate of 1 mLmin1. Water
(solvent A) and methanol (solvent B) were used with trifluoroacetic
acid (0.5% v/v) added if necessary. For analysis of enzyme products
of tryptophan and simple indole derivatives, a linear gradient of
20–100% or 40–100% solvent B over 15 min was used. For analysis
of products from hydroxynaphthalene derivatives, a linear gradient
of 40–100% solvent B over 15 or 20 min was used. The column
was then washed with solvent B for 5 min and equilibrated with 20
or 40% solvent B for 5 min. Detection was carried out with a photo-
diode array detector.
The same HPLC equipment and a larger column (25010 mm)
were used to isolate enzyme products. The flow rate was
2.5 mLmin1. Water (solvent A) and methanol (solvent B) without
acid were used as solvents: 40–100 or 65–100% solvent B over dif-
ferent times. The column was then washed with solvent B for
5 min and equilibrated with 40 or 65% solvent B for 5 min.
NMR spectroscopic analysis and high-resolution electrospray
ionization mass spectra (HR-EI-MS): The isolated products were
analyzed by HR-EI-MS with a AutoSpec (Micromass). Positive EI-MS
data are given in Table S3. 1H NMR spectra were recorded on an
ECA-500 spectrometer (JEOL). Chemical shifts were referenced to
CD3OD at 3.31 ppm. All spectra were processed with MestReNova
5.2.2 software (see the Supporting Information). The NMR data are
given in Tables S4 and S5.
Nucleotide sequence accession numbers: The protein sequences
of SAML0654 and Strvi8510 are available at GenBank (accession
numbers CAJ89640 and YP_004818099.1).
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Table S1. Enzyme activity of SAML0654 (6-DMATSSa) and Strvi8510 (6-DMATSSv) towards L-tryptophan and 
derivatives 
 
Substrate Structure Prenyl 
donor 
Relative product yield 
[%] 
Substrate Structure Prenyl 
donor 
Relative product yield 
[%] 
SAML0654 Strvi8510 SAML0654  Strvi8510 
L-tryptophan 
(1a) 
N
H
O
OH
NH2
 
DMAPP 100 100 1-methyl-DL-
tryptophan 
O
OH
N
NH2
 
DMAPP 2.2 5.7 
GPP 46.2 3.7 GPP  n.d. n.d. 
L-abrine 
(2a) 
O
OH
N
H
NH
 
DMAPP  106 121.2 N-acety-DL-
tryptophan 
O
OH
N
H
NH
O  
DMAPP  26.9 16.5 
GPP 18.8 - GPP  n.d. n.d. 
L-ß-
homotrypto-
phan 
(3a) 
N
H
NH2
O
OH
DMAPP  97.2 36.7 DL-indole-3-
lactic acid 
O
OH
N
H
OH
 
DMAPP  26.9 16.4 
GPP 1.5 - GPP  n.d. n.d. 
4-methyl-DL-
tryptophan 
(4a) 
O
OH
N
H
NH2
 
DMAPP 96.4 104.7 indole-3-
propionic acid
O
OH
N
H  
DMAPP  31.1 28.8 
GPP 4 - GPP  n.d. n.d. 
5-methyl-DL-
tryptophan 
(5a) 
O
OH
N
H
NH2
 
DMAPP 87.9 96 trans-indole-3-
acrylic-acid 
O
OH
N
H  
DMAPP  34.5 12.6 
GPP  37.8 6.2 GPP  n.d. n.d. 
6-methyl-DL-
tryptophan 
(6a) 
O
OH
N
H
NH2
 
DMAPP  72.2 82 D- tryptophan
N
H
O
OH
NH2
 
DMAPP  73.5 60.7 
GPP  - - GPP  n.d. n.d. 
7-methyl-DL-
tryptophan 
(7a) 
O
OH
N
H
NH2
 
DMAPP  51.3 32.2 6-fluoro-DL-
tryptophan 
O
OH
N
H
NH2
F
 
DMAPP  8.2 4.4 
GPP  - - GPP  n.d. n.d. 
n.d.: no determined; -: conversion yield <0.5 % 
 
The reaction mixtures contained 1 mM of aromatic substrate and 1 mM DMAPP or GPP and were incubated with 2.3 or 
2.4μM of purified protein at 37°C for 16 h. The conversion yield of L-tryptophan with SAML0654 at 59.4 % and with 
Strvi8510 at 42.2 % were defined as 100% of relative activity. 
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Table S2. Enzyme activity of SAML0654 (6-DMATSSa) and Strvi8510 (6-DMATSSv) towards all tested naphthalene 
derivatives 
Substrate Structure Prenyl 
donor 
Relative product yield [%] Substrate Structure Prenyl 
donor 
Relative product yield [%] 
SAML0654 Strvi8510 SAML0654 Strvi8510 
naphthalene 
 
DMAPP - - 2,3-
dihydroxy 
naphthalene 
(10a) 
 
 
OH
OH
 
DMAPP 43.8 14 
1-naphthol OH
 
DMAPP 2.9 - GPP - - 
2-naphthol OH
 
DMAPP 6.0 - 2,6-
dihydroxy 
naphthalene 
 
OH
OH
 
DMAPP 9.6 - 
1,3-
dihydroxy 
naphthalene 
(8a) 
OH
OH 
DMAPP 61.5 66 - 
GPP - - 2,7-
dihydroxy-
naphthalene 
OHOH
 
DMAPP - 42.1 
1,4-
dihydroxy 
naphthalene 
OH
OH  
DMAPP - - 3,5-
dihydroxy-
2-naphtoic 
acid 
OH
OH
O
OH
 
DMAPP 13.1 - 
1,5-
dihydroxy 
naphthalene 
OH
OH  
DMAPP - - 3,7-
dihydroxy-
2-naphtoic 
acid OH
O
O
OH
 
DMAPP - - 
1,6-
dihydroxy 
naphthalene 
OH
OH
 
DMAPP 7.8 - 5-amino-2-
naphthol 
OH
NH2  
DMAPP 10.4 - 
1,7-
dihydroxyna
phthalene 
(9a) 
OH
OH
 
DMAPP 33.7 5.3 alizarine OH
OH
O
O
 
DMAPP - - 
GPP - -   
-: not detected, conversion rate ≤ 0.2 % 
 
The reaction mixtures of SAML0654 contain 1 mM aromatic substrate, 2 mM DMAPP or GPP and 9.6 µM protein. The 
reaction mixtures of Strvi8510 contain 1 mM aromatic substrate, 1mM DMAPP and 4.6 µM protein. The reaction 
mixtures were incubated at 37°C for 16 h. The conversion yield of Strvi8510 towards L-tryptophan at 53 % was defined 
as 100% of relative activity. Under the conditions used for naphthalene derivatives, L-tryptophan was completely 
converted by SAML0654. 
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Table S3. HR-EI-MS data of enzyme products of 6-DMATSSa for L-tryptophan and derivatives as well 
as hydroxynaphthalenes 
 HR-EI-MS([M]+)
Compound Chemical 
formula 
Calculated Measured Deviation 
(ppm) 
6-DMA-L-tryptophan (1b) C16 H20N2O2 272.1525 272.1532 -2.6 
6-geranyl-L-tryptophan (1c) C21H28N2O2 340.2151 340.2138  3.8 
6-DMA-L-abrine (2b) C17H22N2O2 286.1681 286.1704  -8 
6-geranyl-L-abrine (2c) C22H30N2O2 354.2307 354.2324 -4.8 
6-DMA-L-ß-homotryptophan (3b) C17H22N2O2 286.1681 286.1714  -11.5 
6-geranyl-L-ß-homotryptophan (3c) C22H40N2O2 354.2307 354.2282  7.1 
6-DMA-4-methyl-DL-tryptophan (4b) C17H22N2O2 286.1681 286.1715 -11.9 
6-DMA-5-methyl-DL-tryptophan (5b) C17H22N2O2 286.1681 286.1704  -8.0 
7-DMA-6-methyl-DL-tryptophan (6b) C17H22N2O2 286.1681 286.1691 -3.5 
6-DMA-7-methyl-DL-tryptophan (7b) C17H22N2O2 286.1681 286.1724  -15 
6- or 7-DMA-1,3-dihydroxynaphthalene (8b) C15H16O2 228.1150 228.1145 2.2 
4-DMA-1,7-dihydroxynaphthalene (9b) C15H16O2 228.1150 228.1165 -6.6 
6-DMA-2,3-dihydroxynaphthalene (10b) C15H16O2 228.1150 228.1139 4.8 
DMA: dimethylallyl 
55
6 
T
ab
le
 S
4.
11
H
-N
M
R
 d
at
a 
of
 p
re
ny
la
te
d 
en
zy
m
e 
pr
od
uc
ts
 (6
-D
M
A
TS
Sa
) f
or
 L
-tr
yp
to
ph
an
 a
nd
 d
er
iv
at
iv
es
 w
ith
 th
e 
pr
en
yl
 d
on
or
 D
M
A
PP
 o
bt
ai
ne
d 
in
 C
D
3O
D
  
 
6-
D
M
A
-L
-T
rp
 
(1
b)
 
12
O
O
H
9
8
4
75
6
3
2
N H 1
10
11 N
H
2
1'2
'
3'
5'
4'
6 -
D
M
A
- L
-a
br
in
e 
(2
b)
 
12
O
O
H
9
8
4
75
6
3
2
N H 1
10
11 N
H
1'2'
3'
5' 4'
13
6 -
D
M
A
- L
-ß
-
ho
m
o-
Tr
p 
(3
b)
 
12
9
8
4
75
6
3
2
N H 1
10
11 N
H
2
13O O
H
1'
2'3'4'
5'
6-
D
M
A
-4
-
m
et
hy
l-D
L
-T
rp
 
(4
b)
 
12O
O
H
9
84
75
6
3
2
N H 1
10
11
N
H
2
13
1'2
'
3'
4'5'
7 -
D
M
A
-4
-m
et
hy
l-
D
L
-T
rp
 
(4
c)
 
1'
2'
3'
4'
5'
12O
O
H
9
84
7
5
6
3
2
N H 1
10
11
N
H
2
13
6-
D
M
A
-5
-m
et
hy
l-
D
L
-T
rp
 
(5
b)
 
12
O
O
H
9
8
4
7
5
6
3
2
N H 1
10
11 N
H
2
1'2'
3'
5' 4'
7 -
D
M
A
-6
-
m
et
hy
l-D
L
-T
rp
 
(6
b)
 
12
O
O
H
9
8
4
7
5
6
3
2
N H 1
10
11 N
H
2
13
1'
2'
3'
4'
5'
6-
D
M
A
-7
-D
L
-
m
et
hy
l-T
rp
 
(7
b)
 
12
O
O
H
9
8
4
7
5
6
3
2
N H 1
10
11
N
H
2
1'2'
3'
5' 4'
13
Po
s 
δ H,
 m
ul
ti.
, J
 
δ H,
 m
ul
ti.
, J
 
δ H,
 m
ul
ti.
, J
 
δ H,
 m
ul
ti.
, J
 
δ H,
 m
ul
ti.
, J
 
δ H,
 m
ul
ti.
, J
 
δ H,
 m
ul
ti.
, J
 
δ H,
 m
ul
ti.
, J
 
2 
7.
12
, s
 
7.
15
, s
 
7.
09
,s 
7.
08
, s
 
7.
16
, s
 
7.
08
,s 
7.
13
,s 
7.
14
,s 
4 
7.
58
, d
, 8
.2
 
7.
58
 ,d
, 8
.2
 
7.
47
, d
, 8
.2
 
- 
- 
7.
47
,s 
7.
43
, d
 ,8
.1
 
7.
44
, d
, 8
.1
 
5 
6,
89
, d
d,
 8
.2
,1
.4
 
6.
89
, d
d,
 8
.2
, 1
.5
 
6.
89
, d
d 
,8
.2
, 1
.2
 
6.
97
, s
 
6.
77
, d
, 7
.2
 
- 
6.
89
, d
, 8
.1
 
6.
88
, d
, 8
.1
 
6 
- 
- 
- 
- 
6.
71
, d
, 7
.2
 
- 
- 
- 
7 
7.
15
, d
, 1
.4
 
7.
15
, b
r s
 
7.
15
, s
 
6.
61
, s
 
- 
7.
13
, s
 
- 
- 
10
a 
3.
49
, d
d,
 1
5.
3,
 4
.0
, 
0.
8 
3.
45
, d
dd
, 1
5.
5,
 
4.
6,
 0
.8
 
2.
52
, d
d,
 1
6.
9,
 3
.8
 
3.
79
,o
ve
rla
pp
in
g 
3.
85
, m
 
3.
48
,d
d,
15
.1
, 3
.7
 
3.
49
, d
d,
 1
5.
3,
 4
.0
 
3.
49
, d
d,
 1
5.
2,
 4
.0
 
10
b 
3.
12
,d
d,
15
.3
,9
.5
 
3.
25
,d
d,
15
.5
,8
.0
 
2.
34
,d
d,
16
.9
,8
.9
 
3.
09
, d
d,
15
.3
,1
1.
5 
3.
12
, o
ve
rla
pp
in
g 
3.
08
,d
d,
 1
5.
1,
 9
.6
 
3.
09
, d
d,
 1
5.
3,
 9
.4
 
3.
11
, d
d,
15
.2
,9
.5
 
11
 
3,
84
, d
d,
 9
.5
, 4
.0
 
3.
76
, d
d,
 8
.0
, 4
.6
 
3.
33
, m
 
3.
79
, o
ve
rla
pp
in
g 
3.
83
, o
ve
rla
pp
in
g 
3.
84
, d
d,
 9
.6
, 3
.7
 
3.
85
, d
d,
 9
.4
, 4
.0
 
3.
84
, d
d,
 9
.5
,4
.0
 
12
 
- 
- 
3.
05
,d
,7
.0
4 
- 
- 
- 
- 
- 
13
 
- 
2.
56
, s
 
- 
2.
69
, s
 
2.
65
, s
 
2.
36
, s
 
2.
32
, s
 
2.
4,
 s 
1’
 
3.
41
,d
,7
.4
 
3.
41
,d
,7
.4
 
3.
41
,d
,7
.3
 
3.
49
,d
, 7
.3
 
3.
48
, o
ve
rla
pp
in
g 
3.
37
,d
,7
.1
 
3.
56
,d
,6
.7
 
3.
42
,d
,7
.1
 
2’
 
5.
34
, t
se
pt
, 7
.4
, 1
.5
 
5.
34
, t
se
pt
, 7
.4
, 
1.
5 
5.
35
, t
se
pt
, 7
.3
, 1
.5
 
5.
33
, t
se
pt
, 7
.3
,1
.5
 
5.
40
, t
 se
pt
, 7
.3
, 1
.5
 
5.
25
, t
se
pt
, 7
.1
, 1
.5
 
5.
09
, t
se
pt
, 6
.7
, 
1.
5 
5.
20
, t
se
pt
, 7
.1
, 1
.5
 
4’
 
1.
74
, b
rs
 
1.
74
 s 
1.
75
, s
 
1.
74
, b
rs
 
1.
74
, o
ve
rla
pp
in
g 
1.
75
, s
 
1.
83
, s
 
1.
77
, s
 
5‘
 
1.
74
, b
r s
 
1.
74
 s 
1.
75
, s
 
1.
74
, b
rs
 
1.
74
, o
ve
rla
pp
in
g 
1.
74
,s 
 
1.
68
, d
, 1
.2
 
1.
71
, d
, 1
.1
 
C
he
m
ic
al
 sh
ift
s (
δ)
 a
re
 g
iv
en
 in
 p
pm
 a
nd
 c
ou
pl
in
g 
co
ns
ta
nt
s (
J)
 in
 H
z
56
7 
Table S4.21H-NMR data of enzyme products (6-DMATSSa) for L-tryptophan (1a), L-abrine (2a) and 
5-methyl-DL-tryptophan (5a) with the prenyl donor GPP in CD3OD  
6-Geranyl-L-Trp 
(1c) 
9
8
4
7
5
3
2N
H
1
10
11
12
NH2
8' 7' 6'
5'
4'
3'
2'
1'
10' 9'
OH
O
6-Geranyl-L-abrine 
(2c) 
9
8
4
7
5
3
2N
H
1
10
11
12
O
OH
NH
8' 7' 6'
5'
4'
3'
2'
1'
10' 9'
13
6-Geranyl-5-methyl-DL-Trp 
(5c) 
9
8
4
7
5
3
2N
H
1
10
11
12
O
OH
NH2
8'
7'
6'
5'
4'
3'
2'
1'
10'
9'
13
Pos. δH, multi., J δH, multi., J δH, multi., J 
2 7.12, s 7.14, s 7.07, s 
4 7.59, d, 8.2 7.58, d, 8.2 7.48, s 
5 6,89, dd, 8.2, 1.4 6.90, dd, 8.2, 1.4 - 
7 7.16, dd, 1.4, 0.7 7.15, dd, 1.4, 0.7 7.14, s 
10 3.49, dd, 15.0, 4.0 
3.10, dd, 15.0, 9.4 
3.44, dd, 15.5, 4.6 
3.23, dd, 15.5, 8.0 
3.46, dd, 15.2, 4.0 
3.06, dd, 15.2, 9.6 
11 3,82, dd, 9.4, 4.0 3.73, dd, 8.0, 4.6 3.82, dd, 9.6, 4.0 
13 - 2.55, s 2.36, s 
1’ 3.42, d, 7.4 3.42, d, 7.4 3.38, d, 6.8 
2’ 5.34, tsept, 7.4, 1.4 5.35, tsept, 7.4, 1.4 5.24, m 
4’ 2.12, m 2.11, m 2,12, m 
5’ 2.04, m  2.04, m 2.04, m  
6’ 5.11, tsept, 6.9, 1.4 5.11, tsept, 6.9, 1.4 5.10, m 
8’ 1.74, s 1.74, s 1.74, s 
9’ 1.66, s 1.66, s 1.65, s 
10’ 1.59, s 1.59, s 1.59, s 
Chemical shifts (δ) are given in ppm and coupling constants (J) in Hz 
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Table S5. 1H-NMR data of enzyme products (6-DMATSSa) for selected dihydroxynaphthalenes 
obtained in CD3OD  
7 or 6-DMA-1,3-
dihydroxynaphthalene 
(8b) 
1 2
3
45
6
7
8
9
10
OH
1'
2'
3'
4'
5'
OH
or 
1'
2'
3'
4'
5'
1 2
3
45
6
7
8
9
10
OH
OH
4-DMA-1,7-
dihydroxynaphthalene
(9b) 
10
9
8
5
7
6
2
3
1
4
OH
OH
1' 2'
3'
4' 5'
6-DMA-2,3-
dihydroxynaphthalene 
(10b) 
1'
2'
3'
5'
4'
10
9
8
5
7
6
2
3
1
4
OH
OH
Pos.  δH, multi., J δH, multi., J δH, multi., J
1   ‐  ‐  7.04, s
2  6.56, d, 2.1  6.63, d, 7.6 ‐
3  ‐  6.87, d, 7.6 ‐
4  6.43, d, 2.1 ‐ 7.01, s
5 
7.44, d, 8.4 
7.15, dd, 8.4, 1.8 
7.80, br s 
7.77, d, 9.1 7.29, br s
6  7.04, dd, 9.1, 2.6 ‐
7  ‐ 7.02, dd, 8.4, 1.8
8  7.48, d, 2.6 7.45, d, 8.4
1‘  3.42, d, 7.4,  3.59, d, 6.9 3.40, d, 7.4
2‘  5,37, tsept, 7.4, 1.4 5.31, tsept, 6.9, 1.4 5.36, tsept, 7.4, 1.4
4‘  1.76, s  1.78, s 1,76, s
5‘  1.76, s  1.73, s 1.76, s
Chemical shifts (δ) are given in ppm and coupling constants (J) in Hz.  
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Figure S1. SDS-PAGE analysis of the recombinant proteins SAML0654 (A) and of Strvi8510 (B). 
A) Lane 1: molecular mass standard; lane 2: total protein before induction; lane 3: total protein after
IPTG induction, lane 4: soluble protein fraction, lane 5: flow through fraction, lane 6: wash fraction of 
Ni-NTA-agarose; lanes 7 and 8: purified SAML0654-His6. B) Lane 1: molecular mass standard, lane 
2: purified His8- Strvi8510. 
Figure S2. Ion dependency of the 6-DMATSSa reaction 
The enzyme assays containing 1 mM L-tryptophan, 1 mM DMAPP, 5 mM metal ions and were 
incubated with 1.2 µM protein for 2 h. The enzyme activity without additives was defined as 100 %. 
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Figure S3.1. 1H-NMR spectrum of 1b in CD3OD (500 MHz) 
Figure S3.2. 1H-NMR spectrum of 1c in CD3OD (500 MHz) 
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Figure S3.3. 1H-NMR spectrum of 2b in CD3OD (500 MHz) 
Figure S3.4. 1H-NMR spectrum of 2c in CD3OD (500 MHz) 
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Figure S3.5. 1H-NMR spectrum of 3b in CD3OD (500 MHz) 
Figure S3.6. 1H-NMR spectrum of 4b and 4c in CD3OD (500 MHz) 
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Figure S3.7. 1H-NMR spectrum of 4b and 4c in DMSO-d6 (500 MHz) 
Figure S3.8. 1H-NMR spectrum of 5b in CD3OD (500 MHz) 
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Figure S3.9. 1H-NMR spectrum of 5c in CD3OD (500 MHz) 
Figure S3.10. 1H-NMR spectrum of 6b in CD3OD (500 MHz) 
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15 
 
 
Figure S3.11. 1H-NMR spectrum of 7b in CD3OD (500 MHz) 
 
 
Figure S3.12. 1H-NMR spectrum of 8b in CD3OD (500 MHz) 
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Figure S3.13. 1H-NMR spectrum of 9b in CD3OD (500 MHz) 
Figure S3.14. 1H-NMR spectrum of 10b in CD3OD (500 MHz) 
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Figure S4.1. Dependence of product formation on L-tryptophan (1a) concentrations 
Figure S4.2. Dependence of product formation on L-abrine (2a) concentrations 
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Figure S4.3. Dependence of product formation on L-ß-homotryptophan (3a) concentrations 
Figure S4.4. Dependence of product formation on 4-methyl-DL-tryptophan (4a) concentrations 
68
19 
Figure S4.5. Dependence of product formation on 5-methyl-DL-tryptophan (5a) concentrations 
Figure S4.6. Dependence of product formation on 6-methyl-DL-tryptophan (6a) concentrations 
69
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Figure S4.7. Dependence of product formation on 7-methyl-DL-tryptophan (7a) concentrations 
Figure S4.8. Dependence of product formation on 1,3-dihydroxynaphthalene (8a) concentrations 
70
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Figure S4.9. Dependence of product formation on 1,7-dihydroxynaphthalene (9a) concentrations 
Figure S4.10. Dependence of product formation on 2,3-dihydroxynaphthalene (10a) concentrations 
71
22 
Figure S4.11. Dependence of product formation on DMAPP concentrations in the presence of L-
tryptophan (1a) 
Figure S4.12. Dependence of product formation on GPP concentrations in the presence of L-
tryptophan (1a) 
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Abstract: The behavior of four dimethylallyltrypto-
phan synthases (DMATSs) (5-DMATS and 5-
DMATSSc as tryptophan C5-prenyltransferases, and
6-DMATSSa and 6-DMATSSv as C6-prenyltransfer-
ases) and one l-tyrosine prenyltransferase with
a tryptophan C7-prenyltransferase activity was inves-
tigated in the presence of two unnatural alkyl donors
(methylallyl and 2-pentenyl diphosphate) and one
benzyl donor (benzyl diphosphate). Detailed bio-
chemical investigations revealed the acceptance of
these dimethylallyl diphosphate (DMAPP) ana-
logues by all tested enzymes with different relative
activities. Enzyme products with the allyl or benzyl
moiety attached to different positions were identified
in the reaction mixtures, whereby C-6 alkylated or
benzylated l-tryptophan was found as one of the
main products. This observation demonstrates a pref-
erence of the five prenyltransferases toward C-6 of
the indole ring in the presence of unnatural DMAPP
derivatives. Molecular dynamics simulation experi-
ments with a homologous model of 5-DMATS ex-
plained well its reactions with methylallyl and 2-pen-
tenyl diphosphate. Furthermore this study expands
significantly the potential usage of tryptophan preny-
lating enzymes as biocatalysts for Friedel–Crafts al-
kylation.
Keywords: dimethylallyltryptophan synthase;
enzyme catalysis; Friedel–Crafts alkylation; prenyl-
transferase; regioselectivity
Introduction
Secondary metabolites with biological activities repre-
sent an important source for medicinal research and
drug development.[1,2] They are widely distributed in
nature, especially in plants and microorganisms.[1–3]
Among microorganisms, fungi of Ascomycetes and
bacteria of Actinomycetes are important producers of
biologically active compounds.[3,4] Due to significant
progress in genome sequencing and genome mining,
a number of gene clusters involved in the biosynthesis
of such metabolites have been identified in recent
years.[4–8] A large group of natural products comprises
the prenylated aromatic substances derived from
prenyl diphosphate and an aromatic scaffold from dif-
ferent pathways.[9,10] Prenyltransferases catalyze the
linkage of these two residues and play an important
role in the structural diversity of these compounds.
Indole prenyltransferases belong to the dimethylallyl-
tryptophan synthase (DMATS) superfamily, which
catalyze the underlying prenylation reaction of indole
derivatives in nature, and represent one of the most
investigated class of prenyltransferases.[11] In the pres-
ence of the natural prenyl donor dimethylallyl diphos-
phate (DMAPP), most members of this superfamily
usually show remarkable flexibility toward their aro-
matic substrates, but high regioselectivity of the pre-
nylation position on the indole ring.[12–15] These char-
acteristics were observed for fungal tryptophan pre-
nyltransferases, e.g., FgaPT2, 5-DMATS and 7-
Adv. Synth. Catal. 2015, 357, 975 – 986 Õ 2015 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim 975
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DMATS from different Aspergillus spp., which cata-
lyze tryptophan C4-, C5- and C7-prenylations, respec-
tively (Scheme 1). Two bacterial enzymes, SCO7467
from Streptomyces coelicolor A3(2) and IptA from
Streptomyces sp. SN-593, are tryptophan C5- and C6-
prenyltransferases, respectively.[12,16] IptA is involved
in the biosynthesis of 6-dimethylallylindole-3-carbal-
dehyde.[12,17] Recently, two further 6-DMATS en-
zymes, 6-DMATSSa (SAML0654) from Streptomyces
ambofaciens (S. ambofaciens) ATCC238 and 6-
DMATSSv (Strvi8510) from Streptomyces violaceus-
niger (S. violaceusniger) Tî4113 were identified and
characterized biochemically.[18] These two 6-DMATS
enzymes showed high flexibility toward their prenyl
donor and acceptor. In contrast to other indole pre-
nyltransferases, both DMAPP and geranyl diphos-
phate (GPP) were used by both enzymes.[18] Conse-
quently, this flexibility makes them interesting candi-
dates for further investigations on the acceptance of
unnatural alkyl or benzyl donors.
Biochemical investigations on the tryptophan pre-
nyltransferases FgaPT2 and 5-DMATS with methyl-
allyl (MAPP) and 2-pentenyl diphosphate (2-penten-
yl-PP) showed that these enzymes also accepted such
unnatural alkyl donors. The alkylation positions were
shifted partially or completely to the neighboring po-
sition.[19] The tryptophan C4-prenyltransferase
FgaPT2 even accepted benzyl diphosphate (benzyl-
PP) as substrate and catalyzed the regiospecific ben-
zylation of l-tryptophan at position C-5.[20] Our previ-
ous data on the reactions of tryptophan prenyltrans-
ferases with unnatural alkyl and benzyl donors were
limited to enzymes which catalyzed the transfer reac-
tions of the dimethylallyl moiety onto position C-4
and C-5 of the indole ring.[19,20] In a previous study,
the behavior of the 7-DMATS from A. fumigatus
could not be investigated in detail, due to its low ac-
tivity in the presence of unnatural DMAPP ana-
logues.[19]
Fortunately, the recently identified l-tyrosine pre-
nyltransferase TyrPT from Aspergillus niger showed
a remarkable tryptophan C7-prenyltransferase activi-
ty[21] and can be considered as a tryptophan C7-preny-
lating enzyme in this study. As shown in Scheme 1,
the five enzymes 5-DMATS,[13] 5-DMATSSc,
[17] 6-
DMATSSa,
[18] 6-DMATSSv
[18] and TyrPT[21] used in this
study share the same substrates (tryptophan and
DMAPP), but catalyze regiospecific prenylations at
different positions of the indole ring. After having the
availability of the two tryptophan C6-prenyltransfer-
ases 6-DMATSSa and 6-DMATSSv as well as of TyrPT
in our laboratory, we initiated a study to prove their
behavior toward MAPP, 2-pentenyl-PP and benzyl-
PP.
Results and Discussion
C-6 Alkylated/Benzylated Derivatives as Unique
Enzyme Products of the Two C6-Prenyltransferases
The purified recombinant proteins 6-DMATSSa and 6-
DMATSSv were firstly incubated with l-tryptophan in
the presence of one of the three unnatural DMAPP
analogues MAPP (I), 2-pentenyl-PP (II), and benzyl-
PP (III). HPLC analysis of the enzyme assays showed
clear product formation in all of these reaction mix-
tures, with the highest conversions of 91.20.07%
and 89.30.6% observed in the presence of 2-penten-
yl-PP for 6-DMATSSa and 6-DMATSSv, respectively
(Figure 1, Scheme 2, see the Supporting Information,
Table S1). Lower conversion yields of 51.10.5% and
37.60.3% were observed in the incubation mixtures
with MAPP, and 13.90.3% and 8.20.3% with
benzyl-PP (Figure 1, Scheme 2, see the Supporting In-
formation, Table S1). To determine the alkylation po-
sition, enzyme assays were prepared on a large scale.
The enzyme products Ia–IIIa were isolated from both
assays of 6-DMATSSa and 6-DMATSSv on HPLC and
their structures were elucidated by MS and NMR
analyses. For better understanding, we named the
products by a combination of I (product from
MAPP), II (2-pentenyl-PP) or III (benzyl-PP) with
a (regular alkyl or benzyl at C-6), b1 (regular alkyl at
C-7), b2 (reverse alkyl at C-7), b (benzyl at C-7) or
c (regular alkyl or benzyl at C-5). MS data confirmed
the monoalkylation or benzylation of the isolated
products. 1H NMR analysis (for structural elucidation
see the Supporting Information) proved the regular
attachment of the alkyl or benzyl residue onto posi-
Scheme 1. Regiospecific prenylation of tryptophan by the
five prenyltransferases used in this study in the presence of
their natural prenyl donor DMAPP. Origin of the enzymes:
6-DMATSSa from Streptomyces ambofaciens, 6-DMATSSv
from Streptomyces violaceusniger, 5-DMATS from Aspergil-
lus clavatus, 5-DMATSSc from Streptomyces coelicolor and
TyrPT from Aspergillus niger.
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Figure 1. HPLC analysis of the reaction mixtures of l-tryptophan with unnatural DMAPP analogues.
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tion C-6 of the indole ring in all of these cases (see
the Supporting Information, Figures S9–S11). This
conclusion was drawn by comparison of the coupling
patterns of the signals for aromatic protons with those
of the published data for C-6 alkylated l-trypto-
phan.[18–20] In the presence of the natural prenyl
donors DMAPP or GPP, 6-DMATSSa and 6-DMATSSv
also catalyze a C-6 prenylation.[18] Therefore, the alky-
lation position for both enzymes was proven to be in-
dependent of the used alkyl or benzyl donor.
C-6 Alkylated/Benzylated derivatives were Main
Products of TyrPT Reactions with DMAPP
Analogues
Taking the data on 6-DMATSSa and 6-DMATSSv with
the previous published results on FgaPT2 and 5-
DMATS[19,20,22] together, we have shown the behavior
of tryptophan C4-, C5- and C6-prenyltransferases
toward unnatural DMAPP analogues. It would be in-
teresting to complete this series with C7-prenylating
Scheme 2. Alkylation/benzylation of l-tryptophan catalyzed by C5-, C6- and C7-prenylating enzymes in the presences of
three DMAPP analogues. –: product yields <0.3%. The mean of the total conversion yields were measured in duplicate by
HPLC and the percentages for different products were calculated by using the corresponding NMR data.
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enzymes. A previous study showed that the trypto-
phan C7-prenyltransferase 7-DMATS from A. fumi-
gatus[23] accepted very poorly MAPP and 2-pentenyl-
PP.[19] Recently, CAK41583 from A. niger was identi-
fied as a tyrosine prenyltransferase (TyrPT), catalyz-
ing an O-prenylation at the phenolic hydroxy group
of l-tyrosine.[21] As in the case of SirD from Leptos-
phaeria maculans,[24] TyrPT also catalyzed the transfer
reaction of a dimethylallyl moiety from DMAPP to
C-7 of l-tryptophan and several derivatives thereof.[21]
The broad substrate specificity of TyrPT led us to test
its activity for DMAPP analogues in the presence of
l-tryptophan. In analogy to 6-DMATSSa and 6-
DMATSSv, TyrPT was incubated with l-tryptophan in
the presence of MAPP, 2-pentenyl-PP and benzyl-PP.
Product formation was detected in all three incuba-
tion mixtures (Figure 1). However, the observed
enzyme activities were much lower than those of the
two 6-DMATS enzymes. Total product yields of
38.30.6, 17.70.2 and 8.51.0% were calculated
for 2-pentenyl-PP, MAPP and benzyl-PP, respectively
(Figure 1, Scheme 2, see the Supporting Information,
Table S1). This is justified by the fact that l-tyrosine,
but not l-tryptophan is the best accepted aromatic
substrate by TyrPT, also in the presence of DMAPP.
Interestingly, the ratio of the relative activities toward
the three DMAPP analogues was similar to those of
the two 6-DMATS enzymes. In contrast to the unique
C-7 prenylation of l-tryptophan by TyrPT in the pres-
ence of DMAPP, interpretation of the individual
peaks of the 1H NMR spectra indicated the presence
of more than one product each in the incubation mix-
tures with DMAPP analogues. Optimization of the
HPLC conditions and the application of a Chiralpak
Zwix (+) column (see the Supporting Information,
Figure S1) allowed a partial separation of these prod-
uct mixtures. Although the compounds to be separat-
ed differ from each other by alkylation positions
rather than by stereochemistry, they showed different
behavior on the Chiralpak Zwix (+) column. It seems
that the indole derivatives had different interactions
with the column material.
HPLC analysis of the incubation mixture with 2-
pentenyl-PP and interpretation of the NMR data led
to the identification of three substances with a regular
alkyl moiety attached to C-6 (IIa), C-7 (IIb1) and C-5
(IIc), respectively. Product yields of 21.50.4, 9.9
0.2 and 3.30.03% were calculated for these products
(Scheme 2, see also the Supporting Information). In
addition, a reversely C-7 alkylated l-tryptophan
(IIb2) was isolated with a product yield of 3.50.7%
(Scheme 2, see the Supporting Information, Fig-
ure S21). With MAPP as alkyl donor, regularly C-6
(Ia) and C-7 alkylated (Ib1) as well as reversely C-7
alkylated derivatives (Ib2) were identified by inter-
pretation of their NMR spectra (see the Supporting
Information). Product yields of 5.90.08, 8.90.1
and 2.90.4% were calculated for Ia, Ib1 and Ib2, re-
spectively. Regularly C-6, C-7 and C-5 benzylated
products (IIIa, IIIb, IIIc) with product yields of 5.7
0.7, 1.90.2 and 0.90.1% were identified in the re-
action mixture of l-tryptophan with benzyl-PP. These
results demonstrated clearly that C-6 alkylated or
benzylated derivatives were main or one of two pre-
dominant products of TyrPT reactions in the presence
of the unnatural donors (Scheme 2) and differed
clearly from that of l-tryptophan with DMAPP.[21]
Comparison of Bacterial and Fungal Alkylation/
Benzylation Reactions by Investigations on 5-
DMATS and 5-DMATSSc
As described above, the two 6-DMATS enzymes from
bacteria catalyzed the regiospecific alkylation and
only one product with the same position, i.e, C-6, was
identified, independent of DMAPP, GPP[18] or the
DMAPP analogues MAPP, 2-pentenyl-PP or benzyl-
PP. In comparison, the fungal prenyltransferases
FgaPT2 and 5-DMATS catalyzed the regiospecific C-
4 and C-5 prenylation in the presence of DMAPP, re-
spectively.[13,14] But in the presence of the unnatural
DMAPP analogues, the regioselectivity was partially
or completely shifted.[19,20] In the presence of l-trypto-
phan, the fungal l-tyrosine O-prenyltransferase
TyrPT also accepted DMAPP analogues as substrates.
In the case of 2-pentenyl-PP and benzyl-PP, C-6 alky-
lated or benzylated l-tryptophan was the predomi-
nant product. In the presence of methylally-PP, the C-
6 alkylated derivative was one of the two dominant
products. It seems that in the presence of DMAPP
analogues, C-6 is the preferable alkylation position
for enzymes which usually catalyzed the prenylation
of l-tryptophan at C-5 (like 5-DMATS), C-6 (6-
DMATS enzymes) and C-7 (TyrPT).
These results pose an important question on the
possible reason for the decreasing regioselectivity of
5-DMATS and TyrPT. One plausible explanation
could be the orientation of the DMAPP analogues in
the binding sites of the enzymes, which make C-6 to
be the preferable alkylation position. However, it
cannot be excluded that the observed regiospecific al-
kylation or benzylation of l-tryptophan at the same
position by 6-DMATSSa and 6-DMATSSv in the pres-
ence of DMAPP, GPP and DMAPP analogues is
based on their bacterial origin. It could be speculated
that bacterial prenyltransferases retain their regiose-
lectivities independent of the used donors, while
fungal enzymes exhibit relaxed selectivity in the pres-
ence of different alkyl donors. 5-DMATS and TyrPT
are fungal enzymes and therefore showed different
behavior regarding regioselectivity compared with 6-
DMATS enzymes. The latter hypothesis would also
be supported by the fact that FgaPT2 catalyzed tryp-
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tophan alkylation and benzylation in the presence of
these unnatural alkyl and benzyl donors with partial
or complete shift of the attachment positions.[19,20]
To clarify the possible reason for this difference, we
investigated the regioselectivity of the tryptophan C5-
prenyltransferase SCO7467 (5-DMATSSc) from the
bacterium Streptomyces coelicolor A3(2) in the bio-
synthesis of 5-dimethylallylindole-3-acetonitrile.[16,17]
SCO7467 was overproduced in E. coli as reported by
Ozaki,[17] purified and investigated in the presence of
MAPP, 2-pentenyl-PP and benzyl-PP. For comparison,
the behavior of the fungal 5-DMATS from A. clava-
tus,[13] toward MAPP and 2-pentenyl-PP[19] was repro-
duced in this study. In addition, this enzyme was as-
sayed with benzyl-PP in the presence of l-tryptophan.
The previously reported data for 5-DMATS[19] were
reproduced in this study by identification of C-5 and
C-6 alkylated products with MAPP, with products
yields of 13.60.02 and 45.30.05%, respectively. In
the presence of 2-pentenyl-PP, the alkylation position
was completely shifted from C-5 to C-6. Similar to
those of MAPP, C-5 and C-6 benzylated products
with yields of 5.70.06 and 22.90.01% were detect-
ed in the assay with benzyl-PP (Figure 1, Scheme 2).
Again, C-6 alkylated or benzylated l-tryptophan rep-
resented the predominant product.
HPLC analysis clearly revealed product formation
in the reaction mixtures of l-tryptophan with the re-
combinant 5-DMATSSc in the presence of all three
DMAPP analogues (Figure 1). HR-MS data con-
firmed the attachment of one alkyl or benzyl residue
on the substrate for all of the obtained products (see
the Experimental Section). Structure elucidation by
NMR indicated that the isolated product peaks con-
sisted of more than one substance. C-6, C-7 and C-5
alkylated derivatives were identified with ratios of
3:3:1 for 2-pentenyl-PP and of 4:4:1 for MAPP. By
using a Chiralpak Zwix (+) column, the C-7 alkylated
products were purified from these mixtures
(Scheme 2, see the Supporting Information, Fig-
ure S1). With 2-pentenyl-PP as alkyl donor, a product
yield of 9.30.02% was calculated for C-5 (IIc) and
27.90.06% each for C-6 (IIa) and C-7 alkylated
(IIb1) l-tryptophan (Scheme 2). In the case of MAPP,
product yields of 9.30.2, 9.30.2 and 2.30.05%
were determined for Ia, Ib1 and Ic, respectively. In-
spection of the NMR spectra of the products obtained
with benzyl-PP revealed the presence of 6-benzyl-l-
tryptophan (IIIa) with a product yield of 5.30.1%
and 7-benzyl-l-tryptophan (IIIb) of 0.90.02% (see
the Supporting Information, Figures S11 and S22). In
addition, signals of a C-5 benzylated l-tryptophan
(IIIc) with a product yield of 0.40.009% could also
be observed (together with IIIa as a mixture, see the
Supporting Information, Figure S2).
The results obtained with the bacterial 5-DMATSSc
were distinguishable not only from those with the
fungal 5-DMATS, but also from those of the two bac-
terial 6-DMATS enzymes. Formation of three differ-
ent alkylated or benzylated products by 5-DMATSSc
in all of the three incubations disproved the bacterial
origin of the observed high regiospecificity for the
two 6-DMATS enzymes. These results confirmed the
preference of the enzymes investigated in this study
for C-6 of the indole ring in the presence of the three
unnatural DMAPP analogues.
Kinetic Parameters
Determination of the kinetic parameters of the en-
zymes with the DMAPP analogues indicated that the
observed reactions were consistent with Michaelis–
Menten kinetics (Table 1). KM values in the range of
0.011 to 0.13 mM proved their relatively high affinity
toward the tested DMAPP analogues. In contrast, the
turnover numbers of the reactions with these
DMAPP analogues were much lower than those with
DMAPP. As observed in Figure 1 and given in
Scheme 2, 2-pentenyl-PP was accepted in most cases
as the best unnatural alkyl donor. This was also con-
firmed by the kinetic parameters with an exception
for TyrPT. Here the efficiencies toward MAPP and 2-
pentenyl-PP are almost identical, although higher rel-
ative activities toward 2-pentenyl-PP were observed.
The unnatural donor MAPP was also well accepted
but to a lesser degree. Benzyl-PP is a poor substrate
for all enzymes, as verified by kinetic parameters.
Homology Modelling of 5-DMATS
To get insights into the reduced regioselectivity of the
tested enzymes in the presence of DMAPP analogues
and to assess how the protein might be able to dis-
criminate between the different analogues, we homol-
ogy modelled 5-DMATS. Four enzymes from the
DMATS superfamily, FgaPT2,[25] FtmPT1,[26]
CdpNPT[27] and AnaPT[28] could principally serve as
templates. As expected, the structure of the trypto-
phan C4-prenyltransferase FgaPT2 is the most suita-
ble for this purpose, owing to the sequence identity of
52% with the target. As shown in Figure 2A and Fig-
ure S26 in the Supporting Information, our model of
5-DMATS consists of five abßa units, being similar to
those of the known structures of the DMATS en-
zymes. Due to the low homology of only about 26%
or less on the amino acid level to proteins with
known structures, no model with a sufficient level of
detail for the approaches used in this study could be
obtained for 5-DMATSSc, 6-DMATSSa, 6-DMATSSv,
or TyrPT.
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Figure 2. Homology model of 5-DMATS (A). a-helices are
colored in red, b-sheets in yellow and turns and loops in
green, respectively. The ABBA motif of dimethylallyltrypto-
phan synthases is reproduced in the model, the Ca-RMSD
between model and template being 0.1 è. Active site resi-
dues of the model (orange) and template (white) are shown
(B and C). The corresponding amino acids are labelled as
pairs (FgaPT2/5-DMATS). C is rotated by 908 with respect
to B.
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Docking Experiments with DMAPP and Analogues
Initial docking experiments led to acceptor and donor
poses consistent with the interactions observed for
the respective molecules in the template X-ray struc-
ture. In particular, contacts with the conserved basic
residues interacting with the pyrophosphate tail of the
donor molecules are preserved. Yet, this static picture
of protein acceptor–donor interactions did not allow
us to formulate a hypothesis that was consistent with
the experimental findings. Thus, we carried out molec-
ular dynamics (MD) calculations to assess how the in-
teractions might change over time.
These MD studies (Supporting Information, Fig-
ure S27) showed that DMAPP resides in the cavity
with a mean distance of 4.32 è between its C-1 and
the C-5 of the indole ring (Figure 3A). In contrast,
the average distance between C-1 and C-6 on l-tryp-
tophan is significantly larger, thus providing a possible
explanation for the formation of solely C-5 prenylated
tryptophan in the presence of DMAPP. In compari-
son, C-1 of 2-pentenyl-PP is predominantly close to
C-6 of the indole ring with a distance of 4.82 è (com-
pared to 5.11 è between C-1 and C-5; Figure 3B), so
that an exclusive C-6 alkylation is plausible. As
shown in Figure 3C, C-1 of MAPP is located at
a shorter distance to C-6 of the indole ring, which is
also consistent with the formation of the predomi-
nantly C-6 alkylated derivative for this donor. All
these simulations were remarkably stable over the
simulation time, as evidenced by the RMSD and
RMSF plots in Figure S28 and S29 of the Supporting
Information and the overlay of the starting structure
and the final snapshot (Supporting Information, Fig-
ure S27). In contrast, the MD simulations with
benzyl-PP became unstable shortly after the start of
the unrestrained equilibration step (despite several
repetitions), with an unusual edge-to-face orientation
of benzyl-PP with respect to l-tryptophan (Supporting
Information, Figure S27). We were thus unable to use
these data within the present study. We speculate that
the reason for this behavior of the simulations could
be that the binding sites for the prenyl donors in the
structures of the DMATS enzymes were determined
with linear DMAPP analogues, which have signifi-
cantly different sizes and electron densities than
benzyl-PP.
It also seems intuitive that the donor–acceptor dis-
tance is a major factor determining the regioselectivi-
ty of alkylations: As evidenced by the experiments,
the reactivitoies of both C-5 and C-6 can be consid-
ered as equal. Thus, the preference for prenylation at
a certain position can be a direct effect of the number
of times donor and acceptor come so close to each
other that an activated complex can be formed.
Conclusions
In conclusion, all the tested enzymes used MAPP, 2-
pentenyl-PP and benzyl-PP as substrates and cata-
lyzed Friedel–Crafts alkylation or benzylation reac-
tions on the indole ring. The observed reactions differ
from each other in relative activities and regioselec-
tivity of the attached position. One to four alkylated
or benzylated derivatives have been identified as
enzyme products (Scheme 2). From Scheme 2, it is ob-
vious that in the presence of unnatural DMAPP ana-
logues, C-6 of tryptophan was the preferable alkyla-
tion and benzylation position for tryptophan C5-, C6-
and C7-prenylating enzymes. C-6 Alkylated or benzy-
lated derivatives were identified in all the reaction
mixtures. It was found as a unique product in the
cases of the both 6-DMATS enzymes with all of the
Figure 3. For each donor molecule the distances between the C-1 atom of the donor and the C-5 and C-6 atoms of trypto-
phan were measured over 2500 generated snapshots. Distance distributions are shown as box plots: Grey circles represent
mean values, white circles measurements outside the 95th percentile. Boxes span 50% of the measurements, whiskers 95%.
White boxes correspond to distances between the C-1 and C-5 atom, while shaded boxes show distances between the C-
1 and C-6 atom, respectively.
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three DMAPP analogues or as one of two main prod-
ucts in the reaction mixtures of 5-DMATSSc with
MAPP and 2-pentenyl-PP. Such derivatives were pre-
dominant products in all other reaction mixtures.
From Scheme 2, it is also clear that the tryptophan
C5-prenyltransferases 5-DMATS and 5-DMATSSc as
well as TyrPT with a tryptophan C7-prenyltransferase
activity also produced C-5 or/and C-7 alkylated or
benzylated derivatives, indicating a shift of the alkyla-
tion or benzylation position from C-5 to C-7 and vice
versa. By using the program MODELLER, a structur-
al model was constructed for 5-DMATS from A. clav-
atus and used for docking and MD studies with
DMAPP, MAPP and 2-pentenyl-PP, leading to a dis-
tance-based explanation of their observed reaction
preferences. Unfortunately, the MD simulations with
benzyl-PP became unstable. It seems that the avail-
able structure information is still too limited for a uni-
versal interpretation or prediction of all possible
enzyme reactions. Therefore, it will be interesting to
have more protein structures elucidated in the near
future, most importantly also as complexes with dif-
ferent acceptors and donors including unnatural
DMAPP analogues.
Experimental Section
Chemicals
Syntheses of methylallyl-PP (MAPP), 2-pentenyl-PP and
benzyl-PP were carried out as described previously.[19,29] l-
Tryptophan was purchased from Roth (Karlsruhe, Germa-
ny).
Overproduction and Purification of the Recombinant
Proteins
Gene expression and subsequent protein purification of the
recombinant 6-DMATSSa-His6, His8-6-DMATSSv, His6-TyrPT
and 5-DMATS-His6 were carried out as described previous-
ly.[13,18,21]
Cloning and Expression of 5-DMATSSc (SCO7467)
PCR amplification of SCO7467 from Streptomyces coelicol-
or A3(2) was carried out as described by Ozaki et al.[30] The
expression vector pHis8 containing the coding sequence was
termed pML10. E. coli BL21 [DE3] cells harboring pML10
were cultivated in 1 L liquid lysogeny broth (LB) medium
supplemented with kanamycin (50 mgmL¢1) until an absorp-
tion at 600 nm of 0.6. For induction of gene expression,
IPTG was added to a final concentration of 0.5 mM. After
further incubation at 30 8C and 220 rpm for 6 h, the recombi-
nant protein was purified as routinely on Ni-NTA agarose.
Enzyme Assays for Determination of the Activities
and Kinetic Parameters
The reaction mixtures (100 mL) for determination of the
enzyme activities contained 1 mM l-tryptophan, 5 mM
CaCl2, 2 mM alkyl diphosphate [DMAPP, MAPP (I), 2-pen-
tenyl-PP (II)] or benzyl-PP (III), 1.0–1.5% (v/v) glycerol,
50 mM Tris-HCl (pH 7.5) and 7.5 mM of purified recombi-
nant protein. The reaction mixtures were incubated at 37 8C
for 16 h. For HPLC analysis, the reactions were terminated
with 100 mL MeOH. Protein was then removed by centrifu-
gation at 17,000×g for 15 min. HPLC measurements were
carried out in duplicate on a RP-18 and a Chiralpak Zwix
column (+).
Enzyme assays for determination of the kinetic parame-
ters for DMAPP and its analogues MAPP, 2-pentenyl-PP
and benzyl-PP contained 1 mM l-tryptophan, 5 mM CaCl2
for fungal or MgCl2 for bacterial prenyltransferases, 0.15%
(v/v) glycerol, 50 mM Tris-HCl (pH 7.5) and the respective
alkyl or benzyl diphosphate in final concentrations of up to
0.5 mM or 1 mM in the case of 5-DMATS with benzyl-PP
were incubated at 37 8C in duplicates. For 6-DMATSSa, a pro-
tein amount of 5 mg and an incubation time of 30 min were
used in the presence of 2-pentenyl-PP. For incubation with
MAPP or benzyl-PP, the protein amount and incubation
time were 10 mg and 60 min. 1 mg 6-DMATSSv was assayed
with DMAPP for 5 min and 10 mg with DMAPP analogues
for 60 min. The assays for TyrPT contained 15 mg protein
and were incubated for 60 min with 2-pentenyl-PP and
90 min with MAPP or benzyl-PP. 10 mg 5-DMATSSc and an
incubation time of 60 min were used for 2-pentenyl-PP,
20 mg and 90 min for MAPP. For the reactions with benzyl-
PP, 25 mg 5-DMATSSc and an incubation time of 90 min
were used. Kinetic parameters of 5-DMATS were obtained
from enzyme assays with 20 mg of purified protein and incu-
bation time of 60 min. The reactions were terminated with
100 mL MeOH and the protein was removed by centrifuga-
tion at 17.000×g for 15 min. Parameters of Michaelis–
Menten kinetics such as KM and turnover number (kcat)
were determined by Lineweaver–Burk, Hanes–Woolf and
Eadie–Hofstee plots.
Enzyme Assays for Isolation and Structure
Elucidation
Assays for isolation of the enzyme products were carried
out in large scales (10 mL) containing 1 mM l-tryptophan,
2 mM MAPP, 2-pentenyl-PP or benzyl-PP, 5 mM CaCl2, 0.0–
1.5% (v/v) glycerol, 50 mM Tris-HCl (pH 7.5) and with 2 to
4 mg of purified recombinant protein. After incubation for
16 h at 37 8C, the reaction mixtures were terminated with
10 mL MeOH and precipitated protein was removed by cen-
trifugation at 4.750×g for 15 min. The obtained supernatant
was then concentrated on a rotating vacuum evaporator to
1 mL for injection in HPLC.
HPLC Analysis and Isolation of the Enzyme
Products for Structure Elucidation
The enzyme products were analyzed on an Agilent series
1200 HPLC (Agilent Technologies Deutschland GmbH, Bç-
blingen, Germany) with a Multospher 120 RP-18 column
(250×4 mm, 5 mm, C+S-Chromatography Service, Langer-
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wehe, Germany) at a flow rate of 1 mLmin¢1. Water (sol-
vent A) and methanol (solvent B) were used as solvents for
analysis and isolation of the enzyme products. For analysis
of the alkylated tryptophan, a linear gradient of 40–100%
(v/v) solvent B over 15 min was used. The column was then
washed with 100% solvent B for 5 min and equilibrated
with 40% solvent B for 5 min. Detection was carried out on
a photo diode array detector.
By using the same HPLC equipment and a semiprepara-
tive Multospher 120 RP-18 column (250×10 mm, 5 mm, C+
S-Chromatographie Service, Langerwehe, Germany), the
enzyme products were isolated at a flow rate of
2.5 mLmin¢1 and a gradient of 60–100% solvent B in 20–
25 min. If necessary, an isocratic step with solvent B before
the gradient was included for 5 min. After each run the
column was washed with 100% solvent B and equilibrated
with 60% solvent B for 5 min.
A much better separation of the l-tryptophan derivatives
with different alkylation positions on the indole ring was
achieved by using a Chiralpak Zwix column (+) (150×
3 mm, 3 mm, Chiral technologies Europe, Daicel Group, Ill-
kirch Cedex, France). This column was used for detailed in-
vestigations on the enzyme products in the incubation mix-
tures (Figure S1, Supporting Information) and for separation
of the product mixtures that were not separated by using
the semipreparative Multospher 120 RP-18 column men-
tioned above. Analysis of the enzyme assays and isolation of
the products were carried out at a flow rate of 0.5 mLmin¢1
with water (solvent A) and methanol (solvent B) as solvents.
An isocratic run with 50% solvent B was used.
NMR and MS Analyses as well as Structure
Elucidation
NMR including two-dimensional HSQC and HMBC spectra
were recorded on JEOL ECA-500 (JEOL Germany GmbH,
Munich, Germany) or Bruker Avance-600 (Bruker Corpora-
tion, Billerica, USA) spectrometers, respectively. The spec-
tra were processed with MestReNova 6.0.2. Chemical shifts
were referred to the signals of CD3OD at dH=3.31 and dC=
49.2 ppm. The isolated compounds were also analyzed by
electrospray ionization (ESI-MS) or electron impact mass
spectrometry (EI-MS) on a Q-Trap 2000 (Life Technologies
Ltd, Paisley, United Kingdom) and by high resolution elec-
trospray ionization (HR-ESI-MS) or electron impact mass
spectrometry (HR-EI-MS) on an Auto SPEC (Waters MS
Technology Centre, Manchester, United Kingdom).
Compound Ia: 1H NMR (MeOH-d4, 500 MHz): d=7.60
(dd, J=8.1, 0.4 Hz, H-4), 7.15 (d, 0.7, H-7), 7.12 (s, H-2),
6.89 (dd, J=8.1, 1.4 Hz, H-5), 5.60 (dtq, J=15.1, 6.6, 1.4 Hz,
H-2’), 5.51 (dqt, J=15.1, 6.3, 1.3 Hz, H-3’), 3.84 (dd, J=9.5,
4.0 Hz, H-11), 3.49 (ddd, J=15.2, 4.0, 0.6 Hz, H-10), 3.37 (d,
J=6.7 Hz, H2-1’), 3.11 (dd, J=15.2, 9.5 Hz, H-10), 1.67 (dd,
J=6.2, 1.4 Hz, H3-4’); ESI-MS: m/z (intensity)=517.30
[2M+H]+ (100), 539.3 [2M+Na]+ (58), 297.10 [M+K]+
(47), 259.10 [M+H]+ (31), 281.10 [M+Na]+(24); HR-EI-
MS: m/z=258.1322, calcd. for C15H18N2O2 [M]
+: 258.1368.
Compound IIa: 1H NMR (MeOH-d4, 500 MHz): d=7.60
(d, J=8.2 Hz, H-4), 7.16 (d, J=0.6 Hz, H-7), 7.13 (s, H-2),
6.90 (dd, J=8.2, 1.4 Hz, H-5), 5.63–5.50 (m, H-2’/H-3’), 3.84
(dd, J=9.5, 4.0 Hz, H-11), 3.49 (ddd, J=15.1, 4.0, 0.6 Hz, H-
10), 3.38 (d, J=6.0 Hz, H2-1’), 3.12 (dd, J=15.2, 9.5 Hz, H-
10), 2.04 (m, H2-4’), 0.99 (t, J=7.5 Hz, H3-5’); ESI-MS: m/z
(intensity)=273.25 [M+H]+ (100), 295.14 [M+Na]+ (87),
HR-EI-MS: m/z=272.1557, calcd. for C16H20N2O2 [M]
+:
272.1525.
Compound IIIa: 1H NMR (MeOH-d4, 500 MHz): d=7.60
(dd, J=8.2, 0.6 Hz, H-4), 7.25–7.17 (m, H-2’/H-6’, H-3’/H-
5’), 7.18 (s, H-7, overlaid with H-2’/H-6Ï, H-3’/H-5’), 7.15–
7.11 (m, H-4’), 7.13 (s, H-2Ï overlaid with H-4’), 6.93 (dd, J=
8.2, 1.5 Hz, H-5), 4.04 (s, H2-1’), 3.82 (dd, J=9.4, 4.0 Hz, H-
11), 3.48 (ddd, J=15.2, 4.0, 0.7 Hz, H-10), 3.11 (dd, J=15.2,
9.4 Hz, H-10); ESI-MS: m/z (intensity)=295.20 [M+H]+
(100), 589.70 [2M+H]+ (50), 316.92 [M+Na]+ (11); HR-
EI-MS: m/z=294.1368, calcd. for C18H18N2O2 [M]
+:
294.1362.
Compound Ib1: 1H NMR (MeOH-d4, 500 MHz): d=7.56
(dd, J=7.9, 1.0 Hz, H-4), 7.19 (s, H-2), 7.00 (dd, J=7.9,
7.1 Hz, H-5), 6.93 (dd, J=7.1, 0.6 Hz, H-6), 5.65 (dtq, J=
15.1, 6.4, 1.4 Hz, H-2’), 5.57 (dqt, J=15.1, 6.2, 1.2 Hz, H-3’),
3.85 (dd, J=9.5, 4.0 Hz, H-11), 3.53 (d, J=5.2 Hz, H2-1’),
3.51 (m, H-10, overlaid with H-1’), 3.14 (dd, J=15.4, 9.5 Hz,
H-10), 1.66 (ddt, J=6.0, 1.4, 1.3 Hz, H3-4’); ESI-MS: m/z
(intensity)=259.30 [M+H]+ (100), 281.10 [M+Na]+ (55.8),
539.23 [2M+Na]+ (14), 517.32 [2M+H]+ (8), 297.00 [M+
K]+ (6); HR-ESI-MS: m/z=281.1266, calcd. for C15H18N2O2
[M+Na]+: 281.1288.
Compound IIb1: 1H NMR (MeOH-d4, 600 MHz): 7.55 (d,
J=7.8 Hz, H-4), 7.19 (s, H-2), 7.00 (t, J=7.5 Hz, H-5), 6.93,
(d, J=7.0 Hz, H-6), 5.67–5.58 (m, H-2’/H-3’), 3.84 (dd, J=
9.3, 3.8 Hz, H-11), 3.54 (d, J=3.3 Hz, H2-1’), 3.50 (dd, J=
15.1, 3.8 Hz, H-10), 3.13 (dd, J=15.1, 9.3 Hz, H-10), 2.03 (m,
H2-4’), 0.97 (t, J=7.5 Hz, H3-5’);
13C NMR (MeOH-d4,
150 MHz, deduced from HSQC/HMBC): d=136.8, 134.1,
128.4, 127.9, 125.1, 124.7, 122.2, 120.2, 117.1, 109.9, 56.5,
35.0, 28.4, 26.1, 13.8; ESI-MS: m/z (intensity)=295.10 [M+
Na]+ (100), 273.14 [M+H]+ (29), 545.35 [2M+H]+ (6),
567.39 [2M+Na]+ (6), 311.10 [M+K]+ (3); HR-ESI-MS:
m/z=295.1395, calcd. for C16H20N2O2 [M+Na]
+: 295.1422.
Compound IIIb: 1H NMR (MeOH-d4, 500 MHz): d=7.58
(dd, J=8.1, 0.8 Hz, H-4), 7.26–7.20 (m, H-2’/H-6’, H-3’/H-
5’), 7.18 (s, H-2), 7.14 (m, H-4’), 7.01 (t, J=7.6 Hz, H-5),
6.92 (dd, J=7.2, 0.4 Hz, H-6), 4.20 (s, H2-1’), 3.83 (dd, J=
9.4, 4.0 Hz, H-11), 3.50 (dd, J=15.1. 4.0 Hz, H-10), 3.13 (dd,
J=15.1, 9.4 Hz, H-10); ESI-MS: m/z (intensity)=316.90
[M+Na]+ (100), 295.2 [M+H]+ (11.4). HR-EI-MS: m/z=
294.1368, calcd. for C18H18N2O2 [M]
+: 294.1339 (as a mixture
with IIIa).
Compound Ib2: 1H NMR (MeOH-d4, 500 MHz): d=7.56
(dd, J=7.8, 1.1 Hz, H-4), 7.20 (s, H-2), 7.03 (t, J=7.6 Hz, H-
5), 6.98 (d, J=7.1 Hz, H-6), 6.12 (ddd, J=17.2, 10.3, 6.3 Hz,
H-2’), 5.12 (dt, J=17.2, 1.6 Hz, H-1’), 5.04 (dt, J=10.3,
1.6 Hz, H-1’), 3.89 (m, H-3’), 3.85 (dd, J=9.3, 4.1 Hz, H-11),
3.51 (ddd, J=15.1, 4.1, 0.9 Hz, H-10), 3.15 (dd, J=15.1,
9.3 Hz, H-10), 1.44 (d, J=7.0 Hz, H3-4’); ESI-MS: m/z (in-
tensity)=281.30 [M+Na]+ (100), 259.16 [M+H]+ (63),
539.40 [2M+Na]+ (12), 517.40 [2M+H]+ (8), HR-ESI-MS:
m/z=281.1255, calcd. for C15H18N2O2 [M+Na]
+: 281.1266.
Compound IIb2: 1H NMR (MeOH-d4, 500 MHz): d=7.55
(dd, J=7.8, 1.1 Hz, H-4), 7.16 (s, H-2), 7.01 (t, J=7.5 Hz, H-
5), 6.96 (d, J=7.5 Hz, H-6), 6.06 (ddd, J=17.2, 10.2, 7.6 Hz,
H-2’), 5.08 (dt, J=17.2, 1.5 Hz, H-1’), 4.99 (ddd, J=10.2, 1.9,
1.0 Hz, H-1’), 3.71 (m, H-11), 3.59 (m, H-3’), 3.41 (m, H-10),
3.04 (dd, J=14.9, 8.5 Hz, H-10), 1.86 (m, H2-4’), 0.89 (t, J=
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7.4 Hz, H3-5’), coupling constants of signals observed for H-
11, H-3Ï and H-10 were not determinable, due to low signal
intensity; ESI-MS: m/z (intensity)=295.30 [M+Na]+ (100),
273.34 [M+H]+ (18), 568.10 [2M+Na]+ (5), 318.10 [M+
2Na]+ (2); HR-ESI-MS: m/z=295.1437, calcd. for
C16H20N2O2 [M+Na]
+: 295.1422.
Compound Ic: 1H NMR (MeOH-d4, 500 MHz): d=7.50
(s, H-4), 7.27 (dd, J=8.4, 0.6 Hz, H-7), 6.96, (dd, J=8.5,
1.7 Hz, H-6), signals at approx. 7.17–7.15 (H-2), 5.67–5.61
(H-2’), 5.54–5.47 (H-3’), 3.86–3.82 (H-11), 3.52–3.48 (H-10),
3,41–3.38 (H-1’) 3.12–3.06 (H-10) and 1.69–1.66 (H-4’) are
overlaid with those of Ia ; ESI-MS: m/z (intensity)=281.04
[M+Na]+ (100), 259.11 [M+H]+ (10), 517.26 [2M+H]+
(6), HR-EI-MS: m/z=258.1366, calcd. for C15H18N2O2 [M]
+:
258.1368 (in a mixture with Ia).
Compound IIc: 1H NMR (MeOH-d4, 500 MHz): d=7.50
(s H-4), 7.27 (d, J=8.2 Hz, H-7), 7.15 (s, H-2), 6.97 (dd, J=
8.3, 1.6 Hz, H-6), 3,48 (dd, J=15.0, 4.6 Hz, H-10), 3.40 (d,
J=6.6 Hz, H-1’), signals at approx. 5.66–5.50 (H-2’ and H-
3’), 3.85–3.82 (H-11), 3.11–3.05 (H-10), 2.07–2.00 (H-4’) and
1.00–0.96 (H-5’) are overlaid with those of IIa ; ESI-MS: m/z
(intensity)=295.08 [M+Na]+ (100), 273.20 [M+H]+ (7),
567.58 [2M+Na]+ (6), 545.39 [M+H]+(3); HR-ESI-MS:
m/z=295.1433, calcd. for C16H20N2O2 [M+Na]
+: 295.1422
(in a mixture with IIa).
Compound IIIc: 1H NMR (MeOH-d4, 500 MHz): d=7.60
(dd, J=1.5, 0.7 Hz, H-4), 7.27 (dd, J=8.3, 0.5 Hz, H-7), 7.16
(s, H-2), 6.97 (dd, J=8.3, 1.6 Hz, H-6), 4.05 (s, H2-1’), 3.84
(m, H-11), 3.51 (m, H-10), signals at approx. 7.25–7.17 (H-2’/
H-6’, H-3’/H-5’), 7.14–7.10 (H-4’), 3.12–3.06 (H-10), are over-
laid with those of IIIa ; ESI-MS: m/z (intensity)=295.14
[M+H]+ (100), 589.19 [2M+H]+ (31), 317.37 [M+Na]+
(6); HR-EI-MS: m/z=294.1368, calcd. for C18H18N2O2 [M]
+:
294.1339 (as a mixture with IIIa).
Homology Model of 5-DMATS
The 3D structure of the 5-DMATS from A. clavatus was
generated with the software MODELLER[31] using the X-
ray structure of the C4-prenyltransferase FgaPT2[25] as tem-
plate. The overall sequence identity between the two pro-
teins is 52%, and the sequences were aligned with UniProt.
Since the FgaPT2 structure was solved with l-tryptophan
and DMSPP within the active site, these molecules were in-
cluded during 5-DMATS model building to obtain a model
with an active site conformation close to the one of the
FgaPT2 X-ray structure. Furthermore, and in contrast to
FgaPT2, raw initial models showed two pairs of cysteine res-
idues within disulfide bonding distance. These cysteine pairs,
Cys63–Cys127 and Cys96–Cys363, were then explicitly mod-
elled as disulfide bridges in the final model.
Due to the stochastic component in conformational sam-
pling during homology modelling, five models were con-
structed using the same alignment. The most accurate model
was selected according to the DOPE (Discrete Optimized
Protein Energy) atomic distance-dependent statistical poten-
tial function,[32] which is implemented in MODELLER. The
best-scored model was visually inspected in order to ascer-
tain sensible structural motifs. Criteria in this visual inspec-
tion were the absence of obvious steric clashes between side
chains themselves or with the ligand used; orientation of the
tryptophan substrate away from Arg243 and Glu91; correct
conformation of charged and polar residues in the pyrophos-
phate sub-pocket responsible for fixation of the diphosphate
moiety of the donor molecule. Model refinement was car-
ried out within the active site by minimizing amino acids di-
rectly interacting with either the substrate or donor mole-
cule using CHARMM.[33]
Docking Studies
All calculations were carried out using FRED[34] and confor-
mations of tryptophan and the four donor molecules were
generated with OMEGA (OMEGA 2.5.1.4: OpenEye Sci-
entific Software, Santa Fe, NM; http://www.eyesopen.com;
P.C.D. Hawkins, A.G. Skillman, G.L. Warren, B.A. Elling-
son, M. T. Stahl). For receptor preparation, the homology
model of 5-DMATS was processed with the apopdb2recep-
tor-tool (part of the FRED docking suite) in order to deter-
mine the docking volume. The five molecules, i.e., trypto-
phan and the four donor molecules DMAPP, MAPP 2-pen-
tenyl-PP and benzyl-PP, were docked independently, storing
the best 10,000 poses of each for further processing.
The first percentile of the stored poses was selected for
visual inspection. Among these poses, the most reasonable
ones by physicochemical criteria were selected as starting
points for molecular dynamics (MD) calculations.
Molecular Dynamics Studies
The three-dimensional model structure of 5-DMATS used
for docking and the selected docking poses of pairs of sub-
strate and donor were processed further using MOE [Molec-
ular Operating Environment (MOE) 2010.10. Quebec:
Chemical Computing Group; 2010]. Protonation states were
calculated with the Protonate3D routine within MOE and
visually inspected for plausibility. AMBER atom types were
assigned to protein, substrate and donor atoms.
The MD simulations were run with the Amber14 software
suite (University of California, San Francisco). The force
field parameters were determined using the antechamber
program (within the Amber14 suite). Amber coordinate, pa-
rameter and topology files were generated by xleap and an
octahedral explicit water box (based on the TIP3P water
model)[35] was constructed 10 è away from the protein. The
resulting systems were minimized, heated from 100 K to
300 K over 20 ps at constant number of particles, volume
and temperature (NVT) and equilibrated at 300 K for
100 ps at constant pressure (NPT) with unrestrained water
molecules and restrained protein, substrate and donor mole-
cules. One more minimization step and subsequent heating
from 100 K to 300 K for 20 ps (NVT) followed by five sepa-
rate equilibration steps [four steps of 100 ps each and a final
step of 2 ns at 300 K (NPT)] were performed while lowering
the restraints applied to protein, substrate and donor with
each step (unrestrained system at the final equilibration
step). The productive simulation was carried out for 5 ns at
300 K (NVT) and 2 fs time step, storing the coordinates
every picosecond. All simulations were carried out with the
pmemd.cuda module of the Amber14 suite on four GPUs.
The simulations were visualized with VMD.[36] Dynamic
trajectory analysis and geometric data extraction was per-
formed with cpptraj (Amber14 suite). Graphical representa-
tions of the simulated complexes were prepared using
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PyMOL (The PyMOL Molecular Graphics System, Version
1.5.0.4 Schrçdinger, LLC.).
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Structure elucidation 
In the 1H-NMR spectra of Ia, signals of the indole moiety at 7.60 (1H, dd, 8.1, 0.4), 7.15 (1H, 
d, 0.7), 7.12 (1H, s) and 6.89 ppm (1H, dd, 8.1, 1.4) superimposed with those for H-4, H-7, H-
2 and H-5 of 6-methylallyl-L-tryptophan, respectively.1 The signals of H-10 and H-11 as well 
as H-1’ and H-4’ of Ia were also overlapping almost completely (maximum shift 0.03 ppm) 
with those of 6-methylallyl-L-tryptophan.1 This proved unequivocally the regular C6-
alkylation of L-tryptophan with MAPP as alkyl donor in the presence of the tested 
prenyltransferases (6-DMATSSa, 6-DMATSSv, TyrPT, 5-DMATSSc and 5-DMATS). 
Comparing the 1H-NMR spectrum of IIa with that of C6-(2-pentenyl)-L-tryptophan1 showed 
nearly identical chemical shifts and coupling patterns for all of the protons. This verified the 
regular alkylation of L-tryptophan at position C-6 of the indole ring by using 2-pentenyl-PP as 
alkyl donor. The aromatic protons of IIIa at 7.60 (1H, dd, 8.2, 0.6), 7.18 (1H, s), 7.12 (1H, s) 
and 6.93 ppm (1H, dd, 8.2, 1.5) showed the same coupling pattern and chemical shifts as 
observed for Ia and IIa. These signals also corresponded to those of C6-alkylated L-
tryptophan derivatives1 and therefore proved the C6-benzylation of L-tryptophan. The 
chemical shifts observed for H-10 and H-11 at 3.48, 3.11 and 3.82 ppm, also overlapped very 
well with those of the other C6-alkylated L-tryptophan derivatives. The five additional 
aromatic protons and two additional aliphatic protons observed in the 1H-NMR spectra of IIIa 
confirmed the presence of the benzyl moiety. 
From the incubation mixtures of TyrPT and 5-DMATSSc, the regular alkylated products Ib1 
and IIb1 as well as the regular benzylated product IIIb were isolated. The 1H-NMR spectrum 
of IIb1 showed one singlet at 7.19, two doublets at 7.55 and 6.93 and one triplet at 7.00 ppm 
for one proton each. This indicated an alkylation at position C-4 or C-7 of the indole ring. In 
the HMBC spectrum of IIb1 (Figure S16-S19), correlations between H-10 at 3.13  and C-2 at 
124.7 ppm, C-11 at 56.5 ppm with two quaternary carbon atoms at 109.9 and 128.4 ppm were 
observed. Correlations between the proton at 7.00 ppm, which is either H-5 or H-6, and two 
quaternary carbon atoms at 128.4 and at 125.1 ppm but not with that at 109.9 ppm were 
detected. Consequently, the quaternary carbons at 109.9 and 128.4 ppm were assigned to C-3 
and C-9, respectively. Therefore, the signal at 7.00 ppm was assigned to H-5. Further 
correlations were found between the doublet at 7.56 ppm and the quaternary carbons C-3, C-9 
and another one at 136.8 ppm. These correlations are only possible, if the proton at 7.56 ppm 
is for H-4 and the carbons at 136.8 and 125.1 ppm are for C-8 and C-7, respectively. Thus, an 
alkylation at position C-7 was proven. This was further confirmed by correlations between H-
1’ at 3.54 ppm and the quaternary carbons at 125.1 and 136.8 ppm, but not with that at 128.4 
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ppm (C-9). In addition, the doublet at 6.93 ppm also correlated with the quaternary carbons at 
125.1 and 136.8 ppm as well as the signal for H-1’. The signals at 125.1, 136.8 and 6.93 ppm 
were assigned to C-7, C-8 and H-6, accordingly. 
The chemical shifts of the protons in the tryptophan moiety of Ib1 at 7.56 (H-4), 7.19 (H-2), 
7.00 (H-5), 6.93 (H-6), 3.85 (H-11), 3.51 (H-10) and 3.14 ppm (H-10) almost completely 
overlapped with those of IIb1. Similar spectrum was obtained for IIIb. Therefore, the 
alkylation position in Ib1 and benzylation position in IIIb were assigned unequivocally to C-
7 of the indole ring. 
In the presence of TyrPT, the additional products Ib2 and IIb2 were detected by using MAPP 
and 2-pentenyl-PP as alkyl donor, respectively. The coupling patterns and chemical shifts of 
the aromatic protons of both compounds corresponded very well to those of Ib1 and IIb1, 
confirming a C7-alkylation of L-tryptophan (Slight shifts of approximate 0.05 ppm were 
observed). However, the signals of the alkyl residues of Ib2 and IIb2, displayed distinct 
chemical shifts and coupling patterns in comparison to those of Ib1 and IIb1. The coupling 
pattern for H-1’ at  5.12 (1H, dt, 17.3, 1.7) and 5.04 ppm (1H, dt, 10.3, 1.7) as well as for H-2’ 
at 6.12 ppm (1H, ddd, 17.3, 10.3, 6.3) in the spectrum of Ib2 showed clearly a reverse 
alkylation.2 The same was true for H-1’ at 5.08 (1H, dt, 17.2, 1.5) and 4.99 ppm (1H, ddd, 
10.2, 1.9, 1.0) as well as for H-2’ at 6.06 ppm (1H, ddd, 17.2, 10.2, 7.6) in the spectrum of 
IIb2. This proved the reverse orientation of the alkyl residues of both compounds. 
Consequently, Ib2 and IIb2 were identified as 7-(3’-methylallyl-)-L-tryptophan and 7-(3’-
pentenyl-)-L-tryptophan, respectively. From the 1H NMR spectra of Ib2 and IIb2, it was 
evident that only one of the two possible diastereomers was isolated. Unfortunately, the 
stereochemistry of these compounds at position C-3’ could not be determined in this study. 
Due to low conversion and unsuccessful separation on HPLC, Ic, IIc and IIIc were elucidated 
from the mixture with Ia, IIa and IIIa, respectively. The aliphatic signals of the indole moiety 
and those of the alkyl or benzyl residue for Ic were overlapped by those of Ia. The aromatic 
signals of the indole moiety were distinct from those of Ia, and could be used to identify the 
alkylation position. Comparison of the NMR data obtained in this study with those published 
previously 1,3 confirmed that Ic, IIc and IIIc to be 5-methylallyl-L-tryptophan, 5-(2-pentenyl)-
L-tryptophan and 5-benzyl-L-tryptophan 3, respectively.  
Reference List 
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Table S1. Enzyme activities of several prenyltransferases toward L-tryptophan in the presence of DMAPP and 
its analogues MAPP, 2-pentenyl-PP and benzyl-PP. 
DMAPP [%] 2-pentenyl-PP [%] MAPP [%] benzyl-PP [%] 
6-DMATSSa 99.9±0.2 91.2±0.07 51.1±0.5 13.9±0.3 
6-DMATSSv 99.4±0.9 89.3±0.6 37.6±0.3 8.2±0.3 
TyrPT 68.5±0.2 38.3±0.6 17.7±0.2 8.5±1.0 
5-DMATSSc 81.4±2.4 65.0±0.1 21.0±0.4 6.6±0.1 
5-DMATS 99.8±0.35 91.9±0.1 58.9±0.07 28.6±0.07 
The reaction mixtures contained 1 mM L-tryptophan and 2mM DMAPP, 2-pentenyl-PP, MAPP or benzyl-PP 
and were incubated with 7.5 μM of purified protein at 37°C for 16 h. Conversion yields are given as mean of two 
independent measurements. 
90
  
Figure S1. HPLC analysis of the reaction mixtures of L-tryptophan with MAPP (I), 2-pentenyl-PP (II) and 
benzyl-PP (III) on a Chiralpak Zwix (+) column. The enzyme assays of 100 µL contained 1 mM L-tryptophan, 2 
mM alkyl or benzyl diphosphate, 5 mM CaCl2 and 7.5 µM of purified protein were incubated at 37°C for 16 h. 
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Figure S2. Dependence of the product formation of the 6-DMATSSa reaction on the presence of 2-pentenyl-PP, 
methylallyl-PP (MAPP) or benzyl-PP with L-tryptophan. 
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Figure S3. Dependence of the product formation of the 6-DMATSSv reaction on the presence of DMAPP with L-
tryptophan. 
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Figure S4. Dependence of the product formation of the 6-DMATSSv reaction on the presence of 2-pentenyl-PP, 
methylallyl-PP (MAPP) or benzyl-PP with L-tryptophan. 
94
Figure S5. Dependence of the product formation of the TyrPT reaction on the presence of 2-pentenyl-PP, 
methylallyl-PP (MAPP) or benzyl-PP with L-tryptophan. 
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Figure S6. Dependence of the product formation of the 5-DMATSSc reaction on the presence of 2-pentenyl-PP, 
methylallyl-PP (MAPP) or benzyl-PP with L-tryptophan. 
96
Figure S7. Dependence of the product formation of the 5-DMATS reaction on the presence of benzyl-PP with L-
tryptophan. 
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Figure S8. HMBC connectivities of 7-(2-pentenyl-)-L-tryptophan (IIb1). 
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Figure S9. 1H-NMR spectrum of 6-methylallyl-L-tryptophan (Ia) in CD3OD. 
Figure S10. 1H-NMR spectrum of 6-(2-pentenyl-)-L-tryptophan (IIa) in CD3OD. 
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Figure S11. 1H-NMR spectrum of 6-benzyl-L-tryptophan (IIIa) in CD3OD. 
Figure S12. 1H-NMR spectrum of 7-methylallyl-L-tryptophan (Ib1) in CD3OD. 
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Figure S13. 1H-NMR spectrum of 7-(2-pentenyl-)-L-tryptophan (IIb1) in CD3OD. 
Figure S14. HSQC spectrum of 7-(2-pentenyl-)-L-tryptophan (IIb1) in CD3OD. 
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Figure S15. HSQC spectrum of 7-(2-pentenyl-)-L-tryptophan (IIb1) in CD3OD. 
Figure S16. HMBC spectrum of 7-(2-pentenyl-)-L-tryptophan (IIb1) in CD3OD. 
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Figure S17. HMBC spectrum of 7-(2-pentenyl-)-L-tryptophan (IIb1) in CD3OD. 
Figure S18. HMBC spectrum of 7-(2-pentenyl-)-L-tryptophan (IIb1) in CD3OD. 
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Figure S19. HMBC spectrum of 7-(2-pentenyl-)-L-tryptophan (IIb1) in CD3OD. 
Figure S20. 1H-NMR spectrum of 7-(3’S or 3’R-but-1-enyl)-L-tryptophan (Ib2) in CD3OD. 
103
 
Figure S21. 1H-NMR spectrum of 7-(3’S or 3’R-pent-1-enyl -)-L-tryptophan (IIb2) in CD3OD. 
 
Figure S22. 1H-NMR spectrum of 7-benzyl-L-tryptophan (IIIb) in CD3OD. 
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Figure S23. 1H-NMR spectrum of 6-methylallyl-L-tryptophan (Ia) and 5-methylallyl-L-tryptophan (Ic) in 
CD3OD. 
Figure S24. 1H-NMR spectrum of 6-(2-pentenyl-)-L-tryptophan (IIa) and 5-(2-pentenyl-)-L-tryptophan (IIc) in 
CD3OD. 
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Figure S25. 1H-NMR spectrum of 6-benzyl-L-tryptophan (IIIa) and 5-benzyl-L-tryptophan (IIIc) in CD3OD. 
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Figure S26. Homology model of 5-DMATS (orange) superimposed on the X-ray structure of FgaPT2 (white). 
L-tryptophan and DMAPP are shown in magenta. A and C: Cartoon representations, B and D: Cα-trace 
representations of template and model, respectively. 
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Figure S27. Shown are complexes of 5-DMATS, L-tryptophan and A: DMAPP, B: 2-pentenyl-PP, C: MAPP and 
D: benzyl-PP, respectively. Colored in orange and cyan is the equilibrated complex before the productive 
molecular dynamics run. Colored in white and magenta are complexes after 5 ns productive simulation run. 
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Figure S28. Shown are running averages of the RMSD of pairs of L-tryptophan (red) and a donor molecule 
(black) during each step of the simulations indicated by white and grey background, respectively. Tryptophan 
with A: DMAPP, B: 2-pentenyl-PP, C: MAPP and D: benzyl-PP. 
Figure S29. Shown are root-mean-square-fluctuations RMSF of L-tryptophan (TRP) (left) and donor molecules 
(right) during the complete simulation runs. Color-code: blue: TRP and benzyl-PP complex, green: TRP and 2-
pentenyl-PP complex, yellow: TRP and DMAPP complex and red: TRP and MAPP complex. 
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Characterisation of 6-DMATSMo from
Micromonospora olivasterospora leading to
identification of the divergence in enantio-
selectivity, regioselectivity and multiple prenyla-
tion of tryptophan prenyltransferases†
Julia Winkelblech,a,b Xiulan Xiec and Shu-Ming Li*a,b
Prenylated secondary metabolites including indole derivatives usually demonstrate improved biological
and pharmacological activities, which make them promising candidates for drug discovery and develop-
ment. The transfer reactions of a prenyl moiety from a prenyl donor, e.g. dimethylallyl diphosphate
(DMAPP), to an acceptor is catalysed by prenyltransferases. One special group of such enzymes uses
DMAPP and tryptophan as substrates with dimethylallyltryptophans as reaction products and functions
therefore as dimethylallyltryptophan synthases (DMATSs). Sequence homology search with known trypto-
phan prenyltransferases from Streptomyces led to identification of a putative prenyltransferase gene
MolI14.36 in Micromonospora olivasterospora. Expression and biochemical investigations revealed that
MolI14.36 acts as a tryptophan C6-prenyltransferase (6-DMATSMo). Study on substrate specificity of
6-DMATSMo displayed a significantly high activity towards D-tryptophan, which prompted us to carry out
comparative studies on enantioselectivity, regioselectivity and multiple prenylation ability of additional
DMATSs including FgaPT2, 5-DMATS, 5-DMATSSc, 6-DMATSSv, 6-DMATSSa and 7-DMATS towards L- and
D-isomers of tryptophan and their analogues. The relative activities of the tested enzymes towards
D-tryptophan differ clearly from each other. Incubation of L-, D-isomers or the racemates of 5-, 6- and
7-methyltryptophan revealed distinctly different preferences of the DMATS enzymes. Interestingly,
6-DMATSMo and 5-DMATSSc accepted 5-methyl-D-tryptophan much better than the L-enantiomer.
Furthermore, the conversion yields of the D-isomers were strongly inhibited in the reactions with race-
mates. More interestingly, the regioselectivities of FgaPT2, 5-DMATSSc and 7-DMATS towards
D-tryptophan and its C5-methylated derivative differed clearly from those of the L-forms. In addition, both
mono- and diprenylated products were clearly detected for 5-DMATSSc with L- and D-enantiomers of
tryptophan and their methylated derivatives.
Introduction
Chiral molecules such as D- and L-amino acids play an impor-
tant role in biological and chemical processes of life.1
Moreover, the chirality of small molecules is of high impor-
tance for their application as drugs. The biological and
pharmacological activities of D- and L-isomers as well as toxicity
and metabolism could strongly differ from each other.2 The
natural occurrence of α-amino acids is clearly predominated by
the L-form, but also the D-form is widely distributed in nature,
fulfilling essential roles in biological systems.3 For example,
D-amino acids are found in the cell walls of bacteria to provide
protease resistance or as neurotransmitters in the nervous system
of animals.4–6 Moreover, D-amino acids are of great interest for
pharmaceutical application. Peptides containing D-amino acids
are used as antibiotics or considered as potential agents for treat-
ment of Alzheimer’s disease, HIV and cancers.3,7–9 Amino acids
like tryptophan are also key precursors for a number of secondary
metabolites including prenylated indole derivatives.10 These iso-
prenoid-derived natural products are widely distributed in nature,
†Electronic supplementary information (ESI) available. See DOI: 10.1039/
c6ob01803c
aPhilipps-Universität Marburg, Institut für Pharmazeutische Biologie und
Biotechnologie, Robert-Koch-Straße 4, 35037 Marburg, Germany.
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e.g. in the fungi of ascomycetes and bacteria of actinomycetes.10
The connection of the indole and isoprenoid moieties is usually
catalysed by prenyltransferases.11 Prenylation of aromatic
compounds could improve their biological activity.10,12–15 For
instance, studies on the antifungal activity of substituted indole
analogues revealed the importance of the allyl side chain of
6-prenylindole for its bioactivity.16
One special group of prenyltransferases uses dimethylallyl
diphosphate (DMAPP) as the donor and L-tryptophan as the
acceptor and functions thus as dimethylallyltryptophan
synthase (DMATS). For example, FgaPT2 from the ascomyce-
tous fungus Aspergillus fumigatus (A. fumigatus) catalyses the
transfer of a dimethylallyl moiety from DMAPP to C-4 of
L-tryptophan and is involved in the biosynthesis of ergot
alkaloids.17 Later on, at least six additional fungal DMATSs
were identified, which act as C4-, C5-, and C7-prenylating
enzymes.11 In contrast with DMATSs from fungi, a few
members of the bacterial tryptophan prenyltransferases were
only recently characterised biochemically. Therefore, bio-
chemical characterisation of new DMATSs from bacteria will
contribute to our understanding on the catalytic features of
these enzymes from different origins. The known bacterial
DMATSs are from actinomycetes, catalyse the transfer of the di-
methylallyl moiety to C-5, C-6 or C-7 of the indole ring, and are
involved in the biosynthesis of prenylated indole derivatives.11
For example, IptA from Streptomyces sp. SN-593 functions
as a 6-DMATS and is involved in the biosynthesis of 6-di-
methylallylindole-3-carbaldehyde.18 Three IptA orthologues,
IptAAm from Actinoplanes missouriensis,
19 6-DMATSSa from
Streptomyces ambofaciens (S. ambofaciens), and 6-DMATSSv
from S. violaceusniger have been recently identified and charac-
terised.20 SCO7467 from S. coelicolor A3(2) belongs to a gene
cluster being responsible for the biosynthesis of 5-dimethyl-
allylindole-3-acetonitrile and the encoded protein acts as a
5-DMATS (5-DMATSSc).
21,22 Recently, Wu et al. have identified
a biosynthetic gene cluster for a new antibiotic 7-prenylisatin
in Streptomyces MBT28-91. Thereby, the prenyltransferase IsaA
catalyses the prenylation of L-tryptophan at C-7.23
In the present study, we continue to expand our knowledge
on DMATSs from bacteria by cloning, expression and bio-
chemical investigations on a putative prenyltransferase MolI14.36
from Micromonospora olivasterospora (M. olivasterospora).
Biochemical investigations revealed that MolI14.36 acts
as a tryptophan C6-prenyltransferase (6-DMATSMo). Previous
studies on DMATSs revealed that L-tryptophan was much better
accepted than D-tryptophan.24 In comparison, D-tryptophan
was very well accepted by 6-DMATSMo. This finding promoted
us to carry out systematic investigation on the acceptance and
enzyme products of L- and D-tryptophan and their methylated
derivatives including 5-, 6-, and 7-methyltryptophan by
DMATSs from bacteria and fungi. These include three fungal
(FgaPT2, 5-DMATS, and 7-DMATS) and four bacterial DMATSs
(5-DMATSSc, 6-DMATSSa, 6-DMATSSv, and 6-DMATSMo).
Evaluation of the enzyme products demonstrated a clear differ-
ence in substrate specificity, regioselectivity of the prenyl trans-
fer reactions as well as the ability for multiple prenylation.
Results and discussion
Identification and characterisation of a new 6-DMATS from
M. olivasterospora
BLAST search by using known bacterial tryptophan prenyl-
transferases led to the identification of a putative prenyltrans-
ferase from M. olivasterospora. MolI14.36 comprises 376 amino
acids and has a predicted molecular mass of 40.6 kDa.
MolI14.36 shares clearly different sequence identities with
known tryptophan C6-prenyltransferases on the amino acid
level, e.g. 68% with IptAAm from A. missouriensis,
19 44% with
IptA from Streptomyces sp. SN-593,18 42% with 6-DMATSSv
from S. violaceusniger,20 and 38% with 6-DMATSSa from
S. ambofaciens.20 The differences of the sequence identities
raised the question about the function of MolI14.36.
MolI14.36 was then cloned from genomic DNA into the
expression vector pHIS8 and overexpressed in E. coli. The
recombinant His8-tagged protein with a molecular mass of
43.5 kDa was purified to near homogeneity with a yield of
16 mg per litre culture (Fig. S1, ESI†). Size exclusion chromato-
graphy revealed that the enzyme acts as a monomer.
To prove its function and substrate specificity, the purified
recombinant MolI14.36 (1 µM) was incubated with 0.5 mM of
L-tryptophan (1a), D-tryptophan (1b), and eight analogues
thereof (2a, 3a, 4–8, and 9a) in the presence of 1 mM DMAPP.
To show the relationships of the enantiomers, we use
Arabic numbers for racemates, numbers with a for L-isomers
and with b for D-isomers. After incubation at 37 °C for 1 h, the
reaction mixtures were analysed on HPLC under the con-
ditions listed in Table S1 in the ESI.† As shown in Table 1 and
the ESI (Fig. S2 and S3†), eight of them, 1a, 1b, 2a, 3a, 4, 5, 8,
and 9a, were well accepted by this enzyme, with 1a as the best
substrate. In the presence of L-tryptophan (1a), MolI14.36 also
used geranyl diphosphate as the prenyl donor, but with a sig-
nificantly lower product yield than with DMAPP (about 10% of
that of DMAPP). Farnesyl diphosphate was not accepted by
MolI14.36 (Table S2, ESI†). HPLC analysis of the reaction mix-
tures of MolI14.36 with seven tryptophan-containing cyclic
dipeptides showed product formation, but with much lower
conversion yields than with tryptophan and its analogues (less
than 8% of that of 1a) (Table S3, ESI†). These results provided
evidence for the function of MolI14.36 as a dimethylallyl
diphosphate:L-tryptophan transferase.
To confirm the prenylation in their structures and particu-
larly the prenylation positions, the enzyme products of trypto-
phan and its analogues were isolated from large-scale incu-
bation mixtures on preparative HPLC and subsequently ana-
lysed by MS and NMR including homonuclear correlation
spectroscopy (1H–1H COSY) for 5-C5–5-C7, 6-C6 and 6-C7
(Tables S4–S7 and Fig. S4–S22, ESI†). For better understand-
ing, the enzyme products were termed by addition of the
prenylation position like C4, C5, C6 or C7 to the number of the
substrate. Inspection of the NMR spectra of the isolated peaks
confirmed the unique C6-prenylated products 1a-C6, 1b-C6,
2a-C6, 3a-C6, 4-C6, 8-C6, and 9a-C6 from the reaction mixtures
of 1a, 1b, 2a, 3a, 4, 8, and 9a, whereas three products with the
Paper Organic & Biomolecular Chemistry
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Table 1 Prenyl transfer reactions catalysed by 6-DMATSMo
Substrate Product (relative product yield in %)
1a
1b
2a
3a
4
5
6
7
8
9a
The enzyme assays contained 0.5 mM aromatic substrate, 5 mM MgCl2, and 1 mM DMAPP were incubated with 1 µM of the purified protein at
37 °C for 1 h. The product yield of L-tryptophan at 37.8% was defined as 100%. NMR data of the prenylated products were used for structure elu-
cidation and also for calculation of the ratio of different products.
Organic & Biomolecular Chemistry Paper
This journal is © The Royal Society of Chemistry 2016 Org. Biomol. Chem.
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prenyl moiety attached to C-5 (5-C5), C-6 (5-C6) and C-7 (5-C7)
in a ratio of 0.6 : 1 : 0.6 were identified in the reaction mixture
of 5. Two products either 6-C6 and 6-C7 or 7-C5 and 7-C6 were
detected in those of 6 and 7 (see the ESI† for detailed structure
elucidation, Tables S5–S7, Fig. S4–S22†).
In conclusion, MS and NMR analyses of the isolated
enzyme products prove that MolI14.36 acts as a L-tryptophan
C6-prenyltransferase and is termed 6-DMATSMo, in analogy to
the notation of 6-DMATSSa and 6-DMATSSv.
20 6-DMATSMo
catalyses a unique or predominant C6-prenylation at the
indole ring of tryptophan and its analogues (Table 1). If the
position 6 is blocked by a methyl group as in the case of 7, a
switch of the prenylation site to C-7 was detected, as observed
for IptA and 6-DMATSSa, previously.
18,20
Additional biochemical characterisation revealed that metal
ions are not essential for the enzyme activity as observed for
other members of the DMATS superfamily (Fig. S23,
ESI†).18,20,25 Furthermore, the function of 6-DMATSMo as a
tryptophan prenyltransferase was justified by kinetic studies.
The KM value of 0.014 ± 0.002 mM and a turnover number
kcat of 0.07 ± 0.002 s
−1 were determined for 1a. The kinetic
parameters for the prenyl donor DMAPP were found to be
0.037 ± 0.007 mM and 0.08 ± 0.004 s−1, respectively (Fig. S24,
ESI†). For comparison of the substrate preferences of
6-DMATSMo and its orthologues 6-DMATSSa and 6-DMATSSv,
enzyme assays of 1a, 1b, 2a, 3a, 4–8 and 9a were carried out
for the three 6-DMATSs under similar conditions and the rela-
tive enzyme activities to 1a were compared with each other
(Fig. S3, ESI†). In summary, with the exception for 3a,
6-DMATSSa and 6-DMATSSv seem to share similar substrate
preferences towards the tested tryptophan analogues, whereas
6-DMATSMo shows more distinct preferences from those of the
two other 6-DMATSs. 1b, 4, 5, and 8 were better accepted by
6-DMATSMo, whereas 6, 7, and 9a were better substrates for the
other two 6-DMATS enzymes. The most remarkable feature is
the high acceptance of 1b by 6-DMATSMo, with a relative
activity of approximately 50% of that of 1a (Table 1 and
Fig. S3, ESI†). To the best of our knowledge, such high conver-
sion of 1b has not been reported for other prenyltransferases
prior to this study. In comparison, less than 25% relative
activities of that of 1a were detected for 6-DMATSSa and
6-DMATSSv with 1b under these conditions. These results
prompted us to have detailed insights into the enantio-
selectivity of the DMATS enzymes towards tryptophan.
DMATSs showed different preferences towards D-tryptophan
To gain deeper insights into the substrate preferences of
DMATSs towards the stereoisomers of tryptophan, FgaPT2,
5-DMATS, 5-DMATSSc, 6-DMATSSa, 6-DMATSSv, 6-DMATSMo,
and 7-DMATS were overproduced in E. coli and purified to
near homogeneity as reported previously.20,25–28 As aforemen-
tioned, these enzymes use the same substrates 1a and DMAPP,
but catalyse prenylations at different positions of the indole
ring. By size exclusion chromatography, these enzymes were
determined to have different quaternary structures. The native
forms of FgaPT2 and 5-DMATS were found to be homodimer,
whereas 5-DMATSSc and 7-DMATS were reported to be active as
monomers.17,25,28 In this study, the molecular mass of
6-DMATSSa was determined to be 36.9 kDa and the other two
enzymes 6-DMATSSv and 6-DMATSMo to be 46.0 kDa. This
proved that they are active as monomers, being consistent
with their orthologue IptA.18 Crystal structure analysis of
several fungal prenyltransferases including FgaPT2 revealed
that each single subunit contains one active centre and forms
one catalytic unit.29–32 To ensure adequate comparability, the
following analyses on substrate specificity and kinetic para-
meters of the recombinant proteins all refer to a unique
protein subunit.
For investigations on substrate preferences, the seven
DMATSs were incubated with the prenyl donor DMAPP and 1a,
1b, or their racemate 1. The relative activities to 1a were deter-
mined by HPLC analysis on the CHIRALPAK® Zwix(+) column.
The prenylation of the enzyme products was proven by LC-MS
analysis (Table 2 and Fig. 1, S25–S48, ESI†). As given in
Table 2, clearly different enantioselectivities were observed for
the tested DMATSs. 5-DMATS and 6-DMATSMo accepted 1b
much better than other enzymes, with relative activities of
34.7 and 45.7% of those of L-tryptophan (1a), respectively. In
contrast, 1b was a very poor substrate for FgaPT2 and
7-DMATS with relative conversion yields of approximately 5
and 6%, respectively, corresponding well to the data reported
previously.17,27,28,33 In the reaction mixtures of racemates, the
conversion of 1b was strongly reduced, indicating an inhi-
bition. For better understanding of the observed acceptance of
1a and 1b by the tested DMATSs, kinetic parameters were
determined by nonlinear regression using GraphPad Prism
4.0 (Fig. S49–S55, ESI†). All investigated reactions apparently
followed the Michaelis–Menten kinetics. The calculated
KM values of the seven DMATSs for 1a varied from 0.012 mM
to 0.055 mM, whereas those for 1b were found in the range of
0.10 to 1.76 mM (Table 3). The significantly higher affinity of
the enzymes to the L-form is justified by their native functions
as L-tryptophan prenyltransferases and also explained in parts
the very low conversion of 1b in the reaction with the
racemate. It is plausible that in the initial phase of the
reactions with racemates, only 1a was used as substrate by the
enzymes. However, the higher affinity and turnover numbers
of the tested enzymes towards 1a than 1b could not explain
the observed very low conversion of 1b. Under the conditions
used for the conversion yields given in Table 2, 1a was almost
completely converted. Therefore, we speculated that the
products of 1a should also contribute to the inhibition of
1b reactions.
The calculated turnover numbers (kcat) for 1a from 0.07 to
0.67 s−1 are in almost all cases much higher than those for 1b
between 0.012 and 0.066 s−1. In comparison to 1b reactions
with other enzymes, relative high affinity and turnover
numbers were determined for those with 5-DMATS and
6-DMATSMo. The turnover numbers of 6-DMATSMo towards 1a
and 1b are nearly identical at approximately 0.07 s−1. These
data supported the high conversion yields of 1b by 5-DMATS
and 6-DMATSMo given in Table 2.
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Table 2 Relative activities of DMATSs towards D- and L-isomers of tryptophan and their analogues
Substrate
Relative conversion yields [%]
FgaPT2 5-DMATS 5-DMATSSc 6-DMATSSa 6-DMATSSv 6-DMATSMo 7-DMATS
L-Tryptophan 1a 100.0 ± 2.5 100.0 ± 0.7 100.0 ± 0.04a 100.0 ± 2.7 100.0 ± 0.9 100.0 ± 12.2 100.0 ± 4.3
D-Tryptophan 1b 5.2 ± 0.9 34.7 ± 4.4 20.2 ± 2.6b 10.4 ± 0.02 16.8 ± 1.1 45.7 ± 2.9 6.4 ± 0.2
DL-Tryptophan 1a 96.3 ± 2.1 96.7 ± 4.8 103.5 ± 4.7 99.4 ± 8.2 87.1 ± 2.6 99.9 ± 1.0 98.9 ± 1.5
1b ≤0.5 12.6 ± 2.2 ≤0.5 1.6 ± 0.3 2.5 ± 0.01 1.3 ± 0.1 ≤0.5
5-Methyl-L-tryptophan 6a 43.0 ± 1.8 2.5 ± 0.1 2.3 ± 0.2 102.5 ± 0.2 100.5 ± 0.7 12.9 ± 0.2 84.9 ± 3.8
5-Methyl-D-tryptophan 6b ≤0.5 ≤0.5 57.3 ± 1.8 11.4 ± 0.6 22.4 ± 0.4 66.6 ± 0.5 2.5 ± 0.6
5-Methyl-DL-tryptophan 6a 22.4 ± 4.0 3.1 ± 1.1 3.8 ± 0.6 76.2 ± 6.5 100.7 ± 4.1 13.0 ± 0.6 97.9 ± 4.3
6b ≤0.5 ≤0.5 ≤0.5 2.4 ± 1.1 4.7 ± 0.1 ≤0.5 ≤0.5
6-Methyl-L-tryptophan 7a 84.0 ± 1.2 85.5 ± 5.7 15.0 ± 1.7 9.1 ± 1.7 35.4 ± 2.3 5.5 ± 0.2 17.5 ± 1.1
6-Methyl-D-tryptophan 7b ≤0.5 ≤0.5 1.1 ± 0.1 ≤0.5 ≤0.5 1.2 ± 0.2 ≤0.5
6-Methyl-DL-tryptophan 7a 61.2 ± 0.8 82.5 ± 5.1 15.1 ± 0.2 8.2 ± 0.4 33.2 ± 0.6 5.0 ± 0.6 16.6 ± 0.9
7b ≤0.5 ≤0.5 ≤0.5 ≤0.5 ≤0.5 ≤0.5 ≤0.5
7-Methyl-L-tryptophan 8a 97.8 ± 1.7 75.7 ± 0.5 8.2 ± 2.3 4.3 ± 0.2 7.4 ± 1.6 72.4 ± 8.5 ≤0.5
7-Methyl-D-tryptophan 8b ≤0.5 3.7 ± 1.4 1.9 ± 0.2 ≤0.5 ≤0.5 13.8 ± 3.8 ≤0.5
7-Methyl-DL-tryptophan 8a 68.2 ± 5.0 70.6 ± 4.2 5.9 ± 0.2 3.8 ± 0.4 7.5 ± 0.7 72.5 ± 13.1 ≤0.5
8b ≤0.5 ≤0.5 ≤0.5 ≤0.5 ≤0.5 ≤0.5 ≤0.5
The enzyme assays contained 0.5 mM of the L- or D-isomers or 1 mM of the racemates and 1 mM DMAPP were incubated at 37 °C for 1.5 h with
1 µM purified protein. The conversion yields of L-tryptophan (1a) with FgaPT2 at 97.3%, 5-DMATS at 98.4%, 5-DMATSSc at 96%, 6-DMATSMo at
82.7%, 6-DMATSSv at 96.1%, 6-DMATSSa at 97.0%, and with 7-DMATS at 88.9% were defined as 100% relative activity, respectively. The conversion
yields of D- or L-enantiomers in the reaction mixtures with racemates were calculated separately by considering the respective enantiomer as the
substrate. aDiprenylated products, with a ratio of 0.6 : 1 to the monoprenylated product, were detected. bDiprenylated products, with a ratio of
0.1 : 1 to the monoprenylated product, were detected.
Fig. 1 Evaluation of the enantioselectivity of (A) 5-DMATS and (B) 6-DMATSMo. The enzymes were incubated with 1 mM DMAPP and 0.5 mM of
L-tryptophan, D-tryptophan or a combination of both (1 mM) and the reaction products were profiled by LC-MS and HPLC. 1 µM of the indicated
enzyme was incubated with the indicated substrate(s). UV detection was carried out with a diode array detector and illustrated for absorption at
277 nm. Additional chromatograms and MS analyses for all tested enzymes and substrates are provided as Fig. S25–S48 in the ESI.†
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Different regioselectivities of DMATSs towards 1a and 1b
Previous investigations have shown that the characterised
DMATSs are highly regiospecific for 1a, i.e. C4-prenylation by
FgaPT2,17 C5-prenylation by 5-DMATS and 5-DMATSSc,
22,25,26
C6-prenylation by IptA, 6-DMATSSa, 6-DMATSSv and
6-DMATSMo
18,20 and C7-prenylation by 7-DMATS and
7-DMATSNeo.28,34 In the course of the biochemical characteris-
ation, the enzyme activities of DMATSs towards 1b were
usually demonstrated by HPLC analysis using achiral
columns.18,20,25,27,28,34–36 No product of 1b has been isolated
and characterised. As mentioned above, isolation and structure
elucidation of the enzyme products confirmed the same
C6-prenylation of 6-DMATSMo for 1a and 1b (Tables 4, S5 and
Fig. S4, S5, ESI†). In contrast, inspection of the NMR spectrum
of the enzyme products of 5-DMATSSc with 1b revealed the
presence of a mixture of three compounds (Table 4, Fig. 2 and
Table S8 and Fig. S56, ESI†). Comparison of the chemical
shifts and coupling patterns with the previously published
data of the prenylated derivatives of 1a led to the identification
of these compounds to be C5-prenylated 1b-C5, C6-prenylated
1b-C6, and C7-prenylated 1b-C7 in a ratio of 0.4 : 1 : 0.4. In
comparison, the C5-monoprenylated derivative 1a-C5 is the
unique product in the reaction mixture of 1a with 5-DMATSSc.
To prove the prenylation positions, the seven DMATSs were
incubated with 1a and 1b and analysed on an achiral XDB-C18
column under the improved HPLC condition 4 (Fig. 2 and
Tables S1, S9, ESI†). Under this condition, the enantiomeric
pairs 1a and 1b have the same retention times, which is also
true for their derivatives with the same prenylation positions.
Table 3 Kinetic parameters of DMATSs towards L- and D-forms of tryptophan and 5-methyltryptophan
DMATS
L-Tryptophan D-Tryptophan 5-Methyl-L-tryptophan 5-Methyl-D-tryptophan
1a 1b 6a 6b
KM [mM] kcat [s
−1] KM [mM] kcat [s
−1] KM [mM] kcat [s
−1] KM [mM] kcat [s
−1]
FgaPT2 0.034 ± 0.003 0.67 ± 0.01 0.10 ± 0.007 0.012 ± 0.0002 — — — —
5-DMATS 0.055 ± 0.002 0.39 ± 0.001 0.62 ± 0.08 0.066 ± 0.004 — — — —
5-DMATSSc 0.020 ± 0.002 0.19 ± 0.004 1.47 ± 0.08 0.046 ± 0.001 0.009 ± 0.001 0.005 ± 0.0001 0.03 ± 0.01 0.035 ± 0.005
6-DMATSSa 0.012 ± 0.001 0.10 ± 0.002 1.02 ± 0.07 0.021 ± 0.001 — — — —
6-DMATSSv 0.022 ± 0.002 0.19 ± 0.004 0.77 ± 0.08 0.021 ± 0.001 — — — —
6-DMATSMo 0.014 ± 0.002 0.07 ± 0.002 0.47 ± 0.04 0.066 ± 0.002 0.008 ± 0.001 0.012 ± 0.0002 0.30 ± 0.05 0.042 ± 0.003
7-DMATS 0.043 ± 0.004 0.12 ± 0.002 1.76 ± 0.19 0.013 ± 0.001 — — — —
—, Not determined.
Table 4 Prenylation sites of the enzyme products of L- and D-enantiomers of tryptophan and 5-methyltryptophan
Substrate structures
Enzyme products and their ratios
FgaPT2 5-DMATS 5-DMATSSc 6-DMATSSa 6-DMATSSv 6-DMATSMo 7-DMATS
1a C4 C5 C5 C6 C6 C6 C7
1b C4 : C5 : C7 C5 C5 : C6 : C7 C6 C6 C6 C6 : C7
0.2 : 1 : 0.04 0.4 : 1 : 0.4a 0.05 : 1
6a C4 b C6 : C7 C6 C6 C6 : C7 C7
1 : 1 1 : 0.05
6b C4 : C6/C7 b C6 : C7 C6 C6 C6 : C7 C6 : C7
1 : 0.4 1 : 0.2a 1 : 0.1a 1 : 0.2
The ratio of the enzyme products was evaluated from HPLC chromatograms. a The ratio of the enzyme products was evaluated from 1H NMR
spectra. b Product formation was detected by LC-MS analysis.
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More importantly, C4-, C5-, C6-, and C7-prenylated tryptophan
were well separated from each other. The results in Fig. 2 con-
firmed the previously published regiospecific prenylation of 1a
by the tested DMATSs. The enzyme products of 1b with
5-DMATS and the three C6-prenyltransferases 6-DMATSSa,
6-DMATSSv and 6-DMATSMo had the same prenylation positions
as those of 1a. Interestingly, the main product of 1b with
FgaPT2 was prenylated at position C-5 instead of C-4. C4- and
likely C7-prenylated derivatives were detected as minor products
(Table 4 and Fig. 2). As aforementioned, three products 1b-C5,
1b-C6, and 1b-C7 with a ratio of 0.4 : 1.0 : 0.4 were detected in
the reaction mixture of 1b with 5-DMATSSc (Fig. 2, Tables 4, S8
and Fig. S56, ESI†).20,25,37 HPLC analysis of the reaction mixture
of 1b with 7-DMATS proved the main product to be 7-DMA-D-
tryptophan (1b-C7) and the minor product the C6-prenylated
derivative 1b-C6 in a ratio of 1 : 0.05 (Fig. 2 and Table 4). The
observed changes in regioselectivity could indicate different
orientations of the two enantiomers in the active sites. Crystal
structures of such bacterial tryptophan prenyltransferases could
provide detailed insights into their reaction chambers.
DMATSs also catalyse the diprenylation of 1a and 1b with
different activities
HPLC analysis on a chiral column of the reaction mixture of 1a
with 5-DMATSSc revealed the presence of two product peaks
with retention times at 9.2 and 18.5 min in a ratio of 1 : 0.6
(Fig. S32, ESI†). The main peak was identified as C5-monopre-
nylated tryptophan by Ozaki et al.,21 and also confirmed in
this study, whereas the second peak was not mentioned in the
previous study. LC-MS analysis led to the identification of the
second product peak as diprenylated derivative(s). Isolation
and structure elucidation with the help of 1H NMR confirmed
the diprenylation of 1a and provided evidence for the presence
of a mixture of two products (Table S8 and Fig. S57, ESI†).
Detailed interpretation of the spectra and comparison of the
coupling patterns with those of the previously published data
led to identification of 5,6- and 5,7-di-dimethylallyl-L-trypto-
phan (1a-C5,C6, 1a-C5,C7) in a ratio of approximately
1 : 1.20,25,37 The characteristic singlets for H-4, H-7 and H-2 of
1a-C5,C6 were observed at 7.45, 7.14 and 7.08 ppm,
respectively. For 1a-C5,C7, the signals of H-4 and H-6 were
detected as broad singlets. The two products were well separ-
ated from each other under an improved HPLC condition
(Fig. 3). In the HPLC chromatogram of the reaction mixture of
1b with 5-DMATSSc (Fig. 2), four product peaks were detected.
As mentioned above, three monoprenylated derivatives were
identified as C5-, C6-, and C7-prenylated D-tryptophan. LC-MS
confirmed the additional product peak to be diprenylated
D-tryptophan. An improved HPLC condition (condition 6)
allowed the separation of this peak into one predominant
peak and one minor product peak (Fig. 3), with similar
retention times to those observed for the diprenylated
products of 1a.
Structure elucidation of the isolated diprenylated peak by
NMR analysis confirmed the C5,C6-diprenylation in the main
product 1b-C5,C6 (Table S8 and Fig. S58, ESI†) with three sing-
lets at 7.45, 7.15 and 7.10 ppm for H-4, H-7 and H-2, respect-
ively. In this spectrum, signals of aromatic protons for
C5,C7-diprenylated derivatives 1b-C5,C7 were also detected,
with a low intensity of 5% of that of 1b-C5,C6. To the best of
our knowledge, this is the first report on diprenylation of
tryptophan by a tryptophan prenyltransferase. By UV detection
mentioned above, diprenylated products of 1a, 1b and 1 were
only observed for 5-DMATSSc after incubation for 1.5 h. By
using the extracted ion chromatogram (EIC) mode, dipreny-
lated products were also detected for almost all the DMATSs
with 1a, with an exception for FgaPT2 (Fig. S25–S48, ESI†).
However, the product yields were less than 0.5% of those of
monoprenylated derivatives.
Separation and identification of L- and D-enantiomers of 5-, 6-,
and 7-methyltryptophan
To expand our knowledge on the enantioselectivity and regio-
selectivity of DMATSs, we initiated to investigate their beha-
viours towards enantiomer pairs of methylated tryptophan
derivatives. Unfortunately, these compounds are commercially
Fig. 2 HPLC identification of the enzyme products of DMATSs and 1a
or 1b. The enzymes were incubated with 1 mM DMAPP and 1 mM of
L-tryptophan (1a) or D-tryptophan (1b). Detailed conditions of the
enzyme assays are given in Table S9 in the ESI.† For HPLC analysis, an
Eclipse XDB-C18 column was used (condition 4 in Table S1†). Detection
was carried out on a diode array detector and illustrated for absorption
at 277 nm.
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not available, or available but very expensive. Therefore, we
separated L- and D-enantiomers from the racemates 5-methyl-
DL-tryptophan (6), 6-methyl-DL-tryptophan (7) and 7-methyl-DL-
tryptophan (8) on HPLC by using the CHIRALPAK® Zwix(+)
column (Fig. S59, ESI†). Inspection of the HPLC chromato-
grams of 1a, 1b and their racemate (1) revealed that the
D-enantiomer 1b was eluted from the column prior to the
L-enantiomer 1a. This elution order is also true for C5-, C6-,
and C7-methylated tryptophan, which was proven by determi-
nation of their CD-spectra. Two opposite cotton effects were
observed for the isolated enantiomers, which corresponded
very well to those of 1a and 1b (Fig. S59, ESI†), respectively.
The enantiomers in the racemate 4-methyl-DL-tryptophan (5)
(Fig. S60, ESI†) could not be separated in this study.
Substrate preferences of DMATSs for L- and D-enantiomers of
methylated tryptophan
The isolated L- and D-enantiomers of C5-, C6- and C7-methyl-
ated tryptophan (6a, 6b, 7a, 7b, 8a, 8b) and their racemates
(6, 7, 8) were incubated with the seven DMATSs under similar
conditions (Fig. 4 and S25–S48, ESI†). The observed substrate
preferences of the DMATSs differed clearly from each other
(Table 2). As reported previously20,25,26,28 and demonstrated in
this study, 6 was a poor substrate for the C5-prenyltransferases
5-DMATS and 5-DMATSSc and the C6-methylated derivative 7
was accepted by the C6-prenyltransferases 6-DMATSSa and
6-DMATSMo with low conversion yields. Higher conversion
yields were found for their orthologue 6-DMATSSv (Table 2).
8 was not accepted by 7-DMATS. The low acceptance of trypto-
phan analogues, which were blocked at the prenylation posi-
tion for 1a by a methyl group, was also demonstrated by using
the pure L-enantiomers (Table 2). For methylated tryptophan
analogues, L-enantiomers were in general better or in most
cases much better accepted by DMATSs than D-enantiomers as
in the case of tryptophan.
It seems that FgaPT2 had a much higher enantioselectivity
than other tested enzymes and accepted no D-enantiomers 6b,
7b, or 8b. 7b and 8b were no substrates for 6-DMATSSa,
6-DMATSSv, and 7-DMATS. No product formation was detected
in the reaction mixture of 7b with 5-DMATS. From Table 2, it is
Fig. 3 HPLC analysis of the reaction mixtures of 5-DMATSSc with L- and D-enantiomers of tryptophan and methylated derivatives. 1 µM of the
enzyme was incubated with 1 mM DMAPP and 0.5 mM of the indicated substrate(s) at 37 °C for 16 h. The reaction mixtures were analysed on an
Eclipse Plus-C18 column (condition 6, Table S1, ESI†). The structures of the enzyme products of 1a, 1b, and 6b have been elucidated by NMR and
MS analyses. The main products of 7a, 7b, 8a, and 8b are expected to be C5-prenylated derivatives. Detection was carried out with a diode array
detector and illustrated for absorption at 277 nm.
Paper Organic & Biomolecular Chemistry
Org. Biomol. Chem. This journal is © The Royal Society of Chemistry 2016
Pu
bl
ish
ed
 o
n 
20
 S
ep
te
m
be
r 2
01
6.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f M
ar
bu
rg
 o
n 
29
/0
9/
20
16
 1
7:
26
:0
8.
View Article Online
118
obvious that the reactions of L-enantiomers were almost not
inhibited by D-enantiomers and nearly the same activities were
detected for the L-enantiomers in the racemates. Interestingly,
6b was a much better substrate for 5-DMATSSc and 6-DMATSMo
than 6a. Relative conversion yields of 57.3 ± 1.8 and
66.6 ± 0.5% of that of 1a were calculated for the reactions of 6b
with 5-DMATSSc and 6-DMATSMo, respectively, whereas the
values for 6a are 2.3 ± 0.2 and 12.9 ± 0.2%, respectively
(Table 2 and Fig. 4).
More interestingly, 6b in the racemate 6 was not converted
by these two enzymes, while similar conversion yields for 6a
were observed. This indicated an inhibition of the 6b reactions
in the presence of 6a, which could be explained by determi-
nation of their kinetic parameters. Kinetic parameters of
6-DMATSMo and 5-DMATSSc were then determined for 6a and
6b (Table 3 and Fig. S61–S62, ESI†). Substrate inhibition was
observed for the 5-DMATSSc reaction with 6b at concentrations
higher than 0.05 mM. Therefore, the KM value was determined
from graphical nonlinear evaluation for concentrations less
than 0.05 mM. For calculation of kcat, the maximal velocity
vmax at 0.05 mM 6b was used (Fig. S61, ESI†). For other reac-
tions, kinetic parameters were calculated from nonlinear
regression (Fig. S61 and S62, ESI†) and are given in Table 3.
KM values of 0.009 ± 0.001 and 0.03 ± 0.01 mM and kcat values
of 0.005 ± 0.0001 and 0.035 ± 0.005 s−1 were calculated for
5-DMATSSc reactions with L- and D-isomers, respectively.
For the 6-DMATSMo reaction with 6a, a KM value of
0.008 ± 0.001 mM and a kcat of 0.012 ± 0.0002 s
−1 were deter-
mined. In comparison, a significantly higher KM value of
0.30 ± 0.05 mM and larger kcat of 0.042 ± 0.003 s
−1 were calcu-
lated for the 6-DMATSMo reaction with 6b. In summary,
5-DMATSSc and 6-DMATSMo also display higher affinities to the
L- than the D-enantiomer. The turnover numbers for the
D-enantiomer are, however, clearly higher than those of the
L-enantiomer, confirming the observed conversion yields of
the reactions with pure enantiomers and the inhibition of the
6b reactions in the presence of 6a in the racemates. Due to the
high affinity of the DMATSs towards the L-form, the active site
of the enzyme will be occupied by the L-enantiomer, so that no
or very low prenylation of 6b is observed in the reaction with
the racemate.
Regioselectivity of DMATSs towards L- and D-enantiomers of
methylated tryptophan derivatives
For determination of the prenylation positions, DMATS
enzymes, which accepted D-enantiomers (Table 2), were incu-
bated with 6a and 6b, 7a and 7b as well as 8a and 8b.
As shown in Fig. S63 in the ESI† and given in Table 4, the
three C6-prenyltransferases 6-DMATSSa, 6-DMATSSv and
6-DMATSMo catalysed the same unique or predominant C6-pre-
nylation of 6a and 6b. In the reaction mixtures of 6-DMATSMo
with 6a and 6b, C7-prenylated derivatives were identified as
Fig. 4 Evaluation of the enantioselectivity of (A) 5-DMATSSc and (B) 6-DMATSMo. The enzymes were incubated with 1 mM DMAPP and 0.5 mM of
the L-enantiomer, D-enantiomer of 5-methyltryptophan or a combination of both (1 mM) and the reaction products were profiled by LC-MS and
HPLC. 1 µM of the indicated enzyme was incubated with the indicated substrate(s) prior to chemical profiling. UV detection was carried out with a
diode array detector and illustrated for absorption at 277 nm.
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minor products (Tables 4 and S10, Fig. S63 and S66, ESI†).
Different regioselectivities were observed for the reactions of
6a and 6b with FgaPT2, 5-DMATSSc and 7-DMATS. C4-preny-
lated 6a was detected as the unique product of the FgaPT2
reaction, while an additional product (C6- or C7-prenylated)
was detected for the 6b reaction with FgaPT2 by LC-MS
(Fig. S26, ESI†). In comparison, 5-DMATSSc displayed a low
regioselectivity towards 6a, with C6- and C7-prenylated deriva-
tives 6a-C6 and 6a-C7 in a ratio of approximately 1 : 1 as
enzyme products. For the 5-DMATSSc reaction with 6b, 6b-C6
was detected as the main and 6b-C7 as a minor product in a
ratio of 1 : 0.2 (Table S10 and Fig. S63, ESI†). 1H NMR spectra
of the product mixture confirmed these results (Fig. S66, ESI†).
For the 7-DMATS reaction, a switch from a unique C7-prenyla-
tion with the L-isomer to a predominant C6-prenylation with
the D-isomer of 5-methyltryptophan was observed. 6b-C7 was
detected as a minor product with a relative product yield of
20% to that of 6b-C6 (Fig. S63, ESI†). These results demon-
strated again that stereochemistry of the substrates has influ-
ence on the regioselectivity of the used enzymes, at least in
several cases. For 6-methyl- (7a and 7b) and 7-methyl-
tryptophan (8a and 8b), accurate determination of the prenyla-
tion positions of the enzyme products was not always possible,
because the products could not be separated completely from
each other under the HPLC conditions used in this study
(Fig. S64 and S65, ESI†). C5- and C7-prenylations of 7a and 7b
with 6-DMATSMo confirmed the previous results (Table S1†).
Two product peaks each of the 5-DMATSSc reactions with 7a
and 7b indicate C5- and C7-prenylations. In the HPLC chroma-
tograms of the reaction mixtures of 8a and 8b with 5-DMATS,
5-DMATSSc, and 6-DMATSMo, one monoprenylated product
peak with similar retention times could also be observed.
Diprenylation of methylated tryptophan derivatives by
DMATSs
As mentioned above, diprenylation of tryptophan was observed
for most of the tested DMATSs by the EIC mode in LC-MS.
With exceptions for 5-DMATSSc, the product yields of less than
0.5% were so low that UV detection was almost not possible
for 1.5 h incubation mixtures. Even after extension of the incu-
bation time to 16 h, UV detection of the diprenylated deriva-
tives of 1a and 1b was only observed for 5-DMATSSc (data not
shown). HPLC analysis of the 16 h reaction mixture of 7a with
5-DMATSSc revealed the presence of two mono- and one dipre-
nylated product peaks (Fig. 3). Low product formation was
observed in the reaction mixtures of 5-DMATSSc with 7b, 8a
and 8b. Similar retention times of the products of the D-form
with those of the L-form suggest identical diprenylated pro-
ducts for both enantiomers. The diprenylated features of these
products were confirmed by LC-MS analysis. These results
highlight the increased capability of 5-DMATSSc for diprenyla-
tion of tryptophan and its derivatives. Diprenylation of trypto-
phan and its analogues by tandem reactions of two DMATSs
has been described for FgaPT2 and 7-DMATS.38 However,
diprenylation by one single tryptophan prenyltransferase has
not been reported previously.
Conclusion
This study deals with comparative investigation on the diver-
gence of microbial dimethylallyltryptophan synthases regard-
ing their enantio- and regioselectivities. Different preferences
were clearly observed for the seven tested DMATSs towards
D- and L-enantiomers of tryptophan and methylated deriva-
tives. High flexible enantioselectivity was found for 5-DMATS,
5-DMATSSc, and 6-DMATSMo. Remarkably high conversion
yields were detected for D-tryptophan with 6-DMATSMo and
5-DMATS. 5-Methyl-D-tryptophan was even better accepted by
5-DMATSSc and 6-DMATSMo than the L-enantiomer. In other
cases, the L-forms were the best accepted substrates.
Interestingly, lower or in most cases, no product formation was
observed for D-enantiomers in the presence of L-enantiomers
in the racemates. Kinetic studies of 5-DMATSSc and
6-DMATSMo suggest that the very high affinities towards the
L-enantiomers led, in most cases, to the repression of the
D-enantiomer reaction under the used conditions.
In contrast with the highly regiospecific prenylation on the
L-tryptophan of the tested enzymes, the L-tryptophan C4-pre-
nyltransferase FgaPT2 and C5-prenyltransferase 5-DMATSSc
displayed a reduced regioselectivity towards D-tryptophan
with C5- and C6-prenylated derivatives as the main products,
respectively. Clearly different regioselectivities were also identi-
fied for the enantiomers of 5-methyltryptophan with FgaPT2,
5-DMATSSc and 7-DMATS. Furthermore, diprenylation of
tryptophan by 5-DMATSSc was the first example that a trypto-
phan prenyltransferase catalyses two successive prenylation
steps. These results expand our knowledge on the similarity
and differences in the biochemical features of the tryptophan
prenyltransferases. Moreover, the presented biochemical pro-
perties of these enzymes make them potential biocatalysts in
chemical synthesis for prenylated indole derivatives, which
represent promising candidates for drug discovery and devel-
opment in the pharmaceutical industry. As mentioned in the
Introduction, D-amino acids and their derivatives are interest-
ing drug candidates and could be used for treatment of
different diseases.3,39–44 Testing the bioactivity of these com-
pounds is intended in the near future.
Experimental section
Chemicals
DMAPP, GPP, and FPP were synthesised according to the
method described for GPP reported elsewhere.45 Aromatic sub-
strates used for the enzyme assays were purchased from TCI,
Sigma-Aldrich, Bachem, Roth, and Fluka and were of the
highest available purity.
Bacterial strains and plasmids
pGEM-T Easy was obtained from Promega (Mannheim,
Germany). pHIS8 was kindly provided by Prof. Joseph P. Noel
(Salk Institute for Biological Studies). Escherichia coli strains
XL1 Blue MRF’ (Stratagene, Amsterdam, the Netherlands),
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M15 (pREP4) (Qiagen), and BL21 (DE3) pLysS (AMS
Biotechnology, Abingdon, UK) were used for cloning and
expression experiments. Micromonospora olivasterospora DSM
43868 was purchased from the Deutsche Sammlung von
Mikroorganismen und Zellkulturen (Braunschweig, Germany).
Cloning and expression of MolI14.36
For genomic DNA isolation by phenol-chloroform extraction,46
cultivation of M. olivasterospora was carried out in a 300 ml
cylindrical flask containing 50 ml liquid YMG medium (0.4%
(w/v) yeast extract, 1% (w/v) malt extract, and 0.4% (w/v)
glucose) at 160 rpm on a rotary shaker at 28 °C for three days.
Standard procedures for DNA manipulation in E. coli were
performed as described previously.47
With the isolated genomic DNA as the template, a PCR frag-
ment of 1143 bp containing the coding sequence of MolI14.36
was amplified by using the Expand high fidelity kit (Roche
Diagnostic, Mannheim, Germany) and the primers
Mol_SacI_fw: (5′- ATGGCCGGCTTGTCCG-3′) and
Mol_HindIII_Rev: 5′- TCAGGGTCGGGTACGGC-3′).
Bold underlined letters represent the restriction sites for SacI
and HindIII, located immediately before the predicted start
and at the stop codon in the primer sequences. PCR amplifica-
tion was performed on an iCycler from Bio-Rad. The PCR
product was cloned via the pGEM-T Easy vector into pHIS8
48
resulting in the expression construct pJW32. E. coli BL21 [DE3]
cells harbouring pJW32 were cultivated in 1 L liquid lysogeny
broth (LB) medium supplemented with kanamycin (50 µg
ml−1) until an OD600 of 0.6. For induction of gene expression,
IPTG was added to a final concentration of 1 mM. After further
incubation at 30 °C and 220 rpm for 16 h, the recombinant
His8-tagged protein was purified on Ni-NTA agarose according
to the manufacturer’s protocol.
Overproduction and purification of the recombinant DMATS
enzymes
Escherichia coli (E. coli) M15 [pREP4] (Qiagen) and BL21 (DE3)
pLysS (AMS Biotechnology, Abingdon, UK) were used for
expression. Culture conditions for gene expression and puri-
fication of FgaPT2, 5-DMATS, 5-DMATSSc, 6-DMATSSa,
6-DMATSSv and 7-DMATS were carried out as described
previously.20,21,25,27,28
Protein analyses
The purified proteins were analysed on 12% (w/v) SDS-PAGE49
and stained with Coomassie Brilliant Blue G-250 (Fig. S1,
ESI†). The protein content was determined on a NanoDrop
2000c (Thermo Scientific) at an absorption of 280 nm. The
molecular masses of the native recombinant His8-6-DMATSMo,
His8-6-DMATSv and 6-DMATSa-His6 were determined by size
exclusion chromatography on a HiLoad 16/60 Superdex 200
column (GE Healthcare). 50 mM Tris-HCl buffer (pH 7.5) con-
taining 150 mM NaCl was used to equilibrate the column and
elute proteins. The column was calibrated with blue dextran
2000 (2000 kDa), aldolase (158 kDa), conalbumin (75 kDa),
chymotrypsinogen A (25 kDa) and ribonuclease A (13.7 kDa)
(GE Healthcare).
Enzyme assays
All reaction mixtures contained 50 mM Tris-HCl (pH 7.5) and
were incubated at 37 °C. The conditions of the reaction mix-
tures for identification of the prenylated products are
described in Table S9 in the ESI.†
Kinetic parameters of 6-DMATSMo toward DMAPP were
determined with 1 mM of 1a as the prenyl acceptor. Assays
containing 229.9 nM 6-DMATSMo and DMAPP at final concen-
trations of 0.002 to 0.5 mM were incubated for 30 min.
For determination of the kinetic parameters of different
DMATSs towards 1a, DMAPP at 1 mM and 1a at final concen-
trations of up to 1 mM were used. Assays with 36.2 nM
FgaPT2, 99.2 nM 5-DMATS, 118.5 nM 5-DMATSSc, 121.7 nM
6-DMATSSa, 231.0 nM 6-DMATSSv, 229.9 nM 6-DMATSMo, and
228.8 nM 7-DMATS were incubated for 15 min or in the case of
6-DMATSMo for 30 min. For determination of the kinetic para-
meters of 1b, the maximal substrate concentration was
increased to 2 mM or even 4 mM in the case of 5-DMATSSc.
The assays contained 905.8 nM FgaPT2, 396.8 nM 5-DMATS,
473.9 nM 5-DMATSSc, 486.6 nM 6-DMATSSa, 461.9 nM
6-DMATSSv, 459.8 nM 6-DMATSMo, or 1.4 µM 7-DMATS and
were incubated for 30 min, or in the case of 5-DMATSSc for
15 min. The assays for determination of the kinetic parameters
of 6-DMATSMo for 6a and 6b contained 1 mM DMAPP, 459.8 nM
of the recombinant protein, 6a from 0.002 to 0.5 mM or 6b
from 0.01 to 1 mM. The reaction mixtures were incubated for
30 min. For the 5-DMATSSc reactions with 6a and 6b, the
assays contained 7.1 µM and 473.9 nM of the recombinant
protein and 0.002 to 0.5 mM of 6a or 6b, which were incubated
for 15 min. The conditions for all other enzyme assays are
given in the legends of respective figures or tables.
Assays for isolation of the enzyme products of 6-DMATSMo
were prepared in large scales (10 ml) containing 50 mM
Tris-HCl (pH 7.5), 5 mM MgCl2, 1 mM L-tryptophan or its
analogues, 2 mM DMAPP, and recombinant protein in an
adequate quantity (2.3–6.9 µM). Enzyme products of
6-DMATSMo with 5-methyl-D-tryptophan as well as 5-DMATSSc
with D-tryptophan and 5-methyl-D-tryptophan were isolated
from up-scaled assays (5 ml) containing 50 mM Tris-HCl
(pH 7.5), 5 mM MgCl2, 1 mM D-tryptophan or 0.5 mM
5-methyl-D-tryptophan, 2 mM DMAPP and the recombinant
protein in an adequate quantity (4.7–11.9 µM 5-DMATSSc or
4.6–11.5 µM 6-DMATSMo). Assays were incubated for 16 h.
All enzyme reactions were terminated by addition of one
volume of methanol. Assays of up to 100 µl were centrifuged at
17 000g for 20 min before further analysis on HPLC. Isolation
assays of 5–10 ml were centrifuged at 4500g for 30 min and the
obtained supernatants were concentrated on a rotating vacuum
evaporator at 35 °C to a volume of 1 ml for isolation on HPLC.
HPLC and LC-MS analyses
The methods and the column used for HPLC measurements
are listed as conditions 1–9 in Table S1 in the ESI.† For all ana-
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lyses with the exception of condition 4, an Agilent HPLC 1200
(Böblingen, Germany) was used. Reaction mixtures for com-
parison of the substrate specificities of 6-DMATSSa,
6-DMATSSv, and 6-DMATSMo were analysed under condition
1. For investigation of the substrate preferences of DMATSs
towards L- und D-isomers of tryptophan and analogues thereof,
the incubation mixtures were analysed with a CHIRALPAK®
Zwix(+) column (150 × 3 mm, 3 µm, Chiral Technologies
Europe, Daicel Group, Illkirch Cedex, France) and an isocratic
run (condition 2, Table S1, ESI†). Condition 2 was also used to
determine the kinetic parameters of 5-methyl-L-tryptophan
and 5-methyl-D-tryptophan. Incubation mixtures for kinetic
studies on tryptophan were analysed under condition 1.
To detect prenylation, the assays were analysed on an
Agilent HPLC 1260 equipped with a Bruker microTOF QIII
mass spectrometer. The applied method is illustrated as
condition 3. Chromatograms with UV detection and the
extracted ion chromatograms (EIC) are given in Fig. 1 and 4 as
well as in Fig. S25–S48 (ESI†).
Reaction mixtures for better separation of the enzyme pro-
ducts with prenylations at different positions were analysed
under condition 4 for L- and D-tryptophan or under condition
5 for the L- and D-forms of 5-, 6-, and 7-methyltryptophan as
substrates. Enzyme assays with 5-DMATSSc, illustrated
in Fig. 3, were measured under condition 6. The enantiomeric
substrates were separated isocratically with the same
chiral column by using methanol as the elution solvent
(condition 7).
For isolation of the prenylated products, the same HPLC
equipment under condition 8 or 9 was used. Detection was
carried out with a photodiode array detector and illustrated at
277 nm in this paper.
Structure elucidation by NMR analysis
NMR spectra of the enzyme products were recorded on a JEOL
ECA-500 MHz (1a-C6, 1b-C6, 1a-C5,C6, and 1a-C5,C7), a JEOL
ECX-400 MHz (1b-C5, 1b-C6, 1b-C7, 2a-C6, 3a-C6, 4-C6, 7-C6,
and 9a-C6) (JEOL Germany GmbH, Munich, Germany) or a
Bruker Avance III HD 500 (Bruker Biospin GmbH,
Rheinstetten, Germany) (5-C5, 5-C6, 5-C7, 6-C6, 6-C7, 8-C6,
and 1b-C5,C6) spectrometer. All spectra were processed with
MestReNova 6.0.2-5475 and 1H chemical shifts were referenced
to those of the solvent signals at 3.31 ppm for methanol. The
NMR data are given in the ESI† (Tables S5–S8, S10, and
Fig. S4–S22, S57–58, S66†).
Circular dichroism (CD) spectroscopy of the isolated
substrates
For determination of the configuration, CD spectra of the
L- and D-forms of tryptophan and its methylated derivatives
were taken on a Jasco J-810 CD spectrometer. The samples
were dissolved in water and measured in the range of
180–350 nm by using a 1 mm path length quartz cuvette.
Accession numbers
The nucleotide sequence of MolI14.36 is available in the
GenBank database under accession number AJ628421.2 and
the corresponding protein sequence under accession number
CAF31565.1.
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Structure elucidation of enzyme products of 6-DMATSMo by NMR analysis 
Inspection of the NMR spectra of the isolated peaks revealed the presence of a unique 
product each from the reaction mixtures of 1a, 1b, 2a, 3a, 4, 5, 8, and 9a, whereas three 
products 5-C5, -C6, and -C7 were found from that of 5 and two products each 6-C6 
and 6-C7 or 7-C5 and 7-C6 from those of 6 and 7 (Table S5-S7, Fig. S4-S22). The 
presence of the signals for dimethylallyl moieties at δH 3.30 - 3.56 (d/ or m, 2H-1'), 5.09 
- 5.41 (t sept or m, H-2'), 1.74 - 1.83 (s, 3H-4'), 1.68 - 1.75 ppm (s, 3H-5') verified a 
regular C-prenylation in all the structures (Table S5-S7).2,3,5-7 In comparison to the 
respective substrates, signals for one aromatic proton was absent in the spectra of the 
enzyme products. The presence of the singlet in the range of δH 7.06 - 7.17 ppm for H-
2 implies the prenylation at the benzene ring. 
Comparison of the spectra of 1a, 1b, 2a, 3a, and 4 with each other (Table S5, Fig. S4-
S8) showed similar chemical shifts of the three coupling aromatic protons at δH 7.49 - 
7.59, 6.89 - 6.91, and 7.14 - 7.15 ppm. The two coupling constants of 8.2 and 1.4 - 1.5 
Hz indicates C5- or C6-prenylation in their structures. Considering the relative 
positions of the signals of the aromatic protons and comparison of the spectra with those 
of C5- and C6-prenylated tryptophan and analogues 6,8 led to identification of 1a-C6, 
1b-C6, 2a-C6, 3a-C6, and 4-C6 to be C6-prenylated derivatives. 1a-C6, 2a-C6, and 
3a-C6 have been identified as enzyme products of 1a, 2a, and 3a with 6-DMATSSa.6 
Signals for three products 5-C5, -C6, and -C7 with a ratio of 0.6:1:0.6 were detected in 
the 1H NMR spectrum of the isolated peak from the enzyme assay of 5. Due to different 
coupling pattern, it was possible to determine the prenylation positions in their 
structures. The three singlets at δH 7.06, 6.96, and 6.60 ppm of the main product 5-C6 
verified a C6-prenylation in its structure (Table S6, Fig S9). The correlations in 1H-1H 
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COSY confirmed this conclusion and facilitated the assignment of the protons (Fig S10-
S14). 5-C5 and 5-C7 were identified as C5- and C7-prenylated products by 
interpretation of the 1H-1H COSY correlations and by comparison of their coupling 
pattern with those published previously.4,6,8 
Two products 6-C6 and 6-C7 with a ratio of 1:0.4 were identified as products in the 
reaction mixture of 6 (Table S6, Fig. S15). The chemical shifts and the coupling pattern 
of the main product 6-C6 were nearly the same as those of 6-DMA-5-methyl-DL-
tryptophan, the product of 6-DMATSSa with 6.6 This result was further confirmed by 
the interpretation of correlations in 1H-1H COSY (Fig S16-S19). Three singlets at δH
7.15, 7.35, and 6.76 ppm for three aromatic protons were observed for 6-C7, which are 
distinct from those of 6-C6 and correspond very well to those of the C7-prenylated 
product reported previously for TyrPT.1 Thus, MolI14.36 catalyses mainly a C6-
prenylation of 6 rather than a C7-prenylation. From the reaction mixture of MolI14.36 
with 7, two products 7-C5 and 7-C7 with a ratio of 0.12:1 were isolated as a mixture. 
The 1H NMR data of the main product 7-C7 correspond very well to those observed for 
the C7-prenylated product of 7 reported for 6-DMATSSa.6 Signals of 7-C5 had a very 
low intensity. The observed three singlets of the indole moiety at δH 7.14, 7.45, and 7.07 
ppm indicates a C4- or C5-prenylation of 7 (Table S7, Fig S20). Comparison of these 
data with those of the C5-prenylated derivative proved unequivocally the C5-
prenylation in 7-C5.8 Interpretation of the 1H NMR spectra of 8-C6 and 9a-C6 revealed 
the attachment of the dimethylallyl moiety at position C-6 of the indole ring (Table S7, 
Fig. S21 – S22) 
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Table S1 HPLC conditions for analyses of enzyme assays.  
Condition 1 
Column Multospher 120 RP-18 column (250×4 mm, 5 μm, C+S 
Chromatography Service, Langerwehe, Germany) 
Flow rate 1 ml*min-1 
Solvent A water 
Solvent B methanol 
Elution profile solvent B in A [v/v] duration [min] 
from 40 % to 100 % 15 min 
100 %  5 min 
40 % 5 min 
Condition 2 
Column CHIRALPAK®Zwix(+) column (150  3 mm, 3 µm, Chiral 
technologies Europe, Daicel Group, Illkirch Cedex, France) 
Flow rate 0.5 ml*min-1 
Solvent A water:methanol (1:1), 25 mM diethylamine, 50 mM formic acid 
Solvent B methanol, 25 mM diethylamine, 50 mM formic acid 
Elution profile solvent B in A [v/v] duration [min] 
0% 25 min
100 %  5 min 
0 % 5 min 
Condition 3 
Column Multospher 120-C18 column (250 x 2 mm, 5 µm; C+S 
Chromatography Service, Langenfeld, Germany)) 
Flow rate 0.5 ml*min-1 
Solvent A water, 0.1 % (v/v) formic acid 
Solvent B acetonitrile, 0.1 % (v/v) formic acid  
Elution profile solvent B in A [v/v] duration [min] 
from 5 % to 100 % 40 min 
100 %  10 min 
5 %  5 min 
Condition 4 
Column Eclipse XDB-C18 column (5 µm, 4.6 x 150 mm, Agilent) 
Flow rate 0.5 ml*min-1 
Solvent A water, 0.5 % (v/v) trifluoroacetic acid 
Solvent B acetonitrile, 0.5 % (v/v) trifluoroacetic acid 
Elution profile solvent B in A [v/v] duration [min] 
30 %  5 min 
from 30 % to 45 % 30 min 
100 %  5 min 
30 %  5 min 
Condition 5 
Column Eclipse Plus-C18 column (3.5 µm, 4.6 x 150 mm, Agilent) 
Flow rate 0.5 ml*min-1 
Solvent A water, 0.5 % (v/v) trifluoroacetic acid 
Solvent B acetonitrile, 0.5 % (v/v) trifluoroacetic acid 
Elution profile solvent B in A [v/v] duration [min] 
30 %  5 min 
From 30 % to 35 % 30 min 
100 %  5 min 
30 %  5 min 
Condition 6 
Column Eclipse Plus-C18 column (3.5 µm, 4.6 x 150 mm, Agilent) 
Flow rate 0.5 ml*min-1 
Solvent A water, 0.5 % (v/v) trifluoroacetic acid 
Solvent B acetonitrile, 0.5 % (v/v) trifluoroacetic acid 
Elution profile solvent B in A [v/v] duration [min] 
30 % 5 min 
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from 30 % to 35 % 15 min 
from 35 % to 70 % 25 min 
100 %  5 min 
30 %  5 min 
Condition 7 
Column CHIRALPAK®Zwix(+) column (150  3 mm, 3 µm, Chiral 
technologies Europe, Daicel Group, Illkirch Cedex, France) 
Flow rate 0.5 ml*min-1 
Solvent A methanol 
Elution profile solvent A duration [min] 
100 % 25 min
Condition 8 
Column Multospher 120 RP-18 column (250×10 mm, 5 μm, C+S 
Chromatography Service, Langerwehe, Germany)  
Flow rate 2.5 ml*min-1 
Solvent A water 
Solvent B methanol 
Elution profile solvent B in A [v/v] duration [min] 
60 %  5 min 
from 60 % to 100 % 25 min 
100 %  5 min 
60 %  5 min 
Condition 9 
Column Multospher 120 RP-18 column (250×10 mm, 5 μm, C+S 
Chromatography Service, Langerwehe, Germany)  
Flow rate 2.5 ml*min-1 
Solvent A water 
Solvent B methanol 
Elution profile solvent B in A [v/v] duration [min] 
from 70 % to 100 % 20 min 
100 %  5 min 
70 %  5 min 
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Table S2 Enzyme activities of 6-DMATSMo towards different prenyl donors. 
prenyl donor relative conversion yield [%] 
(4 µM, 4 h,  
1 mM donor) 
(6 µM, 6 h,  
2 mM donor) 
DMAPP 100 100
GPP 7.8 11.7
FPP 0.5  0.5 
The enzyme assays were analyzed on HPLC under condition 1. The conversion yields of L-
tryptophan in the presence of DMAPP at 51.2 % (1 mM DMAPP) or 98.3 % (2 mM DMAPP) 
were defined as 100 % relative activity. 
Table S3 Comparison of enzyme activities of 6-DMATSMo, 6-DMATSSa and 6-
DMATSSv towards tryptophan-containing cyclic dipeptides. 
The enzyme assays contained 0.5 mM aromatic substrate and 1 mM DMAPP were incubated 
at 37 °C for 2 h with 1 μM of the purified protein of 6-DMATSMo, 6-DMATSSa and 6-DMATSSv, 
respectively. Relative product yields were measured in duplicate on HPLC with Multospher 
120 RP-18 column. The conversion yields of 6-DMATSMo, 6-DMATSSv and 6-DMATSSa with 
L-tryptophan at 86.6, 99.5 and 90.3 % were defined as 100 % of relative activity, respectively. 
substrate relative conversion yield [%] 
6-DMATSMo 6-DMATSSv 6-DMATSSa
cyclo-L-Trp-Gly 7.1±0.5 0.8±0.2 1.8±0.3
cyclo-L-Trp-L-Leu 1.3±0.2 1.3±0.1 9.1±1.2
cyclo-L-Trp-L-Trp 2.7±0.3 2.5±0.1 13.3±0.01
cyclo-L-Trp-L-Phe 2.0±0.01 2.3±0.4 6.9±0.8
cyclo-L-Trp-L-Ala 4.4±0.1 0.8±0.01 1.7±0.1
cyclo-L-Trp-L-His 0.5 0.5 0.5
cyclo-L-Trp-L-Tyr 0.9±0.1 1.6±0.1 17.8±14.8
L-Trp 100.0±5.00 100.0±0.1 100.0±10.1
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Table S4 HR-ESI-MS analysis of the enzyme products of MolI14.36 (6-DMATSMo). 
Product 
HR-ESI-MS of the prenylated 
products ([M+H+]) 
Calculated Measured
Deviation 
[ppm] 
1a-C6 273.1598 273.1601 -1.1 
1b-C6 273.1598 273.1590 2.9 
2a-C6 287.1754 287.1775 -7.3 
3a-C6 287.1754 287.1757 -1.0 
4-C6 287.1754 287.1757 -1.0 
5-C5, 5-C6, 5-C7 287.1754 287.1768* -4.9 
6-C6, 6-C7 287.1754 287.1766* -4.2 
7-C5, 7-C7 287.1754 287.1768* -4.9 
8-C6 287.1754 287.1762 -2.8 
9a-C6 291.1503 291.1519 -5.5 
*Mass obtained from a product mixture.
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Table S9 Conditions for enzyme assays to identify enzyme products of DMATSs. 
Enzyme assays of 100µl contained 1 mM DMAPP and 5 mM CaCl2. 
Substrate Protein amount of DMATS Incubation time 
1 mM 1a 0.5 μM FgaPT2 
8.5 μM 5-DMATS 
1.4 μM 5-DMATSSc 
1.2 μM 6-DMATSSa  
3.1 µM 6-DMATSSv 
4.0 μM 6-DMATSMo 
0.6 μM 7-DMATS 
2 h 
1 mM 1b 2.0 μM  
FgaPT2, 5-DMATS, 5-DMATSSc, 
6-DMATSSa, 6-DMATSSv, 6-
DMATSMo, 7-DMATS 
4 h 
0.5 mM 6a 2.7 μM FgaPT2 
3.0 μM 5-DMATS  
3.5 μM 5-DMATSSc  
3.7 μM 6-DMATSSa  
3.5 μM 6-DMATSSv 
3.5 μM 6-DMATSMo 
2.8 μM 7-DMATS 
16 h 
0.5 mM 6b 3.5 μM 5-DMATSSc  
3.7 μM 6-DMATSSa  
3.5 μM 6-DMATSSv 
3.5 μM 6-DMATSMo 
2.8 μM 7-DMATS 
0.5 mM, 7a 2.7 μM FgaPT2 
3.0 μM 5-DMATS  
3.5 μM 5-DMATSSc  
3.5 μM 6-DMATSSv 
3.5 μM 6-DMATSMo 
2.8 μM 7-DMATS  
0.5 mM, 7b 3.0 μM 5-DMATS  
3.5 μM 5-DMATSSc 
3.5 μM 6-DMATSMo 
0.5 mM, 8a 2.7 μM FgaPT2 
3.0 μM 5-DMATS  
3.5 μM 5-DMATSSc 
3.5 μM 6-DMATSSv 
3.5 μM 6-DMATSMo  
0.5 mM, 8b 3.0 μM 5-DMATS 
3.5 μM 5-DMATSSc  
3.5 μM 6-DMATSMo  
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Table S10 1H NMR data of the enzyme products of 5-DMATSSc 6b-C6 and 6b-C7 in 
CD3OD. 
Comp 
6-DMA-5-methyl-D-Trp 
(6b-C6) 
7-DMA-5-methyl-D-Trp  
(6b-C7) 
Pos. δH, multi, J δH, multi, J 
2 7.07, s 7.14, s 
4 7.47, s 7.34, s 
5 - -
6 - 6.75, s
7 7.13, s -
10 3.4, dd, 14.9, 3.3 3.47-3.52, m 
3.08, dd, 14.9, 9.7 3.08, m 
11 3.83, dd, 9.7, 3.3 3.51-3.54, m 
13 2.36, s 2.39, s 
1´ 3.36, d, 7.2 3.38, m 
2´ 5.25, tsept, 7.2, 1.6 5.34, m 
4´ 1.74, s 1.74, s
5´ 1.73, s  1.73, s 
Chemical shifts (δ) are given in ppm and coupling constants (J) in Hz.  
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Fig. S1: SDS-PAGE analysis of 6-DMATSMo from M. olivasterospora. Proteins were 
separated on a 12 % SDS gel and stained with Coomassie Brilliant Blue G-250. Lane 
1: molecular mass standard; Lane 2: total protein before IPTG induction; lane 3: total 
protein after IPTG induction; lane 4: insoluble protein fraction; lane 5: soluble protein 
fraction; lane 6: flow through fraction; lane 7: wash fraction of Ni-NTA-agarose; lanes 
8 and 9: purified His8-tagged recombinant protein. 
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Fig. S2: HPLC analysis of the reaction mixtures of 6-DMATSMo with L-tryptophan and 
analogs. For conditions see legends of Table S2. A Multospher 120 RP-18 column was 
used and an absorption at 277 nm was illustrated. Product yields are given in 
parentheses after product numbers. 
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Fig. S3: Comparison of the substrate preferences of 6-DMATSMo, 6-DMATSSa, and 6-
DMATSSv towards tryptophan and analogs. The reaction mixtures contained 0.5 mM 
aromatic substrate and 1 mM DMAPP were incubated with 1 µM 6-DMATSMo, 6-
DMATSSa, or 6-DMATSSv at 37 °C for 1 h. Relative product yields were measured in 
duplicate on HPLC with Multospher 120 RP-18 column. 
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Fig. S4 1H NMR spectrum of 1a-C6 in CD3OD (500MHz) 
 Fig. S5 1H NMR spectrum of 1b-C6 in CD3OD (500MHz) 
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Fig. S6 1H NMR spectrum of 2a-C6 in CD3OD (400MHz) 
Fig. S7 1H NMR spectrum of 3a-C6 in CD3OD (400MHz) 
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Fig. S8 1H NMR spectrum of 4-C6 in CD3OD (400MHz) 
Fig. S9 1H NMR spectrum of 5-C5, 5-C6, and 5-C7 as a mixture in CD3OD 
(500MHz) 
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Fig. S10 1H-1H COSY spectrum of 5-C5, 5-C6, and 5-C7 as a mixture in CD3OD 
(500MHz) (1) 
Fig. S11 1H-1H COSY spectrum of 5-C5, 5-C6, and 5-C7 as a mixture in CD3OD 
(500MHz) (2) 
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Fig. S12 1H-1H COSY spectrum of 5-C5, 5-C6, and 5-C7 as a mixture in CD3OD 
(500MHz) (3) 
Fig. S13 1H-1H COSY spectrum of 5-C5, 5-C6, and 5-C7 as a mixture in CD3OD 
(500MHz) (4) 
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Fig. S14 Selected 1H-1H COSY connectivities of 5-C6 
 Fig. S15 1H NMR spectrum of the mixture of 6-C6 and 6-C7 in CD3OD (500MHz) 
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Fig. S16 1H-1H COSY spectrum of the mixture of 6-C6 and 6-C7 in CD3OD 
(500MHz) (1) 
Fig. S17 1H-1H COSY spectrum of the mixture of 6-C6 and 6-C7 in CD3OD 
(500MHz) (2) 
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Fig. S18 1H-1H COSY spectrum of the mixture of 6-C6 and 6-C7 in CD3OD 
(500MHz) (3) 
Fig. S19 Selected 1H-1H COSY connectivities of 6-C6 
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Fig. S20 1H NMR spectrum of the mixture of 7-C5 and 7-C7 in CD3OD (400MHz) 
Fig. S21 1H NMR spectrum of 8-C6 in CD3OD (500MHz) 
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Fig. S22 1H NMR spectrum of 9a-C6 in CD3OD (400MHz) 
Fig. S23 Ion dependency of the 6-DMATSMo reaction. 
The enzyme assays containing 1 mM L-tryptophan, 1 mM DMAPP, 5 mM metal ions 
and were incubated with 1 μM of the recombinant protein for 1.5 h. The enzyme activity 
without additives was defined as 100 %. 
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Fig. S24 Determination of the kinetic parameters of 6-DMATSMo towards L-tryptophan 
and DMAPP. Reaction mixtures contained 229.9 nM 6-DMATSMo, 5 mM MgCl2 and 
were incubated for 30 min at 37 °C. 1 mM L-tryptophan and 1 mM DMAPP were used 
for determination of the kinetic parameters of DMAPP and L-tryptophan, respectively. 
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Fig. S25 LC-MS and HPLC analyses of the enzyme assays of tryptophan with FgaPT2. 
The enzyme assays contained 1 mM DMAPP, 1 µM purified protein, and 0.5 mM of L- 
or D-isomer, or 1 mM of their racemate and were incubated at 37 °C for 1.5 h. UV-
detection was carried out on a Diode Array detector and illustrated for absorption at 
277 nm. 
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Fig. S26 LC-MS and HPLC analyses of the enzyme assays of 5-methyltryptophan with 
FgaPT2. The enzyme assays contained 1 mM DMAPP, 1 µM purified protein, and 0.5 
mM of L- or D-isomer, or 1 mM of their racemate were incubated at 37 °C for 1.5 h. 
UV-detection was carried out on a Diode Array detector and illustrated for absorption 
at 277 nm. 
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Fig. S27 LC-MS and HPLC analyses of the enzyme assays of 6-methyltryptophan with 
FgaPT2. The enzyme assays contained 1 mM DMAPP, 1 µM purified protein, and 0.5 
mM of L- or D-isomer, or 1 mM of their racemate were incubated at 37 °C for 1.5 h. 
UV-detection was carried out on a Diode Array detector and illustrated for absorption 
at 277 nm. 
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Fig. S28 LC-MS and HPLC analyses of the enzyme assays of 7-methyltryptophan with 
FgaPT2. The enzyme assays contained 1 mM DMAPP, 1 µM purified protein, and 0.5 
mM of L- or D-isomer, or 1 mM of their racemate were incubated at 37 °C for 1.5 h. 
UV-detection was carried out on a Diode Array detector and illustrated for absorption 
at 277 nm. 
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Fig. S29 LC-MS and HPLC analyses of the enzyme assays of 5-methyltryptophan with 
5-DMATS. The enzyme assays contained 1 mM DMAPP, 1 µM purified protein, and 
0.5 mM of L- or D-isomer, or 1 mM of their racemate were incubated at 37 °C for 1.5 
h. UV-detection was carried out on a Diode Array detector and illustrated for absorption
at 277 nm. 
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Fig. S30 LC-MS and HPLC analyses of the enzyme assays of 6-methyltryptophan with 
5-DMATS. The enzyme assays contained 1 mM DMAPP, 1 µM purified protein, and 
0.5 mM of L- or D-isomer, or 1 mM of their racemate were incubated at 37 °C for 1.5 
h. UV-detection was carried out on a Diode Array detector and illustrated for absorption 
at 277 nm. 
 
159
S37 
Fig. S31 LC-MS and HPLC analyses of the enzyme assays of 7-methyltryptophan with 
5-DMATS. The enzyme assays contained 1 mM DMAPP, 1 µM purified protein, and 
0.5 mM of L- or D-isomer, or 1 mM of their racemate were incubated at 37 °C for 1.5 
h. UV-detection was carried out on a Diode Array detector and illustrated for absorption
at 277 nm. 
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Fig. S32 LC-MS and HPLC analyses of the enzyme assays of tryptophan with 5-
DMATSSc. The enzyme assays contained 1 mM DMAPP, 1 µM purified protein, and 
0.5 mM of L- or D-isomer, or 1 mM of their racemate were incubated at 37 °C for 1.5 
h. UV-detection was carried out on a Diode Array detector and illustrated for absorption
at 277 nm. 
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Fig. S33 LC-MS and HPLC analyses of the enzyme assays of 6-methyltryptophan with 
5-DMATSSc. The enzyme assays contained 1 mM DMAPP, 1 µM purified protein, and 
0.5 mM of L- or D-isomer, or 1 mM of their racemate were incubated at 37 °C for 1.5 
h. UV-detection was carried out on a Diode Array detector and illustrated for absorption 
at 277 nm. 
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Fig. S34 LC-MS and HPLC analyses of the enzyme assays of 7-methyltryptophan with 
5-DMATSSc. The enzyme assays contained 1 mM DMAPP, 1 µM purified protein, and 
0.5 mM of L- or D-isomer, or 1 mM of their racemate were incubated at 37 °C for 1.5 
h. UV-detection was carried out on a Diode Array detector and illustrated for absorption 
at 277 nm. 
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Fig. S35 LC-MS and HPLC analyses of the enzyme assays of tryptophan with 6-
DMATSSa. The enzyme assays contained 1 mM DMAPP, 1 µM purified protein, and 
0.5 mM of L- or D-isomer, or 1 mM of their racemate were incubated at 37 °C for 1.5 
h. UV-detection was carried out on a Diode Array detector and illustrated for absorption 
at 277 nm. 
 
164
S42 
Fig. S36 LC-MS and HPLC analyses of the enzyme assays of 5-methyltryptophan with 
6-DMATSSa. The enzyme assays contained 1 mM DMAPP, 1 µM purified protein, and 
0.5 mM of L- or D-isomer, or 1 mM of their racemate were incubated at 37 °C for 1.5 
h. UV-detection was carried out on a Diode Array detector and illustrated for absorption
at 277 nm. 
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Fig. S37 LC-MS and HPLC analyses of the enzyme assays of 6-methyltryptophan with 
6-DMATSSa. The enzyme assays contained 1 mM DMAPP, 1 µM purified protein, and 
0.5 mM of L- or D-isomer, or 1 mM of their racemate were incubated at 37 °C for 1.5 
h. UV-detection was carried out on a Diode Array detector and illustrated for absorption 
at 277 nm. 
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Fig. S38 LC-MS and HPLC analyses of the enzyme assays of 7-methyltryptophan with 
6-DMATSSa. The enzyme assays contained 1 mM DMAPP, 1 µM purified protein, and 
0.5 mM of L- or D-isomer, or 1 mM of their racemate were incubated at 37 °C for 1.5 
h. UV-detection was carried out on a Diode Array detector and illustrated for absorption 
at 277 nm. 
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Fig. S39 LC-MS and HPLC analyses of the enzyme assays of tryptophan with 6-
DMATSSv. The enzyme assays contained 1 mM DMAPP, 1 µM purified protein, and 
0.5 mM of L- or D-isomer, or 1 mM of their racemate were incubated at 37 °C for 1.5 
h. UV-detection was carried out on a Diode Array detector and illustrated for absorption 
at 277 nm. 
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Fig. S40 LC-MS and HPLC analyses of the enzyme assays of 5-methyltryptophan with 
6-DMATSSv. The enzyme assays contained 1 mM DMAPP, 1 µM purified protein, and 
0.5 mM of L- or D-isomer, or 1 mM of their racemate were incubated at 37 °C for 1.5 
h. UV-detection was carried out on a Diode Array detector and illustrated for absorption
at 277 nm. 
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Fig. S41 LC-MS and HPLC analyses of the enzyme assays of 6-methyltryptophan with 
6-DMATSSv. The enzyme assays contained 1 mM DMAPP, 1 µM purified protein, and 
0.5 mM of L- or D-isomer, or 1 mM of their racemate were incubated at 37 °C for 1.5 
h. UV-detection was carried out on a Diode Array detector and illustrated for absorption
at 277 nm. 
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Fig. S42 LC-MS and HPLC analyses of the enzyme assays of 7-methyltryptophan with 
6-DMATSSv. The enzyme assays contained 1 mM DMAPP, 1 µM purified protein, and 
0.5 mM of L- or D-isomer, or 1 mM of their racemate were incubated at 37 °C for 1.5 
h. UV-detection was carried out on a Diode Array detector and illustrated for absorption 
at 277 nm. 
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Fig. S43 LC-MS and HPLC analyses of the enzyme assays of 6-methyltryptophan with 
6-DMATSMo. The enzyme assays contained 1 mM DMAPP, 1 µM purified protein, and 
0.5 mM of L- or D-isomer, or 1 mM of their racemate were incubated at 37 °C for 1.5 
h. UV-detection was carried out on a Diode Array detector and illustrated for absorption
at 277 nm. 
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Fig. S44 LC-MS and HPLC analyses of the enzyme assays of 7-methyltryptophan with 
6-DMATSMo. The enzyme assays contained 1 mM DMAPP, 1 µM purified protein, and 
0.5 mM of L- or D-isomer, or 1 mM of their racemate were incubated at 37 °C for 1.5 
h. UV-detection was carried out on a Diode Array detector and illustrated for absorption
at 277 nm. 
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Fig. S45 LC-MS and HPLC analyses of the enzyme assays of tryptophan with 7-
DMATS. The enzyme assays contained 1 mM DMAPP, 1 µM purified protein, and 0.5 
mM of L- or D-isomer, or 1 mM of their racemate were incubated at 37 °C for 1.5 h. 
UV-detection was carried out on a Diode Array detector and illustrated for absorption 
at 277 nm. 
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Fig. S46 LC-MS and HPLC analyses of the enzyme assays of 5-methyltryptophan with 
7-DMATS. The enzyme assays contained 1 mM DMAPP, 1 µM purified protein, and 
0.5 mM of L- or D-isomer, or 1 mM of their racemate were incubated at 37 °C for 1.5 
h. UV-detection was carried out on a Diode Array detector and illustrated for absorption
at 277 nm. 
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Fig. S47 LC-MS and HPLC analyses of the enzyme assays of 6-methyltryptophan with 
7-DMATS. The enzyme assays contained 1 mM DMAPP, 1 µM purified protein, and 
0.5 mM of L- or D-isomer, or 1 mM of their racemate were incubated at 37 °C for 1.5 
h. UV-detection was carried out on a Diode Array detector and illustrated for absorption 
at 277 nm. 
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Fig. S48 LC-MS and HPLC analyses of the enzyme assays of 7-methyltryptophan with 
7-DMATS. The enzyme assays contained 1 mM DMAPP, 1 µM purified protein, and 
0.5 mM of L- or D-isomer, or 1 mM of their racemate were incubated at 37 °C for 1.5 
h. UV-detection was carried out on a Diode Array detector and illustrated for absorption
at 277 nm. 
177
S55 
 
 
Fig. S49 Determination of the kinetic parameters of FgaPT2 towards L- and D-tryptophan.  
The reaction mixtures with L-tryptophan contained 1 mM DMAPP, 5 mM CaCl2, and 36.2 nM 
of the purified protein and were incubated at 37 °C for 15 min. The reaction mixtures with D-
tryptophan contained 1 mM DMAPP, 5 mM CaCl2, and 905.8 nM of the purified protein and 
were incubated at 37 °C for 30 min. 
 
 
 
 
Fig. S50 Determination of the kinetic parameters of 5-DMATS towards L- and D-tryptophan. 
The reaction mixtures with L -tryptophan contained 1 mM DMAPP, 5 mM CaCl2, and 99.2 
nM of the purified protein and were incubated at 37 °C for 15 min. The reaction mixtures with 
D-tryptophan contained 1 mM DMAPP, 5 mM CaCl2, and 396.8 nM of the purified protein 
and were incubated at 37 °C for 30 min. 
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Fig. S51 Determination of the kinetic parameters of 5-DMATSSc towards L- and D-tryptophan. 
The reaction mixtures with L-tryptophan contained 1 mM DMAPP, 5 mM MgCl2, and 118.5 
nM of the purified protein and were incubated at 37 °C for 15 min. The reaction mixtures with 
D-tryptophan contained 1 mM DMAPP, 5 mM MgCl2, and 473.9 nM of the purified protein 
and were incubated at 37 °C for 15 min. 
 
 
 
 
Fig. S52 Determination of the kinetic parameters of 6-DMATSSa towards L- and D-tryptophan. 
The reaction mixtures with L-tryptophan contained 1 mM DMAPP, 5 mM MgCl2, and 121.7 
nM of the purified protein and were incubated at 37 °C for 15 min. The reaction mixtures with 
D-tryptophan contained 1 mM DMAPP, 5 mM MgCl2, and 486.6 nM of the purified protein 
and were incubated at 37 °C for 30 min. 
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Fig. S53 Determination of the kinetic parameters of 6-DMATSSv towards L- and D-tryptophan.  
The reaction mixtures with L-tryptophan contained 1 mM DMAPP, 5 mM MgCl2, and 231.0 
nM of the purified protein and were incubated at 37 °C for 15 min. The reaction mixtures with 
D-tryptophan contained 1 mM DMAPP, 5 mM MgCl2, and 461.9 nM of the purified protein and 
were incubated at 37 °C for 30 min. 
Fig. S54 Determination of the kinetic parameters of 6-DMATSMo towards D-tryptophan.  
The reaction mixtures contained 1 mM DMAPP, 5 mM MgCl2, and 459.8 nM of the purified 
protein and were incubated at 37 °C for 30 min. 
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Fig. S55 Determination of the kinetic parameters of 7-DMATS towards L- and D-tryptophan.  
The reaction mixtures with L-tryptophan contained 1 mM DMAPP, 5 mM CaCl2, and 228.8 nM 
of the purified protein and were incubated at 37 °C for 15 min. The reaction mixtures with D-
tryptophan contained 1 mM DMAPP, 5 mM CaCl2, and 1.4 µM of the purified protein and were 
incubated at 37 °C for 30 min. 
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Fig. S56 1H NMR spectrum of the isolated enzyme product mixture of 1b-C5, 1b-C6, and -
1b-C7 of 5-DMATSSc in CD3OD (400MHz). 
Fig. S57 1H NMR spectrum of the mixture of 1a-C5,C6 and 1a-C5,C7 in CD3OD (500MHz) 
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Fig. S58 1H NMR spectrum of 1b-C5,C6 in CD3OD (500MHz) 
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Fig. S59 CD spectra of the isolated L- and D-enantiomers. The enantiomers were isolated 
from racemate on a CHIRALPAK®Zwix(+) column and dissolved in water. CD spectra were 
recorded on a Jasco J-810 CD spectrometer in the wavelength range of 180-350 nm.  
 
 
 
Fig. S60 HPLC chromatogram with CHIRALPAK®Zwix(+) column A) and CD-spectrum B) 
of 4-methyl-DL-tryptophan (5).  
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Fig. S61 Determination of the kinetic parameters of 5-DMATSSc towards 5-methyl-L-
tryptophan and 5-methyl-D-tryptophan. The reaction mixtures with 5-methyl-L-tryptophan 
contained 1 mM DMAPP, 5 mM MgCl2 and 7.1 µM of the purified protein and were incubated 
at 37 °C for 15 min. The reaction mixtures with 5-methyl-D-tryptophan contained 1 mM 
DMAPP, 5 mM MgCl2 and 473.9 nM of the purified protein and were incubated at 37 °C for 
15 min. 
Fig. S62 Determination of the kinetic parameters for 6-DMATSMo towards 5-methyl-L-
tryptophan and 5-methyl-D-tryptophan. The reaction mixtures contained 1 mM DMAPP, 5 mM 
MgCl2 and 459.8 nM of the purified protein and were incubated at 37 °C for 30 min.  
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Fig. S63 HPLC analysis for identification of the enzyme products of 5-methyltryptophan. The 
enzyme assays contained 1 mM DMAPP and 0.5 mM of 5-methyl-L-tryptophan (6a) and 5-
methyl-D-tryptophan (6b). Detailed conditions for the incubation mixtures are given in Table 
S9. For HPLC analysis, an Eclipse XDB-C18 column was used (condition 5 in Table S1). 
Detection was carried out with a Diode Array detector and illustrated for absorption at 277 nm. 
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Fig. S64 HPLC analysis for identification of the enzyme products of 6-methyltryptophan. The 
enzyme assays contained 1 mM DMAPP and 0.5 mM of 6-methyl-L-tryptophan (7a) and 6-
methyl-D-tryptophan (7b). Detailed conditions for the incubation mixtures are given in Table 
S9. For HPLC analysis, an Eclipse Plus-C18 column was used (condition 5 in Table S1). 
Detection was carried out with a Diode Array detector and illustrated for absorption at 277 nm. 
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Fig. S65 HPLC analysis for identification of the enzyme products of 7-methyltryptophan. The 
enzyme assays contain 1 mM DMAPP and 0.5 mM of 7-methyl-L-tryptophan (8a) and 7-
methyl-D-tryptophan (8b). Detailed conditions for the incubation mixtures are given in Table 
S9. For HPLC analysis, an Eclipse Plus-C18 column was used (condition 5 in Table S1). 
Detection was carried out with a Diode Array detector and illustrated for absorption at 277 nm. 
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Fig. S66 1H NMR spectrum of the isolated enzyme product mixture of 6b-C6 and 6b-C7 of 5-
DMATSSc in CD3OD (400MHz). 
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Abstract Attachment of isoprene units to various accep-
tors by prenylation plays an important role in primary and
secondary metabolism of living organisms. Protein
prenylation belongs to posttranslational modification and
is involved in cellular regulation process. Prenylated sec-
ondary metabolites usually demonstrate promising biolog-
ical and pharmacological activities. Prenyl transfer reac-
tions catalyzed by prenyltransferases represent the key
steps in the biosynthesis and contribute significantly to
the structural and biological diversity of these com-
pounds. In the last decade, remarkable progress has been
achieved in the biochemical, molecular, and structural bi-
ological investigations of prenyltransferases, especially on
those of the members of the dimethylallyltryptophan syn-
thase (DMATS) superfamily. Until now, more than 40 of
such soluble enzymes are identified and characterized bio-
chemically. They catalyze usually regioselective and
stereoselective prenylations of a series of aromatic sub-
stances including tryptophan, tryptophan-containing pep-
tides, and other indole derivatives as well as tyrosine or
even nitrogen-free substrates. Crystal structures of a num-
ber of prenyltransferases have been solved in the past 10
years and provide a solid basis for understanding the
mechanism of prenyl transfer reactions.
Keywords Aromatic prenyltransferase .
Dimethylallyltryptophan synthase . Peptide
prenyltransferase . Phylogenetic relationships . Prenyl
diphosphate synthase . Protein prenyltransferase . tRNA
prenyltransferase
Introduction
Prenyltransferases catalyze the transfer reactions of prenyl
moieties from different prenyl donors, e.g., dimethylallyl
(DMAPP with a branched C5-chain), geranyl (GPP, C10),
farnesyl (FPP, C15), or geranylgeranyl (GGPP, C20) diphos-
phate, to various aliphatic or aromatic acceptors of both low
and high molecular substances including proteins and nucleic
acids (Dumelin et al. 2012; Heide 2009a; Li 2009a; Oldfield
and Lin 2012; Palsuledesai and Distefano 2015; Xie et al.
2007; Yazaki et al. 2009). The prenylation reactions can take
place in regular manner (regular prenylation) by connection of
the prenyl moieties via their C-1 to an acceptor or reverse
manner (reverse prenylation) via their C-3 atoms (Heide
2009a; Yu and Li 2012).
Prenylated secondary metabolites including indole al-
kaloids, flavonoids, coumarins, xanthones, quinones, and
naphthalenes are widely distributed in terrestrial and ma-
rine organisms (Fig. 1). They exhibit a wide range of
biological activities such as cytotoxicity, antioxidant
(Sunassee and Davies-Coleman 2012), and antimicrobial
activities (Liu et al. 2013a; Oya et al. 2015), which are
often distinct from their non-prenylated precursors. Prenyl
transfer reactions usually represent the key steps in the
biosynthesis of such compounds. Furthermore, the
prenylated products can be further modified by cycliza-
tion, hydroxylation, oxidation, and so on (Raju et al.
2011; Tagami et al. 2013). Therefore, prenyltransferases
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contribute significantly to structural and biological diver-
sity of natural products.
Based on their primary amino acid sequences, bio-
chemical and structural characteristics, prenyltransferases
are categorized into different subgroups (Table 1). Prenyl
diphosphate synthases use prenyl diphosphate as donor
and isopentenyl diphosphate (IPP) as acceptor (Oldfield
and Lin 2012), while protein prenyltransferases catalyze
the transfer reactions of C15 chain from FPP or C20 chain
from GGPP to cysteine residues of proteins (Palsuledesai
and Distefano 2015). Peptide prenyltransferases of the TruF
family catalyze O-prenylations of tyrosyl residues of cyclic
peptides in the presence of DMAPP. DMAPP and GPP serve
as prenyl donors for tRNA prenyltransferases from bacteria
(Dumelin et al. 2012; McIntosh et al. 2011, 2013; Xie et al.
2007). A large prenyltransferase group uses diverse nitrogen-
containing and nitrogen-free aromatic compounds as sub-
strates, and among them, the dimethylallyltryptophan
synthase (DMATS) superfamily is one of the most investigat-
ed subgroup. The name of this superfamily was given due to
their sequence similarity to DMATS involved in the biosyn-
thesis of ergot alkaloids of Claviceps sp. (Tsai et al. 1995).
Since the first reviews on the DMATS enzymes in
2009 (Li 2009a, b; Steffan et al. 2009), significant prog-
ress has been achieved for this enzyme group. Thirty-two
new enzymes have been characterized biochemically. The
natural substrates of the DMATS enzymes were found to
be much broader than just indole derivatives known at
that time. Tyrosine, xanthones, tricyclic or tetracyclic ar-
omatic or even nonaromatic compounds also serve as nat-
ural substrates of enzymes with sequence similarity to
DMATS. In contrast, the spectrum of the natural prenyl
donors of these enzymes is relatively narrow, and most of
the members of the DMATS superfamily use DMAPP for
prenylation. In addition, crystal structures of four DMATS
enzymes were solved and used as basis for understanding
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Fig. 1 Examples of prenylated natural products
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of the reaction mechanism. Since 2009, several reviews
on different aspects of the DMATS superfamily, mainly
on indole prenyltransferases, have appeared (Tanner 2014;
Walsh 2014; Yu and Li 2012). A systematic summary
covering classification, occurrence, natural function, bio-
chemical properties, crystal structures, and reaction mech-
anism of this intriguing enzyme group is now necessary.
For a better understanding of prenyltransferases as nxC5
transferring enzymes onto diverse acceptors and their nat-
ural roles, we begin in this review with a brief overview
on different classes of prenyltransferases and then focus
on the members of the DMATS superfamily. In another
mini-review in this issue, we will discuss the potential
usage of DMATS prenyltransferases in biotechnology,
which has been demonstrated by a large number of studies
in the last years.
Classification of prenyltransferases
IPP and DMAPP, derived from the acetate-mevalonate or
methylerythritol phosphate pathway (Boronat and
Rodriguez-Concepcion 2015; Chang et al. 2013; Zhao
et al. 2013), serve as precursors for prenyl diphosphate
(nxC5) biosynthesis (Oldfield and Lin 2012). The prenyl
diphosphates can be used for the biosynthesis of different
terpenoids by cyclization and oxidation or as prenyl do-
nors for peptide, protein and tRNA prenyltransferases, or
aromatic prenyltransferases. The donors, acceptors, prod-
ucts, and functions of different prenyltransferases are
summarized in Table 1.
Prenyl diphosphate synthases
Over 63,000 isoprenoid natural products have been identified
to date, which bear numerous important biological functions
and show an enormous structural diversity based on their dif-
ferent carbon skeletons and substitutions (Liang et al. 2002;
Ramamoorthy et al. 2015). In the biosynthesis of isoprenoids,
prenyl diphosphate synthases catalyze the formation of the
carbon backbone with defined chain length by sequential con-
densation of DMAPP or other prenyl diphosphates with a
given number of IPP. According to the formed double bond
configuration in the prenyl units, these chain elongating en-
zymes can be classified into two major groups, i.e., trans- and
cis-prenyltransferases (Fig. 2).
FPP synthases (FPPase) belong to the first group and cat-
alyze the formation of all-trans C15 precursor FPP by utilizing
IPP as acceptor for the sequential condensations with DMAPP
and GPP (Poulter 2006). FPP could serve as a precursor for a
number of essential or important metabolites, e.g.,
sesquiterpenoids, triterpenoids, sterols, dolichols, and ubiqui-
nones (Anderson et al. 1989).
GGPP synthases also belong to trans-prenyltransferases
and catalyze, similar to FPPases, the formation of all-trans
configured geranylgeranyl diphosphate. They are involved
in the biosynthesis of plant secondary metabolites like
diterpenoids or carotenoids (Liu et al. 2014b). Furthermore,
octaprenyl diphosphate synthase (OPPS) catalyzes successive
condensation reactions of FPP with five IPP to generate C40
products with trans-configured double bonds (Fig. 2). The
resulted prenyl diphosphate can be used as donor for quinone
Table 1 Classification of prenyltransferases with their natural functions
Enzyme type Donor Acceptor (examples) Function/biosynthesis
prenyl diphosphate synthases
trans-prenyltransferases prenyl diphosphate isopentenyl diphosphate all-trans-isoprenoids, terpenoids,
steroids
cis-prenyltransferases prenyl diphosphate isopentenyl diphosphate trans-/cis-isoprenoids, membrane
components
peptide prenyltransferases dimethylallyl, geranyl diphosphate (cyclic) oligopeptides pheromones/secondary metabolites
protein prenyltransferases farnesyl or geranylgeranyl diphosphate cysteine residue of proteins posttranslational modification of
proteins, cellular localization,
protein-protein interaction
tRNA prenyltransferases dimethylallyl and geranyl diphosphate adenine or 5-methylaminomethyl-
2-thiouridine
translational regulation
aromatic prenyltransferases
membrane-bound
prenyltransferases
prenyl diphosphate benzoic & naphthoic acids,
flavonoids
primary & secondary metabolites
soluble aromatic prenyltransferases
NphB/CloQ group dimethylallyl, geranyl and farnesyl
diphosphate,
naphthalenes, quinones, phenols,
phenazines
secondary metabolites
DMATS family dimethylallyl, geranyl and farnesyl
diphosphate
indole derivatives, tyrosine,
naphthalenes, xanthones
secondary metabolites,
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prenylation in the biosynthesis of ubiquinone, menaquinone,
or plastoquinones (Soballe and Poole 1999). The homodimer-
ic enzymes of trans-prenyltransferases consist of α-helices
with two conserved aspartate-rich DDxxD motifs, which
allowed the binding of the substrates in complex with Mg2+
(Guo et al. 2004).
In contrast, cis-prenyltransferases produce prenyl diphos-
phates containing both Z- and E-configured double bonds,
although they use the same substrates and their catalyzed re-
actions are Mg2+ dependent (Fig. 2). Their amino acid se-
quences and three-dimensional structures completely differ
from those of trans-prenyltransferases. Instead of the
DDxxD motif, an aspartate in the conserved P-loop of cis-
prenyltransferases is involved in the chelating of Mg2+ (Guo
et al. 2005). According to the length of their products, they are
further classified into short- (C15), medium- (C50–C55), and
long-chain (C70–C120) cis-prenyltransferases (Lu et al. 2009;
Takahashi and Koyama 2006). Undecaprenyl diphosphate
synthase for example catalyzes the condensation of FPP with
eight IPPs, resulting in the formation of a C55 product (Fig. 2).
Undecaprenyl monophosphate acts as a lipid carrier in the
peptidoglycan biosynthesis of bacterial cell wall and therefore
serves as a target for antibacterial drugs (Danley et al. 2015).
Prenylated lipids are also found in membranes of archaeal
bacteria. The geranylgeranylglyceryl phosphate synthase
( GGGP s y n t h a s e ) f r o m Me t h a n o b a c t e r i u m
thermoautotrophicum, which shows practically no homology
to other prenyltransferases, catalyzes the alkylation of
glyceryl phosphate in the presence of GGPP (Soderberg
et al. 2001).
Peptide, protein, and tRNA prenyltransferases
The ComX pheromone identified in Bacillus subtilis is a
hexapeptide containing a regularlyC3-geranylated tryptophan
residue. The responsible prenyltransferase ComQ was identi-
fied by overproduction in Escherichia coli (E. coli) and incu-
bation with an oligopeptide comprising 58 amino acids in the
presence of GPP. The C-terminal geranylated hexapeptide cor-
responding to the mature ComX pheromone was identified as
a minor and a C-terminal geranylated heptapeptide as themain
product (Tsuji et al. 2012).
Cyanobactins from Lyngbya aestuarii are cyclic
heptapeptides containing regularly C3-prenylated tyrosyl res-
idues. The prenyltransferase LynF uses cyclic heptapeptides
as substrates and catalyzes regular and reverse O-prenylations
of tyrosyl residues. The reversely prenylated enzyme products
then undergo a Claisen rearrangement resulting in C-
prenylated derivatives (McIntosh et al. 2011, 2013).
Protein prenyltransferases use polypeptides as substrates.
They play an important role in the posttranslational modifica-
tion of proteins in eukaryotes and represent interesting drug
targets (Palsuledesai and Distefano 2015). They transfer either
a farnesyl (C15) or a geranylgeranyl (C20) moiety to a con-
served cysteine residue in a CaaX motif at the C-terminus of
the targeted proteins or peptides (Palsuledesai and Distefano
2015; Perez-Sala 2007). These modifications are responsible
for correct cellular localization and activity of several proteins
including those from the Ras family. The primary sequences
as well as the crystal structures of protein prenyltransferases
clearly differ from that of the prenyl diphosphate synthases.
For the Ras farnesyltransferase reaction, the formation of
Zn2+-activated thiolate by the cysteine residue of the CaaX
box is necessary (Long et al. 2002). Due to the role of
farnesylated proteins in oncogenic processes or several dis-
eases including progeria, aging, parasitic diseases, and bacte-
rial or viral infections, the underlying prenylation reaction and
its inhibition by potential therapeutics have been extensively
investigated (Abuhaie et al. 2013; Palsuledesai and Distefano
2015; Sousa et al. 2009; Zhu et al. 2014).
Modifications by prenylations are not only found in pro-
teins, but also in nucleic acids, e.g., tRNAs. Two
dimethylallyltransferases (DMATase) from Pseudomonas
aeruginosa (P. aeruginosa) and E. coli were proven to
prenylate the amino group of adenosine-37 (A37) of all
tRNAs with uridine at the beginning (Xie et al. 2007).
Fig. 2 Examples of prenyl
diphosphate synthase reactions
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Recently, SelU from E. coli was reported to catalyze S-
geranylation of 5-methylaminomethyl-2-thiouridyl residue in
tRNA in the presence of GPP (Dumelin et al. 2012).
Aromatic prenyltransferases
Aromatic prenyltransferases catalyze the transfer reactions of
prenyl moieties onto aromatic acceptors such as phenols, phe-
nolic acids, flavonoids, coumarins, naphthalenes, phenazines,
or indole derivatives. These enzymes contribute substantially
to the large diversity of prenylated secondary metabolites in
plants, fungi, and bacteria (Heide 2009b; Li 2009b; Yazaki
et al. 2009). They usually catalyze the formation of C–C, C–
O, or C–N bonds between the carbon of the prenyl and carbon
or functional groups of the aromatic substrates. Membrane-
bound and soluble aromatic prenyltransferases were found to
exhibit distinct characteristics such as structural fold, substrate
binding motifs, or metal ion dependency.
Membrane-bound prenyltransferases for aromatic
substrates
Members of this enzyme group are involved in the biosynthe-
sis of both primary metabolites such as ubiquinones and
menaquinones (Boronat and Rodriguez-Concepcion 2015;
Meganathan and Kwon 2009) and secondary metabolites like
microbial and plant natural products (Holm et al. 2014; Wang
et al. 2014; Yazaki et al. 2009; Zeyhle et al. 2014a, b).
Ubiquinones and menaquinones function as electron and
proton carrier in photosynthesis and cellular respiration and
also as antioxidants for prevention of cell damage. Membrane-
bound prenyltransferases contain, similar to the aforemen-
tioned FPPs, characteristic aspartate-rich motifs, e.g.,
NDxxDxxxD, and require metal ions such as Mg2+ for their
catalytic activity. The underlying prenyl transfer reactions were
observed for various aromatic substrates like 4-hydroxybenzoate
(4HB), homogentisic acid, coumarines, flavonoids, 1,4-dihy-
droxy-2-naphthoate, or phenazines (Heide 2009a; Karamat
et al. 2014; Yazaki et al. 2009; Zeyhle et al. 2014a, b). Several
examples of membrane-bound prenyltransferases and their cata-
lyzed reactions are summarized in Table 2. UbiA from E. coli as
a prototype of this family plays an important role in the biosyn-
thesis of ubiquinones and catalyzes the attachment of an all-trans
octaprenyl moiety onto 4HB (Melzer and Heide 1994). UbiA
shows a broad substrate specificity toward prenyl donors and is
able to generate ubiquinones CoQ6 to CoQ10 in different species
(Cheng and Li 2014). Recently, the crystal structure of an archeal
UbiA was reported (Cheng and Li 2014), which provides new
insights into the substrate binding sites and mechanism of the
enzyme catalysis. Very recently, a prenyltransferase UbiX from
P. aeruginosa involved in the biosynthesis of ubiquinones was
demonstrated to use flavin as a prenyl acceptor. In contrast to
prenyl diphosphates for other known prenyltransferases,
dimethylallyl monophosphate (DMAP) serves as prenyl donor
for UbiX reaction (White et al. 2015).
In human cells, COQ2 is involved in the biosynthesis of
ubiquinone for mitochondrial respiration, while UBIAD1 in
the biosynthesis of vitamin K for maintaining vascular ho-
meostasis (Hegarty et al. 2013; Nakagawa et al. 2010).
UbiA homologs, e.g., AtPPT1 from Arabidopsis thaliana
(A. thaliana) and OsPPT1 from Oryza sativa, were found to
be involved in primary metabolism of plants (Okada et al.
2004; Ohara et al. 2006). In plants, membrane-bound aromatic
prenyltransferases are also involved in the biosynthesis of sec-
ondary metabolites. The 4HB geranyltransferases LePGT-1
and LePGT-2 from Lithospermum erythrorhizon are involved
in the biosynthesis of the naphthoquinone shikonin (Yazaki
et al. 2002). In contrast to the 4HB prenyltransferases for
ubiquinone biosynthesis, these enzymes are localized in the
endoplasmatic reticulum rather than in mitochondria. They
show strict substrate specificity for GPP as prenyl donor.
Several members of the membrane-bound prenyltransferases
are involved in the biosynthesis of prenylated flavonoids and
isoflavonoids in plants. N8DT, G6DT, and SfiLDT from
Sophora flavescens catalyze the prenylations of naringenin,
genistein, and isoliquiritigenin, respectively (Chen et al.
2013; Sasaki et al. 2011). Furthermore, the formation of C3′-
prenylated genistein was detected in vitro with LaPT1 from
Lupinus albus (Shen et al. 2012). Pterocarpan 4-
dimethylallytransferase (G4DT) catalyzes the transfer of a
dimethylallyl moiety onto pterocarpan skeleton and is there-
fore responsible for the formation of the soybean phytoalexin
glyceollin (Akashi et al. 2009). In plants, three kinds of
homogentisic acid prenyltransferases use solanesyl (C45),
geranylgeranyl (C20), and phytyl (C20, partially saturated) di-
phosphate for their prenylation reactions in the biosynthesis of
plastoquinones, tocotrienols, and tocopherols, respectively
(Heide 2009a). The last two compounds are also known as
vitamin E. Moreover, 1,4-dihydroxy-2-naphthoate serves as
substrate for the octaprenyltransferase MenA in E. coli and
for the phytyltransferase ABC4 in phylloquinone biosynthesis
in A. thaliana (Shimada et al. 2005; Suvarna et al. 1998). In
addition, chlorophyllide and protoheme IXwere used by chlo-
rophyll synthase ATG4 (Eckhardt et al. 2004) and protoheme
IX farnesyltransferase COX10, both from A. thaliana, respec-
tively (Saiki et al. 1993). Furthermore, two membrane-bound
prenyltransferases were found to catalyze three sequential
prenylation steps in the biosynthesis of bitter acid in hop (Li
et al. 2015). PcPT from parsley was found to be a key enzyme
in the biosynthesis of linear and angular furanocoumarins and
to catalyze prenylations of umbelliferon at both C-6 and C-8
positions (Karamat et al. 2014).
Membrane-bound aromatic prenyltransferases were also
identified for the secondary metabolism in bacteria. One
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example is the farnesyltransferase AuaA from the
myxobacterium Stigmatella aurantiaca in the biosynthesis
of aurachins, which catalyzes the farnesylation of 2-methyl-
4-hydroxyquinoline (Stec et al. 2011). Very recently, two
membrane-bound aromatic prenyltransferases were identified
in Streptomyces and found to be responsible for phenazine
prenylations (Zeyhle et al. 2014a, b).
Soluble prenyltransferases with PT barrel mostly
for aromatic substrates
The large enzyme group for prenylation of aromatic substrates
comprises the CloQ/NphB group and the extensively investi-
gated DMATS superfamily, which are soluble proteins from
bacteria and fungi. One common structural feature of these
enzymes is their aßßa-fold (ABBA), termed PT-barrel and
firstly observed for the naphthalene geranyltransferase NphB
(Kumano et al. 2008; Kuzuyama et al. 2005).
Enzymes of the CloQ/NphB subgroup
Known prenyltransferases of the CloQ/NphB group use only
aromatic compounds as substrates and catalyze prenylations
of naphthalenes, phenazines, quinones, and phenolic com-
pounds (Table 3) (Heide 2009a). They were found in both
bacteria and fungi and differ strongly from the aforemen-
tioned membrane-bound prenyltransferases (Haug-
Schifferdecker et al. 2010). They do not contain the
aspartate-rich NDxxD motif, and their reactions are with
the exception of that for NphB independent of divalent met-
al ions (Bonitz et al. 2011; Heide 2009a). The notation of
the subgroup referred to the first identified enzyme CloQ
from Streptomyces roseochromogenes and the 2 years later
Table 2 Examples of membrane-bound prenyltransferases and their catalyzed reactions
E. Escherichia, L. Lithospermum, P. Petroselinum, H. Humulus
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reported NphB from Streptomyces sp. (Kuzuyama et al.
2005; Pojer et al. 2003). CloQ and its ortholog NovQ from
Streptomyces spheroides catalyze the prenylation of 4-
hydroxyphenylpyruvic acid in the biosynthesis of
clorobiocin (Pojer et al. 2003) and novobiocin (Steffensky
et al. 2000) (Fig. 1). NphB is involved in the biosynthesis of
the geranylated derivative naphterpin (Kuzuyama et al.
2005). The crystal structures of NphB, CloQ, and EpzP
share an ABBA barrel in common (Kuzuyama et al. 2005;
Metzger et al. 2010; Wierenga et al. 2010; Zocher et al.
2012). These structures can serve as basis for molecular
modeling studies and therefore provide valuable contribu-
tions to our knowledge on mechanisms of the prenyl transfer
reactions (Bayse and Merz 2014; Yang et al. 2012).
Furthermore, NphB shows a broad substrate specificity to-
ward several phenolic compounds, e.g., resveratrol, flavo-
noids, and 4-HPP (Heide 2009a; Kumano et al. 2008;
Kuzuyama et al. 2005). In the last years, several additional
prenyltransferases of the CloQ/NphB group have been iden-
tified. SCO7190, a homolog of NphB from Streptomyces
coelicolor A3(2), catalyzes the attachment of the
dimethylallyl from DMAPP, but not geranyl moiety from
GPP onto 1,6-dihydroxynaphthalene (Kumano et al. 2008;
Kuzuyama et al. 2005). SCO7190 and NovQ were success-
fully used for production of novel prenylated polyphenols in
transgenic plants (Sugiyama et al. 2011). Fnq26 from
Streptomyces cinnamonensis DSM 1042 shares a sequence
identity of 40 % with NphB and catalyzes reverse and reg-
ular C- as well as regular O-prenylations of several phenolic
substrates (Haagen et al. 2007). Recently, McI23 from
Streptomyces sp. CNH-189 was found to catalyze the for-
mation of a prenylated precursor of merochlorin by utilizing
a diphosphate of an unusual branched C15 unit as prenyl
donor, which was formed by addition of a dimethylallyl
moiety to GPP in a reverse manner catalyzed by Mcl22
(Teufel et al. 2014). In the secondary metabolism of
Streptomyces cinnamonensis and Streptomyces anulatus,
EpzP and PpzP catalyze the regiospecific C9-prenylation
of 5,10-dihydrophenazine-1-carboxylic acid (Saleh et al.
2009; Seeger et al. 2011). As aforementioned, prenylation
of phenazine derivatives can also be catalyzed by
membrane-bound prenyltransferases (Table 3) (Zeyhle et al.
2014a, b). DzmP from Micromonospora sp. RV115 is the
first member of this subgroup which utilize FPP instead of
DMAPP and GPP as prenyl donor and catalyzes the unusual
N-farnesylation of dibenzodiazepinone (Bonitz et al. 2013).
Enzymes of the DMATS superfamily
The DMATS superfamily is the most investigated subgroup
among the prenyltransferases. In the last years, enormous ad-
vances have been achieved on the biochemical, molecular,
and structural biological investigations of these soluble en-
zymes. So far, more than 40 such enzymes from fungi and
bacteria have been identified mostly by genome mining and
characterized biochemically by using the recombinant pro-
teins (Fan et al. 2014; Pockrandt et al. 2014; Winkelblech
and Li 2014; Wunsch et al. 2015; Yu et al. 2012; Yu and Li
2012). They mainly catalyze the prenylation of indole deriva-
tives including tryptophan and tryptophan-containing cyclic
dipeptides. DMATS prenyltransferases carry no aspartate-
rich motifs and their catalysis is independent of the presence
ofmetal ions, althoughCa2+,Mg2+, or other metal ions strong-
ly enhance their activities in several cases (Li 2009a;
Pockrandt et al. 2012; Yu and Li 2012).
The first member of the DMATS superfamily was the tryp-
tophan C4-prenyltransferase DmaW involved in the biosyn-
thesis of ergot alkaloids in Claviceps fusiformis, reported as
Claviceps purpurea (C. purpurea) (Gebler and Poulter 1992;
Tsai et al. 1995). Its ortholog FgaPT2 from Aspergillus
fumigatus (A. fumigatus) was identified in 2005 by genome
mining using the DmaW sequence from C. purpurea
(Tudzynski et al. 1999; Unsöld and Li 2005). Until now, 12
enzymes were identified, which catalyze different
prenylations of tryptophan at N-1 and C-4 to C-7 (Table 4)
(Li 2010; Yu and Li 2012). Cyclic (di)peptide or related
prenyltransferases with 14 members build the largest group,
which catalyze the prenylations at N-1, C-2, C-3, and C-7 of
the indole ring (Table 5). In addition, a large number of indole
derivatives were identified as substrates of these enzymes
(Table 6). Two members of the DMATS superfamily, SirD
and TyrPT, use tyrosine as substrate and catalyze O-
prenylation (Table 6) (Fan et al. 2014; Kremer and Li 2010).
Since 2010, nitrogen-free or nonaromatic compounds were
identified as substrates of additional 16 prenyltransferases of
the DMATS superfamily (Table 6). In total, 19 such enzymes
have been characterized biochemically so far.
Tryptophan prenyltransferases
As summarized in Table 4, 12 tryptophan prenyltransferases,
five from bacteria and seven from fungi, were identified and
characterized biochemically. These enzymes catalyze the
formation of dimethylallyltryptophan and therefore also
termed DMATSs. As aforementioned, DmaW from
C. fusiformis was identified as the first enzyme from the
DMATS superfamily and catalyzes the first pathway-
specific step in the biosynthesis of ergot alkaloids, i.e.,
the prenylation of tryptophan at C-4 of the indole ring
(Gerhards et al. 2014; Tsai et al. 1995). With the identifi-
cation and characterization of its ortholog, FgaPT2 from
A. fumigatus in 2005 began the systematic study on the
enzymes of the DMATS superfamily by genome mining
and biochemical investigation (Unsöld and Li 2005).
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Later, two additional fungal 4-DMATS, i.e., DmaW-Cs
from Periglandula (Markert et al. 2008; Steiner et al.
2011) and Malbranchea (Ding et al. 2008), were also
identified. Identification of 7-DMATS from A. fumigatus
as a tryptophan C7-prenylating enzyme obligated to do-
nate the position of the prenyl moiety at the indole ring of
tryptophan for prenyltransferase names. 7-DMATS was
proven to be invo lved in the b iosyn thes i s o f
hexadehydroastechrome (Yin et al. 2013c). Identification
of 5-DMATS from A. clavatus filled the last gap of
prenylat ion posi t ions of fungal t ryptophan and
tryptophan-containing cyclic dipeptide prenyltransferases
(Yu et al. 2012).
The first bacterial tryptophan prenyltransferase CymD
was identified in Salinispora arenicola and catalyzes the
N1-prenylation at the indole ring in the biosynthesis of the
anti-inflammatory cyclomarin A and the antibacterial
cyclomarazine A (Schultz et al. 2010). Later, four further
bacterial DMATSs catalyzing the prenylations at C-5 and
C-6 of the indole ring were identified from different
Streptomyces s tra ins (Subramanian et al . 2012;
Takahashi et al. 2010; Winkelblech and Li 2014).
Heterologous expression of the 5-DMATS gene
SCO7467 with the flavin-dependent monooxygenase gene
SCO7468 from Streptomyces coelicolor in Streptomyces
l i v i d a n s r e s u l t e d i n t h e f o r m a t i o n o f 5 -
dimethylallylindole-3-acetonitrile (Ozaki et al. 2013).
IptA from Streptomyces sp. SN-593 was found to
prenylate tryptophan at C-6 in the biosynthesis of 6-
DMAI-3-carbaldehyde (Takahashi et al. 2010). 6-
DMATSSa from Streptomyces ambofaciens and 6-
DMATSSv from Streptomyces violaceusniger were identi-
fied as homologs of IptA. 6-DMATSSa and 6-DMATSSv
can also utilize GPP as a prenyl donor and catalyze
Table 3 Examples of prenyltransferases of the CloQ/NphB subgroup and their catalyzed reactions
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prenylations at the same position as for DMAPP, which
had not been reported for tryptophan prenyltransferases
before (Winkelblech and Li 2014).
Tryptophan-containing cyclic dipeptide and related
prenyltransferases
Tryptophan-containing cyclic dipeptide prenyltransferases
catalyze regiospecific prenylations at different positions of
the indole ring, especially at N-1, C-2, C-3, and C-7
(Grundmann and Li 2005; Wunsch et al. 2015; Yin et al.
2009, 2010, 2013a; Zou et al. 2010). Some peptide-related
substances like cyclo-acetoacetyl-L-tryptophan (cAATrp)
or ardeemin FQ, a derivative of the cyclic tripeptide of
anthranilic acid, alanine, and tryptophan, were also identi-
fied as substrates of this subgroup (Haynes et al. 2013; Liu
and Walsh 2009). Until now, 14 enzymes from this group
have been characterized biochemically (Table 5). With the
exception of the two geranyltransferases, LtxC from the
cyanobacterium Lyngbya majuscule and TleC from the ac-
tinomycetes Streptomyces blastmyceticus, all other 12 en-
zymes are identified in fungi of Aspergillus and
Neosartorya species.
The first identified cyclic dipeptide prenyltransferase
was FtmPT1 from A. fumigatus, which catalyzes a regular
C2-prenylation of brevianamide F (cyclo-L-Trp-L-Pro) in
the biosynthesis of verruculogen/fumitremorgins
(Grundmann and Li 2005; Li 2011). Three cyclic
dipeptide reverse C2-prenyltransferases, NotF from an
Aspergillus sp. and BrePT from Aspergillus versicolor in-
volved in the biosynthesis of notoamides as well as
CdpC2PT from Neosartorya fischeri (N. fischeri), were
identified 5 years later (Table 5) (Ding et al. 2010;
Mundt and Li 2013; Yin et al. 2013a). CdpC2PT was
speculated to be involved in the biosynthesis of
fellutanine (Mundt and Li 2013). Recently, a regular cy-
clic dipeptide C7-prenyltransferase CdpC7PT was identi-
fied in Aspergillus terreus (A. terreus) (Wunsch et al.
2015), with much higher regioselectivity and substrate
flexibility toward cyclic dipeptides than CTrpPT, an N1- and
C7-prenyltransferase from Aspergillus oryzae (A. oryzae)
(Zou et al. 2010). CdpC7PT also accepted cyclo-L-Tyr-L-Tyr
as substrate and catalyzed an O-prenylation at the tyrosyl res-
idue, providing the first example from the DMATS superfam-
ily with an O-prenyltransferase activity toward tyrosine-
containing dipeptides (Wunsch et al. 2015). CdpNPT from
A. fumigatus was reported to catalyze an N1-prenylation of
cyclic dipeptides (Yin et al. 2007). The prenylation position
was later revised to C-3 of the indoline ring (Schuller et al.
2012; Yu et al. 2013).
The DMATS enzymes catalyze not only regiospecific,
but also stereospecific prenylations. For example, AnaPT
from N. fischeri is involved in the biosynthesis of
acetylaszonalenin and catalyzes a reverse C3α-
prenylation of (R)-benzodiazepinedinone, while CdpNPT
from A. fumigatus and CdpC3PT from N. fischeri the
reverse C3ß-prenylations of cyclic dipeptides (Schuller
Table 4 Tryptophan prenyltransferases and their catalyzed reactions
Enzyme (accession number) Organism Prenylation Biosynthetic pathway Reference
CymD (ABW00334) Sa. arenicola N1-reverse cyclomarin/cyclomarazine (Schultz et al. 2010)
DmaW (AAC18893) C. fusiformis C4-regular ergot alkaloids (Tsai et al. 1995)
FgaPT2 (AAX08549) A. fumigatus C4-regular fumigaclavine C (Unsöld and Li 2005)
DmaW-Cs (AAZ29613) Periglandula C4-regular ergot alkaloids (Markert et al. 2008;
Steiner et al. 2011)
MaPT (EU4200091) M. aurantiaca C4-regular unknown (Ding et al. 2008)
5-DMATS (EAW08391) A. clavatus C5-regular unknown (Yu et al. 2012)
5-DMATSSc (NP_631515) S. coelicolor C5-regular 5-DMAI-3-acetonitrile (Subramanian et al. 2012)
IptA (BAJ07990) Streptomyces sp C6-regular 6-DMAI-3-carbaldehyde (Takahashi et al. 2010)
6-DMATSSa (CAJ89640) S. ambofaciens C6-regular unknown (Winkelblech and Li 2014)
6-DMATSSv (AEM87819) S.violaceusniger C6-regular unknown (Winkelblech and Li 2014)
7-DMATS (ABS89001) A. fumigatus C7-regular astechrome (Kremer et al. 2007)
7-DMATSNeo (not available) Neosartorya sp. C7-regular unknown (Miyamoto et al. 2014)
A. Aspergillus, C. Claviceps, M. Malbranchea, S. Streptomyces, Sa. Salinispora
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et al. 2012; Yin et al. 2009, 2010). ArdB from Aspergillus
fischeri catalyzes C3ß-prenylation of ardeemin FQ at the
indole ring (Haynes et al. 2013). Investigation with ste-
reoisomers of cyclic dipeptides of tryptophan with proline
or alanine revealed that AnaPT and CdpC3PT catalyze
reverse anti-cis and syn-cis C3-prenylation, respectively.
In contrast, CdpNPT produced both anti-cis and syn-cis
C3-prenylated derivatives (Yu et al. 2013).
The product of a NRPS-PKS hybrid cAATrp was found to
be the substrate of CpaD in the biosynthesis of the fungal
neurotoxin α-cyclopiazonic acid in Aspergillus flavus
(A. flavus) and A. oryzae (Liu and Walsh 2009). CpaD cata-
lyzes the regiospecific C4-prenylation of cAATrp (Table 6)
(Liu and Walsh 2009).
Several cyclic dipeptide prenyltransferases from bacte-
ria use indolactams as substrates and catalyze prenylations
at C-7 of the indole ring. In addition to LtxC mentioned
above (Edwards and Gerwick 2004), the function of TleC
in the biosynthet ic pathway of te leocidin B in
Streptomyces blastmyceticus was also characterized
Table 5 Tryptophan-containing peptide or peptide-related prenyltransferases and their catalyzed reactions
A. Aspergillus, N. Neosartorya, L. Lyngbya, Ant anthranilate, AA acetoacetyl, n.a. not available
a Natural or if unknown the best accepted substrate was given
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biochemically (Awakawa et al. 2014). Gene deletion ex-
periments revealed the involvement of MpnD in the bio-
synthesis of methylpendolmycin in Marinactinospora
thermotolerans (Ma et al. 2012).
Prenyltransferases utilizing other indole
or quinolinone derivatives as prenyl acceptor
In addition to tryptophan and tryptophan-containing cyclic
dipeptide prenyltransferases listed in Tables 4 and 5, eight
members of the DMATS superfamily, which use other indole
derivatives as prenylation substrates, are identified in different
fungal strains (Table 6). These include FtmPT2 and FtmPT3
in the biosynthesis of verruculogen and fumitremorgin A in
A. fumigatus and N. fischeri (Grundmann et al. 2008; Mundt
et al. 2012). FgaPT1 fromA. fumigatus catalyzes a reverseC2-
prenylation, the last step in the biosynthesis of the ergot alka-
loid fumigaclavine C (Unsöld and Li 2006). In addition to the
cyclic dipeptide prenyltransferase NotF, NotC is also involved
in the biosynthesis of stephacidin/notoamides (Ding et al.
2010). TdiB from Aspergillus nidulans (A. nidulans) and
AstPT from A. terreus are involved in the biosynthesis of
prenylated bisindolyl benzoquinones (Balibar et al. 2007;
Schneider et al. 2008; Tarcz et al. 2014). AtmD from
A. flavus and PaxD from Penicillium paxilli use indole diter-
pene derivatives as prenylation substrates (Liu et al. 2013b,
Table 6 DMATS prenyltransferases of other substrates and their catalyzed reactions
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2014a). With the exception of FtmPT3, which catalyzes anO-
prenylation of a secondary alcohol, all other enzymes from
this group carry out reverse or regular prenylations at the
indole ring (Table 6).
Very recently, two members of the DMATS superfamily,
PenI and PenG, have been identified in Penicillium thymicola
and proven to be involved in the biosynthesis of
penigequinolone I. Both enzymes use DMAPP as prenyl donor.
PenI catalyzes the prenylation of the quinolinone core at C-7,
whereas PenG transfers a C5 unit to the dimethylallyl moiety of
the product of PenI, i.e., the elongation of the prenyl moiety by
addition of a second dimethylallyl unit (Zou et al. 2015).
Table 6 (continued)
A. Aspergillus, L. Leptosphaeria, N. Neosartorya, P. Penicillium, T. Trichophyton, n.a. not available
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Prenyltransferases of tyrosine and other aromatic
or nonaromatic substrates
The tyrosine O-prenyltransferase SirD in the biosynthesis of
sirodesmin PL in Leptosphaeria maculans was identified in
2010 as the first member of the DMATS superfamily, which
use nonindole derivatives as prenylation substrates (Kremer
and Li 2010). The second tyrosineO-prenyltransferase TyrPT
of an unknown cluster was identified inAspergillus niger (Fan
et al. 2014). Both enzymes share relatively high sequence
similarity with 7-DMATS from A. fumigatus and also catalyze
theC7-prenylation of tryptophan (Fan et al. 2014; Kremer and
Li 2010).
Since 2010, several enzymes of the DMATS superfamily
were proven to use even polyketide products, e.g., xanthones
by XptB from A. nidulans (Pockrandt et al. 2012),
hydroxynaphthalenes by BAE61387 from A. oryzae
(Pockrandt et al. 2014), or naphtacenedione by VrtC from
Penicillium aethiapicum (Chooi et al. 2010). VrtC utilizes
GPP instead of DMAPP as prenyl donor to generate a
viridicatumtoxin precursor (Chooi et al. 2010). Interestingly,
its homologs from N. fischeri, Microsporum canis, and
Trichophyton tonsurans accepted DMAPP as prenyl donor
and were proven to be involved in the biosynthesis of
neosatoricin (Chooi et al. 2012, 2013; Yin et al. 2013b).
More interestingly, PAPT from Phomopsis amygdali cat-
alyzes an O-prenylation of the glucose moiety in the
biosynthesis of fusicoccin A (Noike et al. 2012). It
should be mentioned that all of the enzymes described
here were identified in fungi.
Crystal structures of DMATS prenyltransferases
providing basic knowledge for understanding
the prenylation reactions
Determination of the crystal structure of the first indole
prenyltransferase FgaPT2 was a fundamental step in the ad-
vanced understanding of prenyltransferases of the DMATS
superfamily and their reaction mechanisms (Metzger et al.
2009). FgaPT2 revealed an unusual PT-barrel fold, formed
by ten antiparallel ß-strands surrounded by ten α-helices
(Fig. 3). The active site is located in the center of the barrel,
and the absence of any metal ion in this area is consistent with
the independency of divalent metals for enzyme activity.
Interestingly, this architecture has been already observed for
the bacterial hydroxynaphthalene prenyltransferase NphB
(Kuzuyama et al. 2005), although its primary amino acid se-
quence and active site differ substantially from that of
FgaPT2. The structural information, gained from this work,
allowed the first understanding of the enzymatic catalysis and
also supported the hypothesis of a common evolutionary ori-
gin of the bacterial and the fungal prenyltransferases of the
ABBA-family (Luk and Tanner 2009; Metzger et al. 2009). In
2010, the crystal structure of the cyclic dipeptide C2-
prenyltransferase FtmPT1 was solved (Jost et al. 2010),
Fig. 3 Structures and enzyme reactions of FgaPT2 (a), FtmPT1 (b), CdpNPT (c), and AnaPT (d)
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followed by the structures of two tryptophan-containing cyclic
dipeptide C3-prenyltransferases CdpNPT and AnaPT in 2012
and 2013 (Schuller et al. 2012; Yu et al. 2013). Currently, the
crystal structures of FgaPT2, FtmPT1, CdpNPT, and AnaPT
are available in their unbound states. In addition, three of them
(FgaPT2, FtmPT1, CdpNPT) were crystallized together with
their aromatic substrates and an unreactive analog of DMAPP
DMSPP (dimethylallyl S-thiolodiphosphate) or SPP (S-
thiolodiphosphate). Comparison of the crystal structures re-
vealed that they share a similar secondary core structure with
the already described PT-barrel fold (Fig. 3). The amino acids
in the DMAPP binding site seem to be strictly conserved in
these four structures, whereas the binding sites of the aromatic
substrates differ from each other. This feature makes molecu-
lar modeling with unknown structures more difficult.
Therefore, additional enzyme structures from this superfamily
are required. Nevertheless, the detailed structure analysis of
the liganded and unliganded structures provides important in-
sight into the catalyzed reaction mechanisms (Jost et al. 2010).
Prenylations catalyzed by the enzymes of the DMATS super-
family were proposed as three-step reactions. They begin with
the formation of a dimethylallyl cation by removal of the
pyrophosphate group, which was proven by a positional iso-
tope exchange with O18-labeled DMAPP (Luk and Tanner
Fig. 4 Phylogenetic relationships of different prenyltransferases (PTs).
The phylogenetic tree was created by using the programs ClustalX2
(http://www.clustal.org/) and Treedyn (www.phylogeny.fr). In addition
to enzymes listed in Tables 2, 3, 4, 5 and 6, cis- and trans-PTs, peptide
and tRNA PTs as well as α- and β-subunits of protein PTs are also
included. The accession numbers or pdb codes of the enzymes are
given in parenthesis
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2009). The subsequent nucleophilic attack of this cation by the
indole nucleus or other electron-rich atoms to form the σ-
complex defined the second step. Then, the resulting arenium
intermediate was deprotonated to generate the final product
(Fig. 3a). The most controversial issue of this mechanism
focused on the second step, whether an electrophilic aromatic
substitution mechanism occurs directly at the site of substitu-
tion or as results of rearrangements after initial prenylation at
C-3 of the indole ring to generate the final product (Luk et al.
2011; Mahmoodi et al. 2013; Mahmoodi and Tanner 2013;
Tanner 2014). Furthermore, these results could be applied for
generation of modified prenyltransferases by modeling and
site-directed mutagenesis experiments. For example, the en-
zymatic reaction of FtmPT1 was modified by a single point
mutation to perform a reverse prenylation at C-3 of the indole
nucleus instead of a regular C2-prenylation.
Phylogenic relationships of different
prenyltransferases
To get insights into the phylogenetic relationships of
prenyltransferases, enzymes listed in Tables 2, 3, 4, 5, and 6
and examples of prenyl diphosphate synthases as well as pep-
tide, protein, and tRNA prenyltransferases were analyzed and
illustrated as a phylogenetic tree in Fig. 4. The phylogenetic
analysis confirmed the diversity of prenyltransferases, which
are located in different clades. The membrane-bound
prenyltransferases from different sources are grouped togeth-
er, while the enzymes of the CloQ/NphB group build a de-
fined clade. The members of the DMATS family are found in
two clades, one with fungal and another with bacterial origin.
The cis- and trans-prenyltransferases of prenyl diphosphate
synthases are clearly separated from each other. The relation-
ships among peptide prenyltransferases appear to be very far.
This is also observed for tRNA prenyltransferases.
Conclusion and outlook
In this review, we demonstrated the sequence, biochemical,
and structural diversities of prenyltransferases, which catalyze
the transfer of nxC5 units to different acceptors such as prenyl
moieties, peptides, proteins, tRNAs, and aliphatic or aromatic
small molecules (Dumelin et al. 2012; McIntosh et al. 2013;
Palsuledesai and Distefano 2015). As given in Fig. 4, enzyme
groups mentioned in this review can be found in different
clades.
Prenyltransferases play important roles in primary and sec-
ondary metabolism as well as in the cellular regulation (Heide
2009a; Palsuledesai and Distefano 2015; Yazaki et al. 2009;
Yu and Li 2012) . The most in tens ively s tudied
prenyltransferases belong to the DMATS superfamily, which
are mainly identified in fungi, but also in bacteria. They are of
great importance for the biosynthesis of secondarymetabolites
in microorganisms. Until now, no example from this group
was known from plants and animals. To date, over 40 mem-
bers of the DMATS superfamily have been identified and
characterized biochemically, and crystal structures of four
members are available. Members of this family do not require
metal ions for their transfer reactions. Most of these enzymes
utilize DMAPP as prenyl donor and an aromatic scaffold as
prenyl acceptor, e.g., tryptophan, tyrosine, tryptophan-
containing cyclic dipeptides, or other indole derivatives.
With the first solved crystal structure of the 4-DMATS and
its unexpected PT-barrel, new insights into reaction mecha-
nism, substrate binding, and evolutionary origin were gained.
As demonstrated in the last years, mining of available ge-
nome sequences has proven to be a convenient approach for
identification of putative prenyltransferase genes. It can be
expected that additional prenyltransferases with new features
will be identified in the next years. Prenyltransferases, espe-
cially the members of the DMATS superfamily, show a high
potential for production of biologically active low molecular
weight compounds by in vitro catalysis or by synthetic biolo-
gy. This has already been demonstrated by a large number of
studies on their substrate and catalytic promiscuity in the last
years. This aspect will be discussed in another mini-review in
the same issue in detail. Moreover, elucidation of further
prenyltransferase structures would provide new chance and
challenge for a better understanding of their functionality.
This in turn will enable us to create modified enzymes with
special features, e.g., changes in substrate specificity, regiose-
lectivity, and stereoselectivity.
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5. Conclusions and future prospects
In this thesis, we gained new insights into the biochemical properties of enzymes belonging to 
the DMATS superfamily regarding their substrate specificity toward donor and acceptor, 
regioselectivity and enantioselectivity. Moreover, the obtained results expand significantly the 
potential usage of microbial DMATS enzymes in chemoenzymatic synthesis. 
At the beginning of this thesis, only limited information about bacterial tryptophan 
prenyltransferases was available and investigations were focused on enzymes from fungi of 
ascomycetes. Bioinformatic analyses led to the finding of several putative tryptophan 
prenyltransferases in bacteria of actinomycetes. Subsequently, three new enzymes were 
identified as tryptophan C6-prenyltransferases 6-DMATSSa, 6-DMATSSv, and 6-DMATSMo. 
Comprehensive investigations on their biochemical properties revealed several interesting 
aspects and expanded significantly our knowledge on bacterial tryptophan prenyltransferases. 
The three 6-DMATSs show a high substrate flexibility toward both prenyl donor and acceptor 
with a strict regioselectivity toward the prenylation position on the indole ring. In addition to a 
number of tryptophan derivatives, also cyclic dipeptides and naphthalene derivatives were 
accepted by these enzymes. Moreover, 6-DMATSSa and 6-DMATSSv used as first examples 
DMAPP and GPP as prenyl donor with same prenylation positions. This high regioselectivity 
was also observed with unnatural donors demonstrated in the advanced study on the acceptance 
of MAPP, 2-pentenyl-PP and benzyl-PP by DMATS enzymes.  
This study complemented the previous projects by investigations on additional bacterial C5-
prenyltransferase 5-DMATSSc, two C6-prenyltransferases 6-DMATSSa and 6-DMATSSv and 
the C7-prenyltransferase TyrPT. The three unnatural DMAPP analogs were accepted by all five 
enzymes with different enzyme activities and regioselectivities. Thereby, C6-alkylation or 
benzylation was preferred by the tested prenyltransferases. Following these results, the 
synthesis of new interesting compounds could be facilitated by the mentioned enzymes as 
biocatalysts. In a further study, the enantioselectivity of seven DMATSs was elucidated, 
initiated by the high relative activity of 6-DMATSMo toward D-tryptophan. Different behaviors 
in regioselectivity and substrate preference toward the L- and D-enantiomers of tryptophan and 
methylated derivatives were observed. Remarkable results were obtained in several cases 
including the reduced regioselectivity of FgaPT2, 5-DMATSSc and 7-DMATS in the presence 
of D-tryptophan. In addition, the C5- and C6-prenyltransferases 5-DMATSSc and 6-DMATSMo 
from Streptomyces accepted the D-enantiomer of 5-methyltryptophan much better than the L-
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enantiomer, although in all other reaction mixtures the L-enantiomer was the better substrate. 
These findings demonstrate that the stereochemistry of the substrates strongly influence the 
enzyme activity and that the behavior of the DMATSs toward the enantiomers differ from each 
other. Furthermore, the enantioselective prenylation of tryptophan and substituted derivatives 
provides new chances for the synthesis of promising biological active compounds. 
The following projects are to be addressed in the future 
 Identification and characterization of further indole prenyltransferases from
actinomycetes.
 Elucidation of the natural function of different gene clusters containing the
prenyltransferase genes by gene deletion experiments or heterologous expression of the
whole gene clusters.
 Protein crystallization and subsequent structure analysis, especially for bacterial
tryptophan prenyltransferases to clarify the reaction mechanism in detail. Protein
structures as complexes with distinct acceptors and donors including natural and
unnatural DMAPP analogs would be useful for understanding their biochemical
properties such as regioselectivity or substrate specificity.
 Mutational analysis to create enzymes with modified biochemical features e.g. substrate
specificity. For instance, in order to increase the acceptance to special donors or to
increase the relative enzyme activity toward D-enantiomers.
 Testing bioactivity of new unnatural compounds synthesized by DMATSs.
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